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Abstract 
Self-assembling peptides (SAPs) have attracted interest due to their potential value in 
therapeutics. The 11-residue family of peptides (P11-X), are able to self-assemble hierarchically 
into β-sheet tapes with higher order structures (ribbons, fibrils and fibres) being produced 
depending on peptide concentration. Previous studies of P11-X peptides aimed at tissue repair 
focused on hydrogel formats where their potential for deposition of hard tissue minerals in vivo 
was demonstrated due in part to their ability to mimic the physiochemical properties of natural 
extracellular matrix (ECM) of bone. However, SAP hydrogels are often associated with 
inherently weak and transient mechanical properties, which make their handling and fixation 
challenging in large load-bearing tissue defects. Accordingly, to engineer a more robust 
scaffold, the present research demonstrates the feasibility of producing electrospun webs 
composed of a biodegradable polymer, poly (e-caprolactone) (PCL) commixed with either P11-
4 (Ac-QQRFEWEFEQQ-Am) or P11-8 (Ac QQRFOWOFEQQ-Am) self-assembling peptides. 
Morphological features of the electrospun webs investigated via scanning and transmission 
electron microscopies (SEM and TEM) revealed that PCL/P11-4 and PCL/P11-8 electrospun 
webs contain fibres in both nano- (10–100 nm) and submicron ranges (100–700 nm), whereas 
PCL fibre webs, produce a predominantly submicron fibre distribution. Homogeneous 
distribution of SAPs within the electrospun fibres was revealed via confocal microscopy. . 
Furthermore, it was discovered by spectroscopic analysis that SAPs exist entirely in their 
monomeric state in the electrospinning solution, and convert from monomeric form to β-sheet 
secondary conformation when converted into fibres. PCL/SAP fibres were shown to exhibit 
enhanced hydrophilicity compared to PCL-only fibres, and induce no cytotoxic response when 
cultured with L929 mouse fibroblasts. A study of the release kinetics of SAP from PCL fibres 
II 
 
in simulated conditions of biological pH (neutral pH of 7.4) after 7 days revealed at least 75% 
of P11-4 and 45% of P11-8 still remained, suggesting potential for long-term therapeutic 
delivery. Finally the ability of SAP embedded PCL fibrous scaffold to nucleate and support 
growth of bone minerals was investigated using two in vitro assays, specifically the simulated 
body fluid (SBF) method and the in vitro nucleation (IVN) tank method. PCL/SAP fibres were 
found to nucleate and support spheroidal growth of hydroxyapatite crystals and were capable 
of comparable mineral nucleation performance as SAP hydrogels. 
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CHAPTER 1 
 
 Introduction 
1 Introduction  
The loss or failure in tissues or organs is one of the most common human health issues (1). The 
prevalent approaches for treatment of tissue/organ loss or failure are transplantation or 
implantation of donor tissue or devices (2). However because of the increasing number of 
patients in need, compared to the number of donors, in the United States alone, approximately 
a quarter of patients requiring organ transplants die while waiting for a suitable donor (3). 
Currently, there is a global population projection of six hundred million people aged sixty five 
and above (4) and the number of people in this category is expected to double within the 
following twenty five years (5), due to decreasing birth rates in developed countries. In 
particular, a substantial number of patients suffer from damaged bones due to trauma, tumours 
or other bone related disease or incidents. Given the aging population, bone or tooth tissue loss 
due to pathologies such as osteoporosis or periodontal disease is a major challenge (6). The 
current therapies for such diseases are bone repair or replacement by either implantation 
devices, allogeneic transplantation of bone tissue from one person to another, or autologous 
bone grafts. The latter technique involves using a donor site as bone replacement material from 
within the patient’s own body, which minimises the risk of immune response complexities (7). 
However, there are number of clinical challenges associated with these therapies, first of which 
is the need for highly invasive surgery. Moreover, autologous therapy causes additional trauma 
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in the donor site of the patient and there is a limit to the amount of bone that can be transplanted 
from donor sites in each person. Owing to the challenges of current therapies, together with the 
increase in demand, due to the aging global population, the need for alternative bone related 
therapeutic strategies is growing. 
1.1 General Tissue Engineering  
Tissue engineering is an emerging field involving the regeneration or repair of living tissue 
using devices known as scaffolds to guide the process and therefore reduce reliance on donated 
tissues and organs or permanent implantable devices that replace biological tissues (1). In tissue 
engineering, by using living cells or stimulation of endogenous cells, the tissue can be formed 
or regenerated in vitro or in vivo (8). This field of science has the potential to bring dramatic 
improvements in medical healthcare for hundreds of thousands of patients annually, and 
equally dramatic reductions in medical costs as it is an alternative for tissue transplantation and 
also medical implants.  
A central component in tissue engineering is the design of a scaffold into which living cells are 
supported so that neo-tissue formation can develop. Two main approaches are possible. In the 
first, a scaffold is seeded with cells and the tissue is cultured in vitro before it is implanted in 
the defect as a prosthesis. Alternatively, the scaffold can be directly implanted into the defect 
either pre-seeded with a relevant cell type or not, to maintain a space for attraction and 
stimulation of endogenous cells and eventually tissue formation in vivo (9).  The scaffold must 
fulfil several criteria such as biocompatibility and degradability capable of supporting three-
dimensional tissue formation. These scaffolds should normally be highly porous with 
interconnected pores to allow cellular integration and also provide sufficient surface area for 
cell attachment and cell migration. Bioactive surfaces, which assist in the processes of cell 
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deposition, proliferation and tissue growth, are of keen interest to tissue engineers since they 
have the potential to contribute to improved tissue regeneration (1, 10). 
One of the most active areas of tissue engineering is mineralised tissue regeneration. 
Mineralised tissues are biological composite tissues in which minerals are incorporated into 
soft matrices. The hard tissues consist of mainly collagen type I fibres and the mineral phase 
of hydroxyapatite (HAP) (11). The scaffold for mineralised tissue/bone regeneration must be 
of materials that can mimic composition and structure of the extracellular matrix (ECM) of 
bone tissue. To date, different strategies have been investigated for bone regeneration including 
cell-based therapies, scaffold-based repair or those involving the use of osteogenic growth 
factors (12).  
1.2 Electrospun Polymer Webs as Tissue Engineering Scaffolds 
Fibrous media are commonly used in medical and applied healthcare and hygiene products 
such as wound dressings, drug delivery, blood filtration and tissue engineering (13). 
Electrospinning is a simple technique for the production of polymeric nanofibres, the 
fundamentals of which have been known since the work of Formhals in the 1930s (14). In this 
method, a high voltage is used to build sufficient electrostatic forces to induce charge repulsion 
that can overcome the surface tension of polymer solution, and a fibre jet is formed at the tip 
of a capillary (10, 15). Fibrous nonwoven webs can then be deposited on a collector with fibre 
diameters ranging from micron down to nanometre-scale (16). Control of fibre diameter and 
morphological features is readily achieved by varying process parameters (17). Electrospun 
fibre webs are promising structures for use in tissue engineering because of the structural 
similarity to natural extra cellular matrix (ECM), and applications in tissue engineering have 
been extensively studied (10, 14, 18-21). The very small fibre diameters and high surface area 
to volume ratio are beneficial for cell attachment and the high porosity and pore 
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interconnectivity are conductive to tissue growth. The electrospinning technique is also very 
versatile, because it allows spinning of different synthetic and natural polymers or blends, as 
well as the incorporation of bioactive materials, or inorganic materials to tailor properties to 
suit different application criteria (22).   
In addition to the structural features of electrospun fibres that can mimic the fibrous 
architecture of the ECM (23), the material composition should be non-toxic and induce the 
intended response of tissue components in vivo or in vitro (19). Biocompatible synthetic 
polymers that have been successfully electrospun include aliphatic linear polyesters such as 
polyglycolic acid (PGA) (24), polylactic acid (PLA) (25, 26) and polycaprolactone (PCL) (15, 
27). Among these, PCL is low-cost, non-toxic and biodegradable and it can be used in FDA 
approved devices such as for drug delivery and tissue engineering (27, 28). 
PCL has been extensively investigated in relation to various biomedical applications, including 
regenerative bone therapies (29-32) in which it has been shown to support the attachment and 
growth of different cell types (22, 29, 33-35). However, due to the lack of cell-binding 
sequences along its polymeric backbone and its hydrophobicity, PCL must be modified by 
means such as plasma treatment, coating, or blending it with bioactive natural polymers (27, 
36, 37).  
Several studies have been reported in which electrospun PCL has been enhanced in terms of 
bioactivity and hydrophilicity, for example by coating with bioactive materials such as self-
assembling peptides (SAPs) or by surface modification (36, 37). To avoid post-treatments, 
biofunctional components can also be blended with PCL to form spinning solutions from which 
electrospun fibres can be directly manufactured in a one step process (32, 38, 39). The resulting 
fibres containing peptide not only exhibit higher bioactivity and wettability compared to that 
of PCL alone, but also improved cell adhesion and proliferation. 
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1.3 Self-assembling Peptides 
Amongst the various materials shown to be biocompatible and hold great promise for tissue 
regeneration in biological conditions are self-assembling peptides (SAPs). SAPs have been the 
focus of research in the last two decades due to their ability to spontaneously assemble into 
ordered nanostructures enabling engineers to manufacture “designer” nanomaterials from the 
bottom-up. Specifically, they have been the focus of research in light of their potential 
application in hard and soft tissue repair (40, 41). They have also potential applications in other 
medical and healthcare devices such as wound dressings, surgical patches, as well as in 
molecular electronics and numerous other applications (42, 43). 
Rationally designed SAPs are composed of amino acidic building blocks that can mimic 
specific molecular features of ECM found in native tissues, such as the RGD cell-binding 
peptide sequence (42) and facilitate the enhancement of cell growth on biomaterials (44-46). 
Designing different primary peptide structures by applying various amino acid side chains and 
altering peptide sequences, enables the physical and biological properties of peptides to be 
tuned according to the intended end use (42).  
The 11-residue family of peptides (P11-X) consists of negatively or positively charged 
hydrogelating materials. They self-assemble hierarchically into long β-sheet tapes (a single-
molecule thick), ribbons (two stacked tapes), fibrils (multiple stacks of ribbons) and entwined 
fibrils (referred to by some as fibres), following application of external stimuli (46). Above a 
critical concentration (C*), peptide monomers assemble into hydrogen bonded β-sheet tapes, 
with higher order structures being produced if the concentration is further increased. This class 
of peptides also undergoes pH (47) and ionic strength-triggered (48) self-assembly which can 
be relevant for their applicability as drug delivery vehicles. So far, most of the published studies 
using P11-X peptides have focused on the molecular design of self-supporting gels, whereby 
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promising properties have been shown with regard to cell growth and specifically hard tissue 
deposition (42, 44, 46, 49). Once self-assembled, these peptides can produce three-dimensional 
scaffolds which mimics the ECM of hard tissues and they can induce mineral deposition in situ 
(50).  
Furthermore, peptide P11-4 (-2 charge) and P11-8 (+2 charge) specifically have shown low 
immunogenicity in vivo and no cytotoxic effect to human and murine cells (46, 51, 52) and 
enhanced bone tissue regeneration (50, 53-55). However, despite their inherent 
biofunctionality, self-assembled peptide gels frequently suffer from poor mechanical strength 
and lack of structural stability. This potentially makes their handling and fixation during 
implantation challenging, particularly in large load-bearing tissue defects. Attaining 
mechanically competent scaffolds capable of supporting cell growth spatially and temporally 
until the newly engineered tissue is formed, is one of the major challenges in the design of 
SAP-based medical devices. Given the practical benefits of electrospun fibres in tissue 
engineering mentioned in Section 1.2, the incorporation of SAPs within water-stable PCL 
electrospun fibres is a potential route to address this challenge, and to deliver the SAPs in a 
structurally reinforced fabric (32, 36, 37). 
1.4 Aims and Objectives 
The incorporation of self-assembling peptides within polymeric fibres is a potential route to 
address the challenges associated with mechanical properties of SAPs as well as to enhance the 
biocompatibility of nonwoven fabrics composed of synthetic polymers such as PCL for 
applications in bone tissue engineering. Accordingly the aim of this work is to investigate 
whether a structurally stable fibrous architecture can be accomplished in one-step via 
electrospinning solutions of two peptides (P11-8 and P11-4) combined with PCL. This study 
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focuses on the electrospinning of SAPs within fibres and experimental characterisation of the 
structure and properties of resulting fibrous assemblies.  
The specific objectives of the study are: 
 To investigate the feasibility of combining self-assembling peptides (SAPs), P11-4 and 
P11-8, with PCL in a one-step manufacturing process and produce electrospun fibre 
webs. 
 To characterise the morphology of resulting fibres and electrospun networks and 
develop an understanding of how SAP self-assembly is affected by manufacturing 
conditions during and after electrospinning. 
 To investigate the peptide release kinetics and behaviour of PCL/SAP fibre in biological 
conditions by studying the behaviour of PCL/SAP fibres in aqueous environment.  
 To determine the cytocompatibility of PCL/SAP fibres and to evaluate the apatite-
formation ability of electrospun PCL/SAPs fibres to understand their potential 
suitability for hard tissue regeneration.  
The outcome of this study will ultimately contribute to the design of an enhanced tissue scaffold 
device for use in hard tissue regeneration.   
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CHAPTER 2 
 
Review of Literature  
2 Review of Literature  
2.1 Introduction  
This chapter critically reviews relevant science and technology related to bone tissue 
engineering and is intended to lay a foundation for the experimental work that follows. 
Moreover, a brief introduction of the background to bone tissue regeneration is provided 
including biological apatite, mineral nucleation, biomineralisation and mineralised tissue. This 
is followed by discussion of the challenges of mineralised tissue repair and tissue engineering 
as a novel approach, and the required scaffold characteristics relevant to hard tissue. 
Furthermore, a discussion of taking a biomimetic approach in relation to self-assembling 
peptides in scaffolds is included. Finally, given the importance to the experimental work, a 
brief review of electrospun scaffolds is presented.   
2.1.1 Principles of Mineral Crystal Nucleation and Secondary Crystal Growth 
Crystal nucleation is defined as the initiation of new mineral phase formation (56). According 
to basic thermodynamic principles, the minerals in a solution, liquid, or vapour can be arranged 
in a crystalline pattern by which a transition from a high-energy state to a low-energy state 
occurs. One of the driving forces behind crystal nucleation is supersaturation, when there is 
more solute in solution than the amount that can be dissolved by the solvent under standard 
temperature and pressure (56, 57). The nucleation process can occur either 
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heterogeneously or homogeneously. In the former, an external interface is needed upon which 
a number of particles (ions, atoms or molecules) will be deposited and arranged to form 
crystals. The surface can be of any substance such as dust particles, phase boundaries or the 
wall of a glass container. However, in homogenous nucleation without any pre-existing nuclei, 
the particles can gather in a correct position while they are moving randomly in the bulk of a 
medium (58). To create a solid surface, a certain amount of energy is required which is equal 
to the total surface tension of its area. In nucleation, solid surface formation will be 
homogenous when a solution with a certain level of internal energy reaches a lower state of 
energy by deposition of particles and formation of solid surface. Based on the Gibbs free energy 
concept, the total interfacial energy of the created solid should be lower than the total existing 
energy of the solution in the first place. Therefore a specific amount of free energy will be 
released upon the formation of a new phase. Heterogeneous nucleation more readily occurs, 
since less energy is required to overcome the interfacial energy at the surface of the nucleation 
sites because their effective surface energy is lower (59).    
Once the nucleation has occurred and a crystal is formed, additional particles can be deposited 
and further crystal growth can take place (58). The processes of nucleation and further growth 
of mineral crystals are the basis of mineralisation. 
2.1.2 Biomineralisation 
Biomineralistaion is an active or passive procedure during which, a living organism generates 
and deposits inorganic-based structures (minerals) for its own functional requirements (60). 
Biomineralisation includes the specific extraction and take-up of minerals from the nearby 
environment and the interaction of them with extracellular organic molecules, which results in 
incorporation of them into functional structures (60).  
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2.1.3 Biological Apatite 
The name ‘apatite’ stands for a family of phosphate minerals that have similar structures but 
potentially different compositions. It most usually refers to hydroxyapatite (HA), 
fluorapatite or chlorapatite. In 1926, it has been identified for the first time that calcium and 
phosphate are the main components of bone and teeth after chemical analysis of enamel, dentin 
and bone in humans (61). Later on, the similarity in X-ray diffraction (XRD) patterns of these 
tissues to those of HA, evidenced the fact that the inorganic phase of human mineralised tissues 
is principally HA with the chemical formula of Ca10(PO4)6(OH)2 (61, 62).  However, there is 
some complexity in biological HA structure, as there may often be impurities in the mineral 
composition.  For example, it may be calcium deficient and enriched with CO32- that replace 
PO43- ions (60). This is known as carbonated apatite, and there are several other calcium 
phosphate phases in different biological mineralised tissues, with differences in compositional 
chemistry. For example, the amorphous calcium phosphate phase (Ca8 H2 (PO4)6) is often 
present in early stage mineralised bone or cartilage. After that, while the mineralisation builds 
up more and more, the calcium phosphate phase within the tissue can become more crystalline 
and is readily transformed to HA. Therefore, for most purposes, Ca10 (PO4)6(OH)2 is considered 
the main calcium phosphate composition of mineralised tissues, and during the course of this 
study bone minerals are referred to hydroxyapatite (HA) with this compositional chemistry 
(60).  
2.2 Mineralised Tissues  
2.2.1 Bone  
Bone is one of the hard, mineralised tissues and its function is protection and mechanical 
support, load bearing, and it contributes towards movement as well. Because bone is 
continuously engaged in a cycle of mineral growth, dissolution and remodelling (in response 
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to internal/external signals), it is often known as a ‘living mineral’. The architecture of bone is 
composed of mineralised HA organised within a fibrillary matrix of collagen, glycoproteins 
(protein with sugar side chain) and other type of proteins. This composite of organic and 
inorganic elements can provide mechanical strength in bones and increased stiffness in 
comparison with HA alone (60, 63). The arrangement of collagen fibres together with the 
amount of mineral content in bone, which controls the level of toughness, can contribute in 
different types of bone based on their specific functions (63). In immature bone, also known as 
woven bone, which is formed primarily, collagen fibres are irregularly arranged with a low 
concentration of mineral deposition. This bone will later be replaced by mature or lamellar 
bone which itself is classified into two types; compact bone (also called dense or cortical bone) 
and trabecular bone (also called cancellous or spongy bone). Cortical bone is dense and has a 
very ordered basic structure whereas cancellous bone is less dense and is often referred to as 
‘spongy bone’ (63). A network of interconnected cells exists within the mineralised structure 
of the bones as well. There are essentially three major cell types; osteoblasts, osteoclasts and 
osteocytes that play a role in modelling and remodelling of bone (63). The first two cell types 
are based at the surface of the bone whereas osteocytes are based in the centre. Osteoblasts 
contribute to bone modelling, which is the process by which bone is constructed. Osteoclasts 
then resorb old bone which will be replaced by new bone made by osteoblasts (64). Bone 
remodelling is defined as the reconstruction of bone during life according to necessity. 
Osteocytes can sense when a change in mechanical pressure and workload happens and 
accordingly they can send chemical or electrochemical signals to the surface of the bone. This 
is to activate osteoblasts or osteoclasts to either begin mineralisation and strengthening of the 
bone or resorbing and reordering of the bone (63, 65).   
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2.2.2 Teeth  
Teeth are another type of mineralised tissue in body, which like bone, have a structure that is a 
complex system able to resist different types of mechanical forces. They are essential organs 
not only for chewing, but also play a role in speech as well.  The outer layer of the tooth, which 
is visible above the gum is called the crown, and it has a coating in the form of a layer of enamel 
which protects the underlying structure. Enamel is the most highly mineralised and hardest 
tissue in the human body, composed of 96% (by weight) of highly crystalline HA (60). The 
remaining proportion is made of organic matrix and water. This large proportion of mineral in 
enamel contributes not only to its strength but also makes it brittle. The firmly packed rows of 
calcium phosphate crystals, originally form within a protein matrix structure, after which the 
fibrillary structure is progressively removed, while the biomineralisation matures and develops 
(66). Unlike bone, enamel is not a living tissue and it cannot undergo the remodelling process 
because its extracellular matrix disappears during the maturation stage of enamel formation. 
Dentine is an elastic mineralised component of the tooth that resides beneath the enamel. It is 
a softer tissue than enamel (composed of 65% by weight of mineralised HA crystals) and it 
contains fibrous collagen matrix as well, which contributes to improved energy absorption. The 
apatite content provides strength and the collagen provides toughness to dentine (67). The 
structure and composition of dentine is comparable to bone and it is able to remodel itself. Pulp 
is a soft connective tissue, which is the central component of the tooth and is known as the 
most vital part of tooth. The primary function of pulp is the formation of dentin. Within the 
pulp, there is a vascular network to supply nutrients to the tooth together with nerves to provide 
sensory function e.g. pain or temperature (68, 69). Figure 2-1 displays a schematic diagram of 
these tissues which form a tooth.   
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Figure 2-1. Schematic diagram indicating the main tissues of tooth (70). 
 
2.2.3 Clinical Challenges in Mineralised Tissue Repair 
There are several diseases associated with mineralised tissues in the human body, which may 
result in tissue loss, a decrease in bone mineral density or a loss of functionality. There is 
expected to be a doubling of the incidence in the number of these disorders and conditions by 
2020, owing in part to the worldwide ageing population (71, 72). In general these disorders 
result from diseases or trauma such as traffic accidents, injuries sustained during war, or 
fighting, primary or secondary tumours related to the bone, chronic joint diseases in older 
people, crippling diseases and deformities in children, rheumatoid arthritis and spinal disorders. 
Moreover, there are metabolic disorders such as osteoporosis, in which bone formation and 
resorption is unbalanced, which may cause severely weakened and fragile bones in patients 
(72).   
Conventionally, the therapy for such disease is the removal of tissue and replacement with 
either implantable devices (alloplasts) or bone grafts. Bone grafting itself is divided into three 
categories: (i) autografts (self-donated tissue transplantation); (ii) allografts (tissue donated 
from another human) or (iii) xenografts (transplantation of a tissue harvested from another 
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species). Of  these options, autografts are considered the ‘Gold Standard’ because of their 
relative histocompatiblity and non-immunogenicity compared to allografts or xenografts, 
which carry risks of post-operative infection or disease transmission (71, 73). However in 
autologous implants as well, since the donor tissue has to be taken from another healthy tissue 
of patient’s own body, there is always a limited supply and it necessitates invasive surgery that 
can result in increased time for anaesthesia and blood loss (74). In addition to limited 
availability, immune rejection, pathogen transfer and donor site disruption challenges, there 
are substantial cost issues associated with these therapies. In the United States alone, bone 
defect repair cost more than US$ 2.5 billion per year (72). The drawbacks associated with  
current bone repair therapies have initiated a search for alternative strategies related to bone 
tissue engineering over the last two decades, which ideally eliminates many of the existing 
clinical challenges (71).  
2.3 Tissue Engineering 
The purposes of tissue engineering are to restore, maintain, or enhance tissue function and it is 
a rapidly developing field dealing with multiple challenges that are encountered in medical 
practice (42). Tissue engineering has been an emerging research field for the last few decades 
and combines biomaterial and biochemical engineering with cell transplantation therapies to 
reconstruct defects and recover tissues of bio-organisms (75). Any injuries that may cause 
organ and tissue loss or failure in a body can be a major human health problem. Tissue or organ 
transplantation and medical implants have been standard therapies to treat such patients, 
however in terms of transplants, there is a large mismatch between supply and demand of 
organs and tissues for transplantation. In the United States alone, approximately a quarter of 
patients die as a result of waiting for a suitable donor (76, 77). Other therapies such as cellular 
therapy, synthetic prosthesis, medical implants or drug therapy, have their own potential 
problems. For example prosthesis and medical implants cannot deliver all of the functionalities 
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of the native organ or tissue (76), and cellular therapy has not been completely successful as 
full control of cell accumulation and cell-to-cell interaction is not easily achieved without 
providing any extracellular support for injected cells (78). 
In tissue engineering, a suitably engineered 3D scaffold containing appropriate bioactive 
chemistry, is placed into a tissue defect to guide the regeneration of the tissue or to assist in the 
restoration of the function of the organ. The scaffold is either seeded with metabolically active 
cells and cultured in vitro before implantation, or it first implanted into the tissue defect, after 
which attachment, migration, and differentiation of endogenous cells takes place, and the 
defected tissue is regenerated in vivo (75, 79). Therefore, developing tissue scaffolds capable 
of being transplanted into a living body to regenerate or restore body tissues with their natural 
functions, is the fundamental challenge in tissue engineering (80). If successfully achieved, this 
approach makes transplantation without a donor a reality.  
So far, since the first clinical application of tissue engineering as a bio-artificial skin to treat 
burn injuries in 1990 (81), other applications include regeneration of liver tissue (82), pancreas, 
intestine, urothelium, esophagus, nerve (83), valve leaflet, cartilage (84), bone (85, 86), 
ligament, and tendon (76). 
2.3.1 Engineering of Mineralised Tissues 
One of the promising areas for tissue engineering is hard tissue engineering. Given the 
challenges involved in the repair of mineralised tissues (Section 2.2.3) and specially treatment 
of large bone defects, bone tissue engineering can play a major role in providing an alternative 
approach to speed up healing of bone in all musculoskeletal disorders and injuries. 
Understanding of bone structure, mechanics and function is crucial to successfully regenerate 
or repair bone. Moreover, the newly restored bone has to perform the functions of native bone 
and it has to fully integrate with the neighbouring host bone (71). Currently, there are different 
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approaches being investigated in bone tissue engineering including cell based and cell free 
strategies, as well as those using osteogenic growth factors or genetic engineering (12). Cell 
based strategies are those utilising live and metabolically active cells of different types from 
the host body (autologous cells) or other donors (exogenous cells), and transplantation of them 
into a tissue defect. In this method, the cells have to be expanded in vitro prior to seeding onto 
scaffolds and subsequent implantation. The 3D scaffold is used to provide additional 
mechanical and structural support and direct ingrowth of the tissue both before implantation 
(in vitro) and after that (in vivo). Moreover growth factors, which are a family of proteins 
capable of controlling the activity of tissue-specific cells, specifically  bone morphogenetic 
proteins (BMPs), can be introduced into scaffolds before implantation to enhance the 
remodelling of bone tissue (87). To improve the success of artificial bone graft substitutes, 
gene therapy can also be employed by delivering specific genes into cells or tissues (88). This 
classical tissue engineering approach has faced numerous critical challenges including cell 
expansion and seeding time which is costly and laborious (89). Figure 2-2 is schematically 
describing the basic cell-based approach in bone tissue engineering. 
 
Figure 2-2. Cell based bone tissue engineering, involving the application of metabolically 
active cells and growth factors using a 3D scaffold for functional bone tissue regeneration 
(12). 
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In addition to this approach, cell-free therapies are being investigated as well. This more 
straight-forward concept also includes applying a 3D scaffold that will be implanted into the 
tissue defect, but cells are recruited from the body’s own resources (resident tissues) to 
stimulate self-healing mechanisms (90). This method, which is also known as in situ tissue 
regeneration, relies on applying a bioactive scaffold which will home endogenous cells and 
stimulate local tissues. It has shown great promise in previous tissue regeneration studies such 
as vascular grafts, nerve as well as hard tissue regeneration (89, 91-94). It can alleviate the risks 
of using exogenous cells or harvesting cells from the host body, which has similar risks as 
autografts and allografts (in Section 2.2.3) (90). In both cell-based and cell-free approaches, 
the scaffold eventually has to undergo cell-mediated degradation and will be replaced with 
natural extracellular matrix (ECM) of newly formed bone.     
2.3.2 Design of Scaffolds for Hard Tissue Engineering 
As in general tissue engineering, in hard tissue regeneration, an engineered bone graft 
substitute, known as scaffold, is needed.  In vivo each cell benefits from an ECM which 
provides a microenvironment surrounding it, in order to behave as a functional unit (95). Bone 
scaffolds must mimic some properties of the original bone ECM, regarding for example its 
composition, porosity, dimensions and physical properties, and in turn it will guide the 
formation of new bone (72, 96, 97). The main effort in the design of scaffolds, which serve as 
temporary matrices for bone regeneration is to try to mimic the microenvironment for cells 
(78). In the design of an ideal scaffold, selection of the biomaterial and designing appropriate 
structural and chemical/physical properties are considered to be the main steps (76). Producing 
a scaffold that meets all the required criteria can be the major challenge in tissue engineering 
(78). For example, for each application and end use, the scaffold should provide the required 
support for cells and biochemical signals contributing to the cell behaviour such as cell 
survival, cell shape development known as morphogenesis, cell populations growth known as 
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proliferation, and cell evolution known as differentiation (95). Bone ECM is a composite 
composed of both an organic component (predominantly type-1 collagen) and a mineralised 
inorganic component (crystalline HA minerals). Therefore, the engineered bone scaffold 
should be capable of both inducing cellular interactions (attachment, growth, differentiation) 
and mineralisation within the implant which results in the new bone formation in vivo (71). 
2.3.2.1 Scaffold Structure 
The macro and microstructure of the scaffold play a vital role in bone tissue engineering as 
they should effectively contribute to form the structure of bone ECM (76). The scaffold that 
serves as a cell and materials carrier, should be porous and three dimensional to permit cells to 
grow in three dimensions (98). The external shape of the scaffold should adopt the size and 
geometry of the bone defect while the internal structure should provide an interconnected 
permeable framework, which allows capillary ingrowth and the transfer of nutrient and oxygen 
needed for cell growth (12). The porosity in scaffolds will lead to a better cell accommodation 
and effective vascularisation. It has also been claimed that having interconnected pores is vital 
for free migration, attachment, proliferation and differentiation of cells as well as mass transfer 
in the scaffold and consequently tissue regeneration (43, 99). Moreover the more surface area 
that is present in scaffolds will provide more places for cell attachment and growth so the cells 
will properly be held to initiate every cell-to-matrix interaction (100).  
Furthermore, it is of pivotal importance that the bone scaffold has sufficient stiffness and 
strength, particularly because it will be influenced by forces during implantation and upon 
transplantation, there will also be biomechanical forces and dynamic loads in vivo. The 
mechanical properties of bone scaffolds should be sufficient especially in hard, load-bearing 
bone tissues, and it should be bio-stable because it will be retained after implantation until the 
new bone is formed. The strength and elasticity of scaffold, as well as its integration into the 
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host tissue and chemical stability and degradation profile are therefore important considerations 
(76).  
2.3.2.2 Biomaterials for Scaffolds  
In designing tissue engineering scaffolds, another crucial step is selection of a suitable 
biomaterial, that is both biocompatible and biodegradable (76, 101). Biocompatibility implies 
an appropriate surface chemistry which can support cell attachment and biodegradability means 
that the materials can be degraded into non-toxic products, which leave the desired living tissue 
upon formation (102). Materials used for bone tissue engineering purposes are vary from 
organic to inorganic biomaterials or a combination of them. The inorganic biomaterials include 
bio ceramics such as HA and other calcium phosphate-based or calcium sulphate-based 
ceramics, and bioactive glasses (12, 103). Under the category of organic materials, there are 
two types of naturally derived polymers (processed allogenic or xenogeneic) and synthetic 
biodegradable polymers. Naturally occurring polymers include proteins of natural ECM of 
different tissues, such as collagen, silk fibroin, elastin-mimetic peptide, fibrinogen, casein, 
lipase enzyme, glycosaminoglycan, alginic acid, chitosan, and even DNA (97). Although use 
of naturally derived scaffolds can fulfil biocompatibility and biodegradability requirements, 
they are derived from a foreign biological environment, and therefore still present the risk of 
pathogen transfer. It is also claimed that these materials can suffer from weak mechanical 
properties and their processability and manipulation is usually challenging (76, 97). 
With regards to mineralised tissues, natural scaffolds from collagen type I, which is the main 
protein in bone, have shown low immunogenicity and promoted bone formation and stimulated 
osteoblast cell differentiation (104-106). However since collagen is derived from animals, it 
still has the limitation of supply problems, and may still carry risk of immunogenicity. 
Moreover because of a lack of mechanical strength, collagen cannot withstand large forces 
during load bearing bone formation (107).   
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Among the organic materials, synthetic polymeric materials have been widely used and they 
have received increasing attention because of their ease of processing and tuneable 
biodegradability (97, 108). The most commonly used synthetic polymers for tissue engineering 
are those approved by the FDA (US food and drug administration) and this includes 
poly(glycolic acid) (PGA) (24), poly(lactic acid) (PLA) (25, 26), and their copolymer of 
poly[lactic-co-(glycolic acid)] (PLGA) and poly(e-caprolactone)(PCL) (15, 27, 109). These 
polymers are biocompatible and they are able to biodegrade in the body over a period of time. 
Although generally using synthetic materials as tissue scaffold materials has limitations in 
terms of cell recognition, it can be enhanced by modification of material chemistry and surface 
treatment before or after scaffold formation. The ability of synthetic materials to be engineered 
is a major advantage and porosity and physical characteristics can be adjusted to give very 
promising bone scaffold designs (1).  
Poly (e-caprolactone) (PCL): 
Among the synthetic biodegradable polymers, PCL has been widely investigated and applied 
in bone tissue repair (29, 30, 110-114) since it possesses the necessary mechanical properties, 
structural integrity, controlled pore size and pore interconnectivity suitable for bone tissue 
engineering (113). PCL is a biodegradable and biocompatible aliphatic polyester with a low 
melting point of 58–63°C and a glass transition temperature of -60°C. It is low-cost, non-toxic 
and biodegrades slowly depending on the molecular weight and can be used in FDA approved 
devices, i.e. for applications in the human body such as drug delivery and tissue engineering 
(27, 28, 115). The molecular structure of PCL consists of repeating five nonpolar methylene 
groups and a single relatively polar ester (Figure 2-3) (116). This polymer is regarded as 
cytocompatible and has been used as a biodegradable structure, in various biomedical 
applications, including regenerative therapies (22, 33) whilst supporting the attachment and 
growth of muscle cells, mesenchymal stem cells, and chondrocytes (29-31). The mechanical 
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properties of bulk PCL (Mw =44,000) has been investigated thoroughly, with a tensile strength 
of 16 MPa, tensile modulus of 400 MPa, flexural modulus of 500 MPa, elongation at yield of 
7%, and elongation at break of 80% (15, 117-120). However, due to the lack of cell-binding 
sequences along its polymeric backbone, its low degradability and its hydrophobicity, PCL is 
also modified using various techniques such as plasma treatment and/or coating (32, 34-37).  
 
Figure 2-3: Molecular repeat structure of PCL. 
 
As it has been discussed in Section 2.3.2.1, mineralised tissue scaffold should provide a porous 
structure which can guide cells ingrowth and at the same time it should maintain a sufficient 
strength to support the structural growth of newly formed bone. With regard to this, it has to 
be noted that a single material with limited range of properties cannot act entirely as a substitute 
for a complex composition such as bone. Therefore for bone tissues, it is of interest to develop 
a composite scaffold that consists of both natural and synthetic polymers, which can combine 
the appropriate mechanical and physiological properties favourable for bone regeneration (112, 
121, 122).     
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2.3.3 Biomimetic Approach 
The term biomimetic is derived from the words ‘bios’ and ‘mimesis’ meaning ‘life’ and ‘to 
imitate’ respectively (123). In the biomimetic approach, which can take a top-down or a 
bottom-up perspective, natural structures are analysed in search of architectures or chemistries 
that can replicate to some extent features of the target tissue. This approach has been adapted 
by many disciplines e.g. in mineralised tissue regeneration (124, 125), whereby either the 
architectural or physiochemical aspects of bone tissue have been mimicked.     
This study focuses on cell free approach of bone tissue engineering and in particular 
development of a scaffold and investigation of its performance in the promotion of 
mineralisation of apatite minerals in vitro. 
2.4 Self-assembling Peptides 
Self-assembling peptides lie between two categories of synthetic and natural materials, as they 
are not naturally occurring, yet are composed of natural building blocks. Although they are still 
largely in the research and development phase, they have shown promising results in meeting 
the criteria of tissue engineering scaffolds (42, 44). Before discussing self-assembling peptides 
and their application in bone tissue scaffolds, it is worthwhile reviewing peptide structures and 
self-assembling conformations and triggers. 
2.4.1 Peptides and Protein 
As discussed in Section 2.3.2, the ECM of mineralised tissues are mainly composed of proteins 
and the proteins themselves, are composed of amino acids that are linked to each other by 
peptide bonds. In general, there are 20 natural amino acids that form the building blocks of 
proteins in the body and that can be combined in different orders to form unique 3D protein 
structures with specific functions. The distinction between peptides and proteins is that proteins 
refer to natural well-defined 3D structures made up of hundreds or thousands of amino acids, 
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but peptides contain significantly shorter sequences of amino acids (between 10 to 100, or even 
fewer) (126, 127).  
Amino acids can be linked via a condensation reaction when a carboxyl group (COOH) (also 
called C-terminus) from one amino acid reacts with an amine group (NH3) (also called N-
terminus) from another adjacent amino acid via a peptide bond (also called an amide bond), 
during which one water molecule is released (Figure 2-4).  Linkage of a series of amino acids 
via peptide bonds forms ‘peptide chains’ (also called peptide backbone) and each amino acid 
unit in a peptide chain is called a ‘residue’. The sequence in which the amino acids are linked 
in a protein/peptide is termed its ‘primary structure’. This process can be repeated indefinitely 
to produce longer peptides since the two ends of the resulting peptide are distinct (128).   
 
Figure 2-4: The condensation of two amino acids forming the peptide linkage (129). 
 
Designing different primary peptide structures by applying various amino acid side chains and 
altering peptide sequences, enables the physical and biological properties of peptides to be 
tuned according to the intended end use (42). 
Peptide chains are rich in hydrogen bonding potential because each residue contains a carbonyl 
group (C=O) and an NH group, which are a good hydrogen-bond acceptor and donor 
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respectively. The further spontaneous interaction between the NH and C=O groups gives rise 
to more hydrogen bond formation and leads to peptides being folded into 3D structures. The 
pattern of these hydrogen bonds and the repetitive conformations in the peptide backbone is 
termed the ‘secondary structure’. The two most common secondary structures for peptides and 
proteins are α-helix and the β-sheet. Other less common structures, are for example, β-turn and 
3-helix (126, 127). The β-sheet secondary structure is constructed from individual extended 
peptide chains, called β-strands, which are arranged in a zigzag manner (Figure 2-5). The β-
sheet tapes are formed by spontaneous association of amino acids to super-molecular fibril-like 
structures and they are stabilised by hydrogen bonds between C=O groups of amino acids in 
one β-strand and the N-H groups of the amino acids in another adjacent β-strand (126, 127). 
Because adjacent strands can have their N- and C- termini oriented in the same or opposite 
sense, β-Sheet can be observed parallel or anti-parallel (Figure 2-6), the dotted lines indicate 
the hydrogen bonds between the tapes). Anti-parallel β-sheets have greater stability because 
the peptide dipoles have a more preferential arrangement and the chains can pack more tightly 
(130-133). 
 
Figure 2-5: Extended peptide chain known as β-strand (129). 
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Figure 2-6: Parallel and antiparallel β-sheet, the dotted lines indicate the hydrogen bonds 
between the chains (129). 
 
2.4.2 Peptide Self-assembly mechanism 
Self-assembly is prevalent in nature and is found at both macroscopic and microscopic levels. 
Molecular self-assembly can be defined as ‘the spontaneous association of molecules under 
equilibrium conditions into stable, structurally well-defined aggregates joined by non-covalent 
bonds’ (134). Self-assembly of peptides relies on intermolecular forces, which assemble small 
units into fibrils and fibres with diameters of nanometre scale (135). Particular proteins such 
as peptides and collagen can undergo spontaneous self-assembly in response to external 
triggers such as pH, temperature and ion concentration (136). This process also depends on the 
concentration of the peptide/protein and only above a certain concentration (C*) does the 
formation of assembled structures occur. Peptide self-assembly follows a nucleated pathway 
in which a chemical difference in peptide monomer faces (due to the amino acid side chains), 
would initiate the assembly process. After this, if all pre-assembly conditions are provided, 
such as C*, temperature and pH, the assembly process will begin.  
2.4.3 P11 Peptides 
The rationally designed 11-residue family of peptides (P11-X) consists of negatively or 
positively charged peptide chains and self-assemble hierarchically into β-sheet tapes and higher 
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ordered structures. This transition from isotropic fluid to a self-supporting nematic hydrogel 
occurs following application of external stimuli (137). Designing different primary peptide 
structures by applying various amino acid side chains and altering peptide sequences, enables 
the physical and biological properties of peptides to be tuned according to the intended end use 
(42). 
2.4.3.1 P11 Peptides Background 
Aggeli and co-workers first reported the rationally designed, self-assembling P11-2 peptide 
(Ac-QQRFQWQFEQQ-Am) in 1997 (138). A number of principles were applied by the 
researchers for a successful design of this β-sheet forming sequence. Side chain interactions 
are an important factor in driving strand assembly, i.e. dimethylenes and aromatic residues 
provide hydrophobic side-chain interactions. Aqueous solubility of peptide tapes is promoted 
through the hydrophilic ends of the side chains of some amino acids. The charges normally 
present at peptide termini were removed by introducing acetyl functional groups to prevent 
unwanted interaction between COO– and NH3+. Finally, the positively charged amino acid 
(arginine acid) and negatively charged one (glutamic acid) residues are positioned such that the 
complementary charges of arginine and glutamic acid on neighbouring strands are adjacent to 
each other if the peptide is in an anti-parallel β-sheet configuration (139). 
Aggeli et al. have also developed a model describing P11 peptide self-assembly related to its 
concentration (140). In this model (Figure 2-7), peptide monomers in a β-strand conformation 
are considered to be chiral rods with chemically distinct faces and complementary donor and 
acceptor groups aligned on opposite sides. When a random coil monomer changes to a β-strand, 
there is a free energy loss of configurational entropy. On the formation of a β-sheet tape (a 
single-molecule thick) from β-strand, there is free energy of intermolecular association for each 
interacting pair of monomers. Because β-strands have a right-hand twist (viewed down the 
polypeptide chain), β-sheet tapes have an inherent left-hand twist (viewed down the tape axis) 
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(141). Tapes contain two distinct faces; one of which interacts more with itself, the other more 
with the solvent, and this is the reason that tapes adopt a helical form. As one side of the tape 
is more hydrophilic than the other, tapes pair into twisted ribbons (two stacked tapes) to exclude 
their less soluble surfaces, in this change there is an associated free energy as well. Fibrils 
(multiple stacks of ribbons) form when ribbons stack, driven by attraction between their faces, 
with a free energy per pair of interacting peptides. If the edges of fibrils are mutually attractive, 
they may stack in pairs and form fibres (or entwined fibrils), with an associated free energy. 
These free energies determine the critical concentration, C∗, for observing each peptide 
structure (140).  
 
Figure 2-7: Hierarchical self-assembly model for chiral rod-like units (image adapted from 
Aggeli et al. (140)). 
 
 28 
 
2.4.3.2 Triggers to Peptide Self-assembly 
Several mechanisms can trigger the self-assembling of peptides, including internal or external 
triggers. Internal triggers include combination of complementary pairs of peptides that have 
opposite net charge (142). The external triggers include pH, temperature and ion concentration 
of the solutions, light or solvent compositions. The P11 class of peptides has been shown to 
undergo pH-triggered self-assembly (47) and ionic strength-triggered self-assembly (48).  
 As an example of the effect of pH, P11-4 (Ac-QQRFEWEFEQQ-Am) can be designed to be 
monomeric in solution at higher pH and to form fibrils at low pH. This allows antiparallel β-
sheet assembly by coulombic interactions and switching between low and high pH can be 
carried out reversibly several times. Conversely, P11-8 (Ac QQRFOWOFEQQ-Am) behaves 
in the opposite manner. At low pH, it is monomeric, while at pH above 7.8, a fibril-containing 
gel is obtained (see Figure 2-8).  
 
Figure 2-8. Graphs showing the change in state of (A) P11-4 and (B) P11-8 in response to a 
change in pH of the solution (47). 
 
The physiological ionic strength effect on the self-assembly can be exemplified by examining 
P11-4 and P11-8 self-assembly with NaCl salt in solution (48). For P11-4 solutions in 130 mM 
NaCl, the transition from β-sheet to random coil is shifted up from pH 7.8 to pH 12 (more than 
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4 pD1 units). This may be the result of a change in side chain acidity by acid-base titration. It 
was also discovered that the structure of the predominant fibrous structures in gels and the 
structure of fluids appeared to be unaffected by the presence of salt. Comparable shifts in 
properties were found when studying P11-8 solutions in 130mM NaCl. The β-sheet to random 
coil transition is decreased by 3 pD units from pH 8 in water to pH 5 in aqueous NaCl solution. 
These two studies related to pH and ionic strength (47, 48), in particular are significant because 
they demonstrate that self-assembly of P11 peptides can be adjusted to suit a particular ionic 
strength and pH, for instance as the they are in vitro or in vivo. Moreover, their triggered self-
assembly is reversible and responsive, which makes them potentially useful in applications 
such as drug delivery. 
2.4.4 Self-assembling Peptides Used in This Study 
The primary structure of peptide P11-4 and P11-8 are given in Table 2-1. The amino acid side 
chains that contain an ionisable acid group are indicated by a negative charge while those that 
contain ionisable basic group are indicated by a positive charge. It is shown in Table 2-1 that 
the only difference in the amino acid sequence of these two peptides is ornithine (O) in P11-8 
which has NH3+, which is replaced by glutamic acid (E) in P11-4, which has COO- (48). As it 
explained in Section 2.4.3.2, self-assembly in both P11-4 and P11-8 is pH sensitive due to their 
ionisable groups and they can self-assemble and adopt a hydrogel state in an opposite manner. 
In physiological conditions, pH 7.4 and a salt concentration of 140 mM, P11-4 and P11-8 carry 
a net charge of -2 and +2 respectively and they can form a hydrogel state when the 
concentration is above 10 mg mL-1. 
Among the P11 category of peptides, peptides P11-4 and P11-8 have been found to be non-
cytotoxic after culturing with human and murine cells and they demonstrated acceptable levels 
                                                 
1 pD is the analogue of pH in deuterated solvents, i.e. − log10[D
+]  
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of biocompatibility and immunogenicity in vivo (143), as well as enhanced bone tissue 
deposition (44, 52, 53, 55). In biological conditions they can be conveniently self-assembled 
at the critical concentration and form fibrillary hydrogels (42). This would suggest that they 
are a promising and novel class of scaffolds for tissue engineering. 
Table 2-1. Diagrams showing the primary structure of P11-4 and P11-8 in physiological 
conditions (47).  
Peptide Primary structure 
P11-4 
 
 
 
P11-8 
 
 
 
 
2.4.5 Peptides Investigated for Hard Tissue Engineering  
A number of self-assembling systems have been previously described and suggested as 
potential candidate materials for skeletal tissue regeneration.  Pioneering work by Stupp’s 
group presented a self-assembling peptide amphiphile (PA) specifically designed to initiate 
nucleation of hydroxyapatite (144). These molecules were shown to direct the nucleation of 
hydroxyapatite nanocrystals in a way that resembled the relationship between collagen fibres 
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and mineral crystals in bone. Later, PAs were combined with porous titanium implants in an 
attempt to combine the bioactivity of the peptides with the mechanical strength of the metal 
(145) and were shown to regenerate bone in a rat femoral model. Self-assembling β-hairpin 
peptides have also been shown to be capable of directing mineralization (146).  Several groups 
have investigated the role of particular motifs derived from or based upon natural peptides or 
proteins in hydroxyapatite nucleation. Dentine matrix protein 1 (DMP-1) self-assembles in 
nature and He et al. (147) could nucleate mineral in vitro using them, with the acidic domains 
being central to the nucleation process.  
To date, there are several published studies using P11 peptides focusing on their use as self-
supporting gels for hard tissue engineering, and these structures have shown promising 
properties (148). In a study by Kyle et al. (143), P11-4 was investigated and shown to form a 
self-supporting isotropic hydrogel at concentration of 10-30 mg mL-1 while supporting primary 
human dermal fibroblast cell proliferation in three dimensions (50). Kirkham et al. (50), 
evaluated P11-4 in treating and preventing dental caries which shown to promote deposition 
and growth of hydroxyapatite. Subsurface caries-like lesions were introduced into extracted 
human teeth by explosion of the teeth to a demineralising solution (at acidic pH) for several 
weeks. Treatment was done using either 10µl of an aqueous P11-4 monomer solution (at pH 8) 
or a control solution without peptide. The teeth were then exposed to a pH cycling model where 
the peptide self-assembly into a gel takes place in the caries in situ and then they were exposed 
to mineralising solutions (at neutral pH) at 35° C for 5 days. Phosphorus levels in the solutions 
were monitored to measure any uptake or loss of mineral and this treatment with peptide 
resulted in a net mineral gain significantly larger than that of the control (50, 55). Following 
these promising clinical trial studies, P11-4 was patented by University of Leeds and 
commercialised for dental repairs by the Swiss company Credentis AG (Zurich, Switzerland) 
(149).  
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In another study, P11-4 and P11-8 hydrogels were applied to critical size defects in rabbit 
calvaria and they showed bone regeneration over three months, although the extent to which 
mineralised tissue ingrowth occurred was greater in the negatively charged P11-4 than 
positively charged P11-8 (53). It was suggested that this was related to its mirroring of natural 
ECM proteins in skeletal tissues especially in the presence of negative charged domains on the 
assembled fibrillar surfaces. The ability of the extracellular matrix (ECM) to influence mineral 
deposition is key to biomineralisation events (150, 151) and this has stimulated much research 
in ECM biomimetic materials.  
Most of the published studies using P11 peptides have focused on the molecular design of self-
supporting gels, however, despite their inherent biofunctionality, self-assembled peptide gels 
frequently suffer from poor mechanical strength and lack of structural stability. This potentially 
makes their handling and fixation during implantation in vivo challenging, particularly in large 
load-bearing tissue defects. Attaining mechanically-competent scaffolds capable of supporting 
cell growth spatially and temporally until the newly engineered tissue is formed, is one of the 
major challenges in the design of SAP-based medical devices (1). The incorporation of SAPs 
within water-stable synthetic fibres is a potential route to address this challenge, and to deliver 
structurally reinforced fabrics. Of the various ways of making fibres, electrospinning is by far 
the most commonly encountered method for tissue engineering. 
2.5 Electrospun Scaffolds 
Electrospinning is a simple, inexpensive, and efficient technique to produce fibrous layers. Ma 
et al. (152) reported that polymeric nanofiber scaffolds produced by electrospinning potentially 
mimic characteristics of natural extracellular matrix (ECM). As electrospun fibres have a high 
pore volume and surface area, and can be produced from a wide range of biocompatible 
polymers, they have been extensively studied in the form of nanofibre scaffolds for tissue 
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engineering and biotechnology (152). The fact that nanofibres are not tightly bonded together 
is considered a benefit in tissue engineering scaffolds, since it helps tissue in-growth and cell 
migration as well as cell distribution in the fibrous structure. However, by producing 
appropriate layering of fibres in a composite electrospun web, the strength can be improved if 
needed (153).  
For bone tissue engineering applications, a 3D, biodegradable and porous scaffold with 
interconnected pores and mechanical stability is required. Electrospinning has emerged as a 
facile method of fabricating bone scaffolds with suitable morphology, porosity and mechanical 
stability (154).  
Typically, synthetic polymers are considerably easier than natural polymers to electrospin, 
which is reflected by the larger number of synthetic polymers that have been electrospun into 
nanofibres. Both organic and water soluble biopolymers have been studied. Amongst the most 
common polymers are poly(e-caprolactone) (PCL), poly(l-lactic acid) (PLA), polyurethane, 
copolymers of poly(ethylene glycol) (PEG) and PCL, poly(l-lactic acid -co- e-caprolactone) 
(P(LLA-CL)), and poly (d,l-lactic–co–glycolic acid) (PLGA), poly(ethylene oxide) (PEO) and 
polyvinyl alcohol (PVA) (24, 155, 156).  
In addition to synthetic polymers, the self-assembly of some (poly-) peptides and proteins has 
been explored using electrospinning, aimed at accomplishing biomimetic scaffolds and unusual 
architectures. Nuansing et al.(157) attempted to electrospin a short peptide of Fmoc-FG 
(Fmoc–Phe–Gly) which resulted in rough fibres with diameters of around 300 nm, while 
Haynie et al. (18) successfully electrospun polypeptides of poly(L-ornithine) (PLO) and 
poly(L-glutamic acid4-co-L-tyrosine) (PLEY) resulting in fibres with diameters ranging from 
0.1µm to several microns. Tayi et al.(158) also attempted to electrospin peptide amphiphiles 
(PAs) into micrometre-scale fibres without a polymer carrier. In all of these studies, in addition 
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to the serious challenges involving the optimisation of the spinning solution as well as 
electrospinning process parameters, the resulting pure electrospun (poly)- peptides webs were 
not mechanically robust enough for handling and clinical use. Since the self-assembly is only 
stabilised by weak non-covalent bonds, resulting architectures can only be partially customised, 
and electrospinning a classical synthetic polymer containing the bioactive SAPs is a logical 
solution. Natural polymers are often blended with synthetic polymers or salts to increase the 
solution viscosity and consistency in electrospinning. For example, to electrospin 
alginate/chitosan composite fibres, poly (ethylene oxide) (PEO) has been added to increase the 
chain entanglements and decrease the conductivity of the charged polysaccharide solution 
(135).  
2.5.1 Principles of Electrospinning   
A substantial body of research has focused on the manufacture, physical properties, chemical 
characteristics and biocompatibility of electrospun fibres for medical applications, including 
bone tissue engineering scaffolds. Electrospinning is an established technology to manufacture 
continuous fibres with average diameters ranging from tens of microns to tens of nanometres. 
The fibres can vary in morphology, and have a high aspect ratio and high surface to volume 
ratio. They are produced from synthetic or natural polymer solutions or synthetic polymer 
melts, assisted by an electric field (135, 159). Electrospinning is a technique in which there are 
several adjustable process parameters allowing manipulation of the structure of the matrix and 
fibre diameter.  
The simplest setup for needle electrospinning (Figure 2-9), consists of a high voltage power 
supply, a spinneret (syringe and needle) and a grounded collector (160). The solution is fed 
from the syringe at a controlled rate and a sufficient voltage is supplied to the needle. In this 
process, the polymer is electrically charged. At the tip of the needle, the resulting repulsion of 
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charges (charge density) overcomes the polymer surface tension and forms a conical shape in 
the solution called Taylor cone. When the electrical repulsion force is greater than the surface 
tension of the polymer, jet emission occurs at the tip of the Taylor cone and fibres will be 
formed. In case of dominancy of the surface tension over the repulsion forces, Raleigh 
instability occurs, and polymer droplets can fall from the needle instead of forming fibres 
heading to the collector (161). 
 
Figure 2-9. Schematic diagram of the needle electrospinning process (image adopted from Ke 
et al.) (162). 
 
Viscosity and cohesive forces of the polymer play an important role regarding Raleigh 
instability and continuous fibre forming. As the fibre is electrically charged and travels towards 
the collector through the electrical field, it interacts with the field and resulting forces make the 
fibres bend or whip leading to stretching of the jet. This instability and spiral movement is 
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mainly responsible for attenuation of the jet and for the ultimate fibre diameters deposited on 
the collector (161).     
2.5.2 Electrospinning Parameters 
Many parameters influence the ability of the dissolved polymer to be electrospun as well as the 
properties of resulting fibres. The main parameters include (163):  
 Solution properties such as, polymer molecular weight (Mw), concentration, viscosity, 
elasticity, conductivity, and surface tension.  
 System variables which include the flow rate, applied voltage, the polarity of the high 
voltage power supply, needle diameter, and needle tip to collector distance.   
 Environmental conditions such as temperature, humidity, pressure and air velocity.  
2.5.2.1 Polymer Solution Parameters 
Although research has been reported on thermoplastic polymer melt-electrospinning, most 
research focuses on electrospinning of polymer solutions. The characteristics of the solution, 
directly affect fibre formation characteristics and consequently influence diameter and the 
morphology of the produced fibres (164). Among the various parameters, Mw and polymer 
concentration have the most direct effect on the viscosity of the polymer and the quality and 
fibres in terms of morphological consistency and freedom from defects (163).  
In practice, polymer concentration usually has an upper and lower limit, if the polymer 
concentration or Mw is too low, there is insufficient chain-entanglement for the formation of 
filaments and there will be bead formation or electrospraying instead of electrospinning. At 
very high polymer concentrations or Mw it is impossible to electrospin as the flow of the 
polymer solution to the needle tip is interrupted due to the viscosity and needle blockage may 
occur (163). 
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There is a relationship between the fibre diameter and polymer solution concentration known 
as the Berry number ([η]c), and this has been reported for polymers such as PVA (165). 
Equation 2-1 shows the relationship between Berry number and fibre diameter (D): 
Equation 2-1 
D (nm) = 18.6 ([η] C) 1.11 
Where; 
[η] is the intrinsic viscosity of the polymer solution, (mL g-1) 
C is the concentration of the polymer solution, (g mL-1) 
Equation 2-1 shows the fibre diameter directly depends on the molecular conformation of the 
polymer in the solution (concentration and viscosity). In constant electrospinning conditions, 
the diameters of fibres obtained from solutions of lower concentration have smaller fibre 
diameters than those obtained from those of higher concentration. In another study, it was 
shown that, at very low concentrations, droplets are formed instead of fibres, and when the 
concentration increases, the fibre diameter increases (166).  
The choice of solvent plays an important role in electrospinning because of the effect on 
resulting fibre properties (164). The rate of solvent evaporation is critical in fibre formation, 
and is affected by the environmental conditions and type of solvent. A study using different 
solvents for electrospinning of polystyrene suggested that the rate of solvent evaporation along 
with jet stretching due to electrical forces, are responsible for the diameter, structure, and 
properties of the deposited nanofibres (164). The rate of solvent evaporation is also likely to 
influence the cross-sectional shape and morphology of fibres collected during electrospinning, 
and whether they are approximately cylindrical or flat, ribbon-like or porous (159).  
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One important physical aspect of electrospun fibres, which can affect fibre shape and diameter, 
is the dryness of the fibres as they are collected. In a study by Wannatong et al. (164), it was 
found that the dryness of electrospun fibres increases if the density and the boiling point of the 
solvent decreases. In addition to the solvent type, the morphologies of electrospun fibres are 
strongly dependent on electrospinning conditions. Therefore, dryness can also be increased by 
increasing the applied voltage and collection distance (164).  
The electrospinning process can only occur when a solution has sufficient charges so that the 
repulsive forces within the solution can overcome the surface tension. The ability for a solution 
to incur stretching and drawing also depends on how well the solution can carry charges (167). 
There are a number of studies reporting that high solution conductivity can cause fibre 
formation free from beads (168-170). Another study has shown that addition of salts to the 
electrospinning solution, can lead to a higher charge density on the jet surface resulting in an 
increase in the elongation and formation of finer fibres free from beads (171).   
2.5.2.2 Processing Parameters  
Understanding electrospinning process parameters is fundamental to controlling web 
characteristics and the structural features of the collected webs.  
Voltage  
A sufficiently high voltage is essential to initiate jet formation. Voltage firstly induces the 
required electrical charges on the polymer solution and secondly it creates the electric field in 
which the jet emerges from the needle tip and is elongated as it travels towards the collector. 
As the voltage increases, the jet is accelerated and the polymer is stretched due to the increase 
in electrical charge (171), which usually leads to smaller diameter fibres. However, when the 
voltage is too high, the acceleration is so fast that the solvent does not have enough time to be 
evaporated and wet fibres may be formed on the collector (172-174).       
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The effect however, is not consistent between polymers. In study by Wannatong et al. (164), 
in which polystyrene fibres were electrospun at different voltage, it was found that by 
increasing applied voltage, bead formation and fibre diameter decreased. There was a slight 
decrease in fibre diameter with increasing applied voltage (from 10kV to 25kV), but with a 
further increase in voltage to 30 kV, the fibre diameter increased. Moreover, the distribution of 
the fibre diameters changed according to voltage. It was very broad at low voltage, narrowed 
as voltage increased, but broadened again at the highest voltages of 25 and 30 kV.  
In order to explain the effect of applied voltage on the fibre diameter, one must refer to the 
relationship of three major forces, coulombic, viscoelastic and surface tension all of which 
operate during the electrospinning process (164). Coulombic force is mainly responsible for 
the stretching of the jet between the spinneret and the collector, as it tries to push apart adjacent 
charged carriers. The viscoelastic force opposes stretching of the charged jet, as does the 
surface tension. 
When the applied voltage is low (164), the coulombic force is not high enough compared to 
the surface tension, resulting in fibres with large diameters and the presence of beads within 
the collected web. When a moderate voltage is applied, all three forces are well balanced, 
resulting in a narrow distribution of fibre diameters and a decrease in fibre diameter. Further 
increases in voltage, lead to coulombic forces being much greater than that of the viscoelastic 
force, resulting in breakage of filaments due to over-stretching of the charged jet between the 
needle and the collector. The coulombic force causes both longitudinal and transverse 
stretching, the latter of which increases the fibre diameter. Moreover, at higher voltage, the jet 
flies to the collector much quicker, and the solvent does not have sufficient time to evaporate, 
leading to formation of merging and thicker fibres in the resulting web (164).  
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By considering the effect of applied voltage in electrospinning, it is recognised that in low-
viscosity (low concentration) solutions, the higher applied voltage causes an increase in fibre 
diameter, because at the constant strain rate, the mass flow rate increases. However, in high-
viscosity (high concentration) solutions, if the applied voltage increases, fibre diameter 
decreases, because in this situation frictional forces between the solution molecules are high, 
and it limits the mass flow rate, while the strain rate increases, and therefore there is a decrease 
in fibre diameter (166).  Some other studies have reported that changing the applied voltage 
while keeping the distance between the electrodes constant, does not significantly change the 
fibre diameter (166).  
Distance  
It is known that by increasing the distance between the needle tip and the collector, the polymer 
solution has more time to travel and be stretched, therefore a smaller fibre dimeter can be 
achieved (167). When the distance is too low, it may result in collection of wet fibres that are 
merged and form junctions in the resulting web (173).  
In a study by Cengiz et al. (166), it was found that polymer solution concentration, the distance 
between the needle and the collector, and applied voltage can significantly control the fibre 
diameter. In the mentioned research (166), polyacrylonitrile (PAN) polymer was dissolved in 
pure dimethyl sulfoxide (DMSO) with concentrations ranging from 10, 13, 15 to 17 w %. 
Moreover different voltage values of 10, 15, 20, 22.5, 30, 35, 40 kV were applied and various 
tip to collector distances of 5, 10, 15, 20 and 25 cm were explored. In terms of the effects of 
applied voltage and the distance between the spinneret and the collector on fibre diameter, the 
fibre diameter increased with increasing voltage and distance. These results were obtained in 
experiments using low solution concentration values (13% w, 15% w). However, at higher 
concentration values such as 17 w%, the opposite behaviour was observed (166). It may be 
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concluded that for each characteristic of polymer solution, the effects of voltage and distance 
on fibre diameter can vary.  
Flow rate 
Typically the polymer solution is ejected from the needle assisted by hydrostatic pressure, 
using a syringe pump. If the electrospinning setup is vertically oriented, gravitational force can 
also affect on the polymer flow rate (175). Finding an appropriate polymer flow rate depends 
on factors such as polymer viscosity and the needle orifice or spinneret diameter. If the flow 
rate is very low, the solution may solidify in the needle and will not be able to form a Taylor 
cone. If the Taylor cone does form the diameter of produced fibres can be very small. In 
contrast, when the flow rate is high, due to the larger volume of solution being discharged, at 
a set distance, the resulting fibres will be thicker (171). 
Polarity of High Voltage Power Supplier 
 Electrospinning uses electrical force to draw and stretch a polymer jet instead of mechanical 
forces (like in melt and wet spinning). In electrospinning, the syringe is usually charged by a 
power supply and the collector plate is grounded, although this can be reversed. Kilic et al. 
(176) investigated the reverse setup and discovered that fibre production efficiency in terms of 
collection of small diameter fibres was inferior to that associated with the conventional setup 
of a charged syringe and grounded collector. In the reverse setup, the columbic force is not 
high enough to stretch the polymer jet (176). Moreover in conventional electrospinning setups 
the power supply is connected to positive polarity electrode, but alternatively, it can be 
connected to negative polarity. Supaphol et al. (177) studied the change in the polarity of charge 
of the syringe needle in electrospinning of polyamide-6 dissolved in formic acid. Their result 
showed that negatively charged jets led to larger fibre diameters than those that were positively 
charged. They claimed that PA-6 cations and PA-6 anions are injected in positively and 
negatively charged needle respectively, and as the cations are larger and bulkier than PA-6 
 42 
 
anions, more columbic force acts in the negatively charged needle which leads to greater 
polymer flow rate and consequently larger fibre diameters in negatively charged conditions 
(177).  
2.5.2.3  Ambient Condition Parameters   
As previously mentioned, environmental parameters such as humidity and temperature can  
affect the electrospinning process and the resulting webs (175). 
Humidity  
According to the type of the solvent, humidity can affect the properties of the polymer solution. 
Aqueous solutions are obviously more affected, since the humidity is a function of vapour 
pressure, can influence the solvent evaporation rate. In non-aqueous solutions, humidity can be 
influential in several ways. For example the solution can absorb water during flight of the 
polymer jet (178), and reduce solvent evaporation and consequently increase fibre diameter 
and create pores in the fibre surface. If the water vapour pressure is too high the evaporation 
rate decreases as a result of the saturation effect.  
Temperature  
Increasing the temperature has two main effects on fibre formation in electrospinning, which 
are an increase in the solvent evaporation rate and a decrease in the viscosity of the solution 
(167). At high temperatures, the polymer solution dries quicker and there is less time for 
elongation of the jet during its flight toward the collector. In contrast, high temperature can 
lead to a decrease in viscosity, which means there is reduced flow resistance in the polymer 
solution, allowing the fibre to elongate more readily during its flight (175). 
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2.5.3 Production of Electrospun Scaffolds Containing Self-assembling Peptides  
As indicated in Section 2.4.5, self-assembling peptides have utility as tissue engineering 
materials, particularly if they can be delivered in a form that lends them greater strength and 
stability when formed in to a scaffold.  
A nano-structured scaffold of PCL fibres coated with self-assembling peptide amphiphile (PA) 
nanofibres, was reported by Tambralli et al. (179). TEM images verified successful PA self-
assembly into nanofibres (diameters of 8 – 10 nm) using a solvent evaporation method. This 
evaporation coating method was used to successfully coat PAs onto PCL nanofibres (diameters 
of 300 – 400 nm), to develop a hybrid bioactive scaffold. SEM characterisation showed not 
only that the PA coatings did not interfere with the porous PCL nanofibre network, but there 
was also greater attachment and spreading of human mesenchymal stem cells (hMSCs), which 
were seeded onto the scaffolds to evaluate their bioactivity. This novel strategy seems to be a 
new solution to overcome the current bioactivity challenges of electrospun scaffolds and 
combines the unique characteristics of PCL fibres and self-assembling PAs, for various 
biomedical applications (179).    
Andukuri et al.(36) coated electrospun PCL fibres with peptide amphiphiles (PAs) for 
cardiovascular implants, whereby PAs were self-assembled at the surface of the nanofibres by 
a solvent evaporation technique. These peptides are capable of carrying enzyme-mediated 
degradable sites and cell-adhesive ligands to biomimic the native endothelium environment. 
Significant improvement was observed in adhesion and proliferation of human umbilical vein 
endothelial cells (HUVECs), however there were limitations in smooth muscle cell 
proliferation and adhesion of platelet cells (36). In another study, electrospun PCL scaffolds 
were covalently modified by perlecan domain IV peptide, and this approach led to significantly 
enhanced cell adherence and infiltration in a 3-D pharmacokinetic cancer model (37).  
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To avoid such post coating treatments, peptides components can also be directly blended with 
polymer in solutions to fabricate commixed electrospun fibres in one step. Single step 
electrospinning of a mixture of poly(lactic-co-glycolic acid) (PLGA) and peptide (CGGRGDS) 
was demonstrated by Gentsch et al. (38), which resulted in fibre surface enrichment with 
peptide. In other approaches, PCL/peptide conjugates were electrospun to specifically and non-
covalently guide the spatial arrangement of biomolecules such as glycosaminoglycans (GAGs) 
within the scaffold, so that biological gradients found in native tissues could be successfully 
mimicked. (39) Furthermore, a variety of self-assembling peptides (EAK, DAK, EAbuK, EYK, 
RGD-EAK, and RGD-EAKsc) have been added into PCL solutions prior to electrospinning 
(32). The resulting fibres containing peptide not only exhibited higher surface wettability and 
amorphous phase compared to that of PCL, but there was also an improvement in h-osteoblast 
cell adhesion. 
A few drug delivery applications using a combination of polycaprolactone and self-assembling 
peptides via electrospinning have also been reported, the result of which suggests that 
encapsulated PCL/SAP electrospun matrices may impact the drug controlled release 
technology area in the future (180, 181). 
2.6 Summary 
Bone tissue engineering has potential to transform medical care for hundreds of thousands of 
patients annually, with the possibility of dramatic reductions in medical costs, since it provides 
an alternative to bone transplantation. The required characteristics of a bone tissue engineering 
scaffold are: 3D structure, highly permeable and porous, interconnected pore network, 
biocompatible and biodegradable material composition, suitable surface chemistry and 
sufficient mechanical properties similar to those of healthy surrounding tissues.  
 45 
 
For effective bone tissue engineering, which is a complex and dynamic process, 
osteoprogenitor cells (preosteoblast cells) need to migrate, proliferate and differentiate such 
that eventually, bone tissue matrix will be formed. Beside this, remodelling of the bone by 
nucleation and growth of bone minerals needs to occur throughout the bone tissue scaffold, 
which should provide mechanical support during the process of repair and regeneration of 
damaged or diseased bone (182).  
Whilst biomaterials in the form of synthetic polymers have good mechanical and physical 
properties and can support tissue growth, they may lack cell recognition signals. Unfortunately, 
natural biomaterials that are biocompatible may promote cell adhesion and proliferation, but 
they usually have poor physical stability.  
Self-assembling peptides are one class of biomaterial that have undergone rapid development 
in the last two decades, and they show promise as scaffold biomaterials. Specifically, peptides 
P11-4 and P11-8 have been found to be non-cytotoxic to human and murine cells and they 
demonstrated acceptable levels of biocompatibility and immunogenicity for tissue engineering. 
There is substantial evidence to support the suggestion that rationally designed P11-4 and       
P11-8 SAPs are capable of inducing de novo mineral nucleation and supporting mineral growth 
for hard tissue regeneration (53). However, despite their inherent biofunctionality, self-
assembled peptide gels suffer from poor mechanical strength and lack of structural stability. 
This potentially makes their handling and fixation during implantation in vivo challenging, 
particularly in large load-bearing tissue defects. Attaining mechanically-competent scaffolds 
capable of supporting cell growth spatially and temporally until the newly engineered tissue is 
formed, is one of the major challenges in the design of SAP-based medical devices (1). The 
incorporation of SAPs within water-stable synthetic fibres is a potential route to address this 
challenge, and to deliver structurally reinforced fabrics. 
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Among the possible manufacturing processes to produce scaffolds containing SAPs, 
electrospinning benefits from simplicity and is an inexpensive setup with the ability to control 
many key factors, such as the fibre diameter, morphology and composition. Electrospun webs 
have the advantage of small fibre diameter and large surface area, which is beneficial for cell 
attachment, and bioactive factors such as SAPs aimed at improving mineralisation can 
potentially be incorporated.  
Therefore, as indicated in Chapter 1, Section 1.4, the aim of this work was to investigate the 
feasibility of producing a functional and structurally stable fibrous scaffold in one-step 
electrospinning of P11-4/P11-8 SAP and PCL.  
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CHAPTER 3 
 
Materials and Methods 
3 Materials and Methods 
This chapter details the raw materials and chemicals used in the research as well as the 
experimental setups, methodologies and characterisation techniques used for the experimental 
work. 
3.1   Materials 
The peptides and other polymers and reagents used in this study for the experimental work 
together with the suppliers are listed in Table 3-1 and Table 3-2 respectively. 
Table 3-1. List of peptides used in the experimental work. 
Peptides Supplier 
Peptide P11-4 (CH3CO-Q-Q-R-F-E-W-E-F-E-Q-Q-
NH2) (1,595 Mw) 
Neosystems SNPE, France.  
Credentis, Switzerland. 
Peptide P11-8 (CH3CO-Q-Q-R-F-O-W-O-F-E-Q-Q-
NH2) (1,565 Mw) 
Neosystems SNPE, France.  
C.S. Bio, USA. 
Fluorescein- β -Ala – P11-4 (Fluorescein-β-Ala-Gln-
Gln-Arg-Phe-Glu-Trp-Glu-Phe-Glu-Gln-Gln-NH2 
(HPLC purity 95.1%). 
Polypeptide Group, France. 
Fluorescein- β -Ala – P11-8 (Fluorescein-β-Ala-Gln-
Gln-Arg-Phe-Orn-Trp-Orn-Phe-Glu-Gln-Gln-NH2 
(HPLC purity 95.1%). 
Polypeptide Group, France. 
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Table 3-2. List of chemicals and reagents used in the experimental work. 
Chemicals Supplier 
Poly(ε-caprolactone) (PCL) (80,000 Mw) Sigma Aldrich, UK. 
Hexafluoro-2-propanol (HFIP), purity≥ 99.0% Sigma Aldrich, UK. 
Dulbecco’s modified eagle’s medium (DMEM)  Sigma Aldrich, UK. 
Dimethyl sulfoxide (DMSO), purity≥ 99.0% Sigma Aldrich, UK. 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
(HEPES) 
Sigma Aldrich, UK. 
Sodium phosphate dibasic dihydrate 
(Na2HPO4.2H2O) 
Sigma Aldrich, UK. 
Calcium nitrate (Ca(NO3)2) Sigma Aldrich, UK. 
Sodium chloride (NaCl) Sigma Aldrich, UK. 
Hydrochloric acid (HCl), 37% Sigma Aldrich, UK. 
Sodium hydroxide (NaOH), ≥98.0% Sigma Aldrich, UK. 
Foetal bovine serum (FBS) Sigma Aldrich, UK. 
Penicillin/streptomycin (P/S) Sigma Aldrich, UK. 
Methylthiazolyldiphenyl-tetrazolium bromide (MTT) Sigma Aldrich, UK. 
CellTiter 96® AQueous One Solution (MTS) Promega, USA. 
Sodium hydrogen carbonate (NaHCO3)  Sigma Aldrich, UK. 
Potassium chloride (KCl) Sigma Aldrich, UK. 
Di-potassium hydrogen phosphate trihydrate (K2HPO4 
. 3H2O) 
Sigma Aldrich, UK. 
Magnesium chloride hexahydrate (MgCl2 . 6H2O) Sigma Aldrich, UK. 
Calcium chloride (CaCl2) Sigma Aldrich, UK. 
Sodium sulphate (Na2SO4) Sigma Aldrich, UK. 
Tris- hydroxymethyl aminomethane 
((HOCH2)3CNH2)  
Sigma Aldrich, UK. 
Agarose Sigma Aldrich, UK. 
Poly-L-glutamic acid sodium Sigma Aldrich, UK. 
Nitric acid (HNO3), ≥90.0% Sigma Aldrich, UK. 
Acetone, 99.5% Sigma Aldrich, UK. 
Distilled water Distilled in house. 
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3.2 Experimental methods 
3.2.1 Electrospinning Solution Preparation 
To determine the best conditions for electrospinning PCL/Peptide solutions to produce a 
suitable web, initial experiments were carried out by first making solutions of 100% PCL in 
hexafluoro-2-propanol (HFIP) at concentrations of 6% (w/w), 8% (w/w), 10% (w/w) and 12% 
(w/w) (Table 3-3). Solutions were prepared by adding PCL material into 10 mL of solvent 
while being stirred with a stirrer bar on a UC151 Stuart stirrer. Each solution was continuously 
stirred at room temperature for 24 h to obtain a clear solution. After stirring, the solutions were 
stored at room temperature under a fume cupboard for 24 h in order to liberate any air bubbles.    
Table 3-3. Spinning solution compositions (w/w) and associated solute and solvent weights.  
Sample 
 
Solvent HFIP 
(volume) 
Solvent HFIP 
(weight) 
PCL 
(weight) 
Concentration  
(w/w) % 
1 10 mL 15.9 g 0.95 g 6% 
2 10 mL 15.9 g 1.27 g 8% 
3 10 mL 15.9 g 1.59 g 10% 
4 10 mL 15.9 g 1.90 g 12% 
 
Next, to prepare the commixed PCL and peptide solutions, all solutions were prepared by 
dissolving PCL in HFIP at a concentration of 6% (w/w) according to the method described at 
the beginning of the current section (Section 3.2.1). The 6% PCL concentration was chosen 
based on the optimum concentration of PCL found in the preliminary results which will be 
described in Section 4.2.1. Then different peptides were added to make two separate spinning 
solutions. The first was P11-4 with a peptide sequence of CH3CO-Gln-Gln-Arg-Phe-Glu-Trp-
Glu-Phe-Glu-Gln-Gln-NH2 (Mw =1,595, a peptide content ~ 94.9% and a HPLC purity of 
95.0%).  The second was P11-8 with peptide sequence of CH3CO-Gln-Gln-Arg-Phe-Orn-Trp-
Orn-Phe-Glu-Gln-Gln-NH2 (Mw =1,565, peptide content ~ 77.8% and a HPLC purity of 96%). 
The peptides were added to the solutions individually at concentrations of 10, 20 and                   
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40 mg mL-1. Then, the solutions were left for 24 h until clear mixtures were obtained. The 
peptide contents for P11-4 and P11-8 in each solution are given in Table 3-4 and Table 3-5.  
Table 3-4. Peptide content in each solution of PCL/P11-4. 
P11-4 in the solution of 
(6% w/w) PCL in HFIP 
Peptide concentration 
mg mL-1 
Peptide content 
mg mL-1 
1 10 9.49 
2 20 18.98 
3 40 37.96 
 
Table 3-5. Peptide content in each solution of PCL/P11-8. 
P11-8 in the solution of 
(6% w/w) PCL in HFIP 
Peptide concentration 
mg mL-1 
Peptide content 
mg mL-1 
1 10 7.78 
2 20 15.56 
3 40 31.12 
 
3.2.2 Needle Electrospinning 
The schematic of conventional needle electrospinning setup used in this study was previousely 
shown in Figure 2-9. The electrospinning solutions were poured in to a 5 mL or a 10 mL syringe 
fitted with a 21 gauge blunt tipped needle. The syringe was connected to a dual head syringe 
pump (Kd Scientific Model 200 Series) and the solution was evacuated with a feed rate of 1 
mL h-1. The voltage was supplied to the needle at its base (Glassman Inc.) via a copper 
electrode. Voltages of 20 kV to 25 kV and a tip to collector distance between 160 mm to 200 
mm was used. The power supply was connected to a positive polarity electrode unless 
otherwise stated. An aluminium foil collector (150 mm × 150 mm) was placed on a non-
conducting board and was grounded by connecting to a ground cable. The electrospinning 
procedure was conducted in a fume cupboard with continuous suction to evacuate the solvent 
vapour. An ambient temperature of 21°C ± 2°C and a humidity of 43% ± 2% were consistently 
recorded in the spinning chamber. After deposition, fibre webs were transferred into a 
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Gallenkamp OVL570 010J vacuum oven to be dried at room temperature under 10×103 Pa 
vacuum for 7 days to ensure all solvent residues were evaporated, unless otherwise stated.  
To determine the approximate concentration of peptides within the as-spun fibres, the weight 
of the spun webs was recorded after drying. Since in needle electrospinning there is always 
deposition of a small amount of fibre outside the collection zone, this calculation is 
approximate. The mass of SAP in the spun webs was calculated assuming a homogeneous 
distribution of peptide within the spun fibres, and based on the initial mass of PCL and SAPs 
in the spinning solution, as in Equation 3-1 and Equation 3-2: 
Equation 3-1 
Mass of SAPs in electrospun fibres = MS × R 
Equation 3-2 
R= MSAP / (MSAP+ MPCL) 
Where; 
MS is mass of electrospun fibre sample. 
MSAP is mass of SAPs in each mL of electrospinning solution.  
MPCL is mass of PCL in each mL of electrospinning solution.   
Since the mass of PCL in each mL of the PCL/SAPs electrospinning solutions (at a 
concentration of 6% (w/w)) was always 95 mg, and based on the pure peptide contents at each 
concentrations (Table 3-4 and Table 3-5), the R for each peptide-concentration was determined 
in Table 3-6.  
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Table 3-6. Ratio (R) of mass of peptide to mass of peptide+PCL in the electrospinning 
solutions based on different peptide concentrations.  
Peptide 
Concentration of SAP (mg) 
in 1 mL ES solutions  
(mg mL-1) 
R 
P11-4 
10 0.090 
20 0.166 
40 0.285 
P11-8 
10 0.075 
20 0.140 
40 0.246 
 
3.2.3 Scanning Electron Microscopy (SEM) 
To elucidate details of the morphology of the electrospun webs as well as the degree of bead 
formation, fibre diameter and fibre orientation, electrospun samples were imaged using a 
scanning electron microscope. A LEO 1530 Gemini field emission scanning electron microscope 
(FESEM) (manufacturer: Zeiss) or a SU8230 high performance cold field emission (CFE) 
microscope (manufacture: Hitachi) were used during the course of this study according to the 
availability of machines. An accelerating voltage between 2 kV and 15 kV were used in order to 
record morphological features of individual fibres. SEM has the advantage of producing images 
with an increased depth of field and greater resolution compared to optical microscopes. In the 
SEM a beam of electrons is focused onto a specimen and the radiation emitted from the specimen 
is detected, which forms the image (183). In order to overcome build-up of electrical charge on 
the surface of the fibres, which have low conductivity, and to obtain high resolution images, 
samples were first coated with a thin layer of conducting material such as gold or platinum (184). 
Prior to imaging, all samples were cut and mounted onto 25 mm aluminium stubs and were 
sputter coated with platinum /palladium in vacuum for 3-4 min to a thickness of 7 nm using an 
Agar AGB7234 high resolution sputter coater machine.  
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3.2.4 Fibre Diameter Measurements  
Fibre diameter measurements of PCL and PCL/SAP fibres were obtained based on SEM images 
using Image Pro Plus 6.2.1 software (Media Cybernetics). In this study, at least 100 fibre 
diameter measurements per sample were obtained to determine mean, maximum and minimum 
fibre diameters, and the associated frequency distributions. In order to ensure random selection 
of fibres, for diameter measurements, two diagonal lines were drawn from top right to bottom 
left and top left to bottom right of the image and the diameter of every fibre crossing the two 
lines were recorded (185).  Two examples of the fibre diameter measurement procedure are 
shown in Figure 3-1. Diameters were measured based on multiple SEM images and at different 
magnifications (20Kx - 120Kx).  
  
Figure 3-1. Examples of SEM micrographs with fibre diameter measurements being made 
along the yellow lines. 
 
3.2.5 Transmission Electron Microscopy (TEM) 
To more extensively investigate the nano- and submicron architecture of the fibres, 
transmission electron microscopy (TEM) was employed as it has the advantage of achieving 
up to fifty million times magnification. TEM is based on transmitted electrons wherein 
electrons are passed through an ultra-thin specimen and as they interact with the atoms of the 
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specimen, the image is formed (186). TEM round copper grids coated with carbon (3.05 mm 
OD) were mounted on the electrospinning collector (aluminium foil) using double sided tape 
and a thin layer of the fibres was directly electrospun onto the collector and consequently onto 
the TEM grids. In this study, TEM analysis was performed using a FEI Tecnai TF20 and carbon 
coated copper grids were purchased from Agar Scientific. 
3.2.6 Environmental Scanning Electron Microscopy (ESEM) 
ESEM is a scanning electron microscopy technique which is able to image specimens in a wet 
or uncoated state by allowing a gaseous environment in the specimen chamber and operating 
in a low vacuum mode. In order to elucidate the effect of drying procedures and solvent 
evaporation on the as-spun fibre and fibril morphology, ESEM was employed. This was 
conducted to understand if air or vacuum drying (immediately after electrospinning) or vacuum 
drying (during the coating preparation of samples, as well as within the vacuumed chamber of 
the normal SEM) have any effects on the structure of fibres. ESEM uses a specialised electron 
detector different from a normal SEM and also employs a differential vacuum pumping system 
(187). However, ESEM has limitations in terms of the resolution of images due to its reliance 
on a gaseous environment, and use of uncoated, electrically low conductive samples creates 
difficulties during imaging due to the lack of surface conductivity. In this research, a FEI 
Quanta 200F FEG ESEM was used in both low vacuum and high vacuum modes. To study as-
spun fibres with the ESEM whilst minimising opportunities for them to fully dry on the 
collector, after a short electrospinning time of 3 min, samples were transferred in liquid 
nitrogen immediately and imaged in low vacuum mode (60 Pa) of ESEM. To determine if 
subsequent drying of as-spun fibres to remove residual solvent had any influence on their 
morphology, the same samples were vacuum dried under the conditions explained in Section 
3.2.2 and inspected in the ESEM at 30Kx magnification in the uncoated state under high 
vacuum mode (0.0006 Pascal). After that, to understand the effects of coating the vacuum dried 
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samples were coated (according to the coating procedure explained in Section 3.2.3) and they 
were imaged under high vacuum mode (0.0006 Pascal).   
3.2.7 Confocal Laser Scanning Microscopy (CLSM) 
The blank (100% PCL samples) and peptide-loaded samples were observed using a confocal 
laser scanning microscopy (Zeiss LSM510) at 3K-5K magnifications. Confocal laser scanning 
microscopy (CLSM) is a technique for obtaining high-resolution optical images that can be 
taken at defined depth of field levels at a time, and therefore the depth of focus can be 
controlled. CLSM is a conventional microscope equipped with a laser light source, a laser 
scanning head, an automatic focusing stage. It can be operated in reflected light or in 
fluorescence mode. In CLSM biological features can be detected if they are first labelled 
with fluorescent dyes (188). In this study, to investigate the peptide distribution throughout the 
fibres, both SAPs in the spinning solution were fluorescently labelled with the oppositely 
charged SAPs functionalized by a fluorescent dye (flouro-SAPs), to aid viewing by confocal 
microscopy. To do this, fluorescein-labelled SAPs, Fluorescein--Ala – P11-4 and Fluorescein-
-Ala – P11-8 were purchased from Polypeptide, France. Each of the SAPs prior to adding into 
the electrospinning solution were doped with its oppositely charged SAPs functionalised by a 
fluorescein moiety at the ratio of 1:60 (flouro-P11-4:P11-8 = 1:60 and flouro-P11-8:P11-4 = 
1:60). The SAPs were labelled with their opposite functionalised SAPs to produce a 
polyelectrolyte--sheet complex. Mixing an anionic and cationic peptide is an alternative way 
to induce self-assembly (137) which in this case was the preferred method to ensure full mixing 
of the flouro-tagged peptides with peptides in solution. A large fluorescein moiety will have a 
high degree of steric hindrance which would, in an anionic–anionic or cationic-cationic system 
phase separate and exclude itself from the bulk of the -sheet structures formed (137).  
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3.2.8 Energy-Dispersive X-Ray Spectroscopy (EDX) 
Energy-dispersive X-ray spectroscopy (EDX) is an analytical technique for elemental analysis 
of SEM specimens. In this technique, atoms of the elements in the sample are targeted and 
excited by a high energy beam of electrons, protons, or X-rays and as a result of disturbance in 
the energy of atoms in their own shell, they emit X rays. By analysing and measuring emitted 
radiation by means of energy-dispersive spectrometers, and since each element has specific 
radiation characteristics, chemical analysis of the material can be performed (189). In this 
research, to characterise the electrospun samples chemically and to detect Nitrogen within the 
fibres, solely attributable to the peptide component, EDX was employed. An Oxford 
Instruments (HAADF detector), INCA 350 EDX system was used in combination with the 
TEM and an AZtecEnergy EDX system was used in combination with SEM analysis at 
an accelerating voltage of 15 kV to generate sufficient X-rays to allow reliable identification 
of peaks. 
3.2.9 X-Ray Diffraction Crystallography (XRD)  
X-ray diffraction crystallography is an analytical technique to determine atomic and molecular 
structure of crystalline materials. In this method, a beam of incident X-ray is directed towards 
a sample, and the interaction of the incident rays and the crystalline atoms within the sample 
diffracts the beam into different specific directions. This allows identification of different 
minerals because each mineral has a set of unique diffraction peaks (190). In this study to 
identify any hydroxyapatite crystals formed during biological evaluation of the fibrous 
samples, an XRD instrument of PANalytical X’Pert MPD fitted with an X’pert Highscore Plus 
software was employed. Fibre samples were ground to a fine powder and data collection was 
performed by the 2θ scan method using Cu Kα radiation. Spectra were collected between 5˚ 
and 70˚with a step size of 0.05˚.   
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3.2.10 Fourier Transform Infra-Red Spectroscopy (FTIR) 
Fourier transform infrared spectroscopy (FTIR) is a technique used to identify materials by 
means of qualitative analysis. The analysis is performed be means of transmission of the IR 
radiation through an interferometer and onto the sample. The sample absorbs all the different 
wavelengths characteristics of its spectrum and this subtracts specific wavelengths from the 
interferogram. The atoms and bonds inside the molecule vibrate at different frequencies 
depending on the type of bond. A detector in the machine records the variation in energy versus 
time for all wavelengths simultaneously. Fourier transform analysis allows the conversion of 
the intensity vs. time spectrum into an intensity vs. frequency spectrum.  According to the 
sample components, resulted spectrum shows molecular IR radiation absorption and 
transmission. The spectrum consists of absorption/transmission picks which represent 
frequencies of vibrations between the bonds of the atoms (191).  
FTIR is also a powerful instrument to determine protein morphology or secondary 
conformations by analysis of amide region vibrations (192, 193). It probes the amide bonds in 
peptide molecules and displays distinct spectra for each conformation. To detect the secondary 
structure of peptides within the fibres in this study, infrared absorption spectrometry was 
performed with a FTIR Perkin Elmer Spectrum BX spotlight spectroscope attached to a 
diamond ATR. Measurements were taken in the range between 4000 – 400 cm-1 with a 
resolution of 4 cm-1 and interval scanning of 2 cm-1. 64 scans were averaged for each spectrum. 
To analyse the peptide status in each spinning solution a Nicolet 6700 FTIR was used to record 
FTIR spectra and the samples were held onto Calcium Fluoride (CaF2) windows. 32 scans were 
averaged for each spectrum and the HFIP solvent spectrum (blank) was subtracted from the 
spinning solution spectra. 
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3.2.11 Circular Dichroism Spectroscopy (CD)  
To analyse the secondary structure of the peptide in solution, circular dichroism was also utilised. 
CD spectroscopy is a technique in which the difference in the absorption of left‐handed circularly 
polarised light (L‐CPL) and right‐handed circularly polarised light (R‐CPL) is measured over a 
range of wavelength. The far-UV CD spectroscopy is frequently used to reflect secondary 
structure content of proteins (194).  
In this study CD spectra were recorded using a Chirascan CD spectrometer and the solutions 
were analysed in 1 mm path-length cuvettes at 22°C (spinning condition). The data were 
acquired in the step resolution of 1 nm and at a scan speed of 60 nm min-1. A bandwidth of 4.3 
nm was used to have smoother spectra. Far-UV spectra were recorded in wavelength range of 
190 to 240 nm. Each spectrum is the average of two scans. The spectrum of HFIP as blank 
solvent has been subtracted from the spectra of the spinning solutions. The data then were 
converted to mean residue ellipticity (deg cm2 dmol-1) and finally a seventh order polynomial 
fitting operation was performed (R2 ≥ 0.95).  
3.2.12 Contact Angle Measurement 
Contact angle measurement was employed to characterise the wettability of the webs. Normally, 
this method is used to analyse solid surfaces. Note that in the analysis of electrospun webs, the 
contact angle between the wetting liquid and the wetted surface is the result of surface energy 
interactions between the solid-liquid-air phases (rough surface). 
In this study an FTA4000 Microdrop goniometer was used to measure the contact angle. The 
main components are a camera, dozing syringe, and a lighting system. The size of the droplet, 
needle to table distance and the image settings are controllable by the goniometer software. The 
test kit and the test procedure are designed based on the EN 828:2013 standard for wettability 
determination by measurement of contact angle. For this test the software was set up to start 
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taking images immediately after the liquid droplet is deposited. For each image the contact 
angles for both right and left sides of the droplet were measured and averaged. A drop of either 
deionised water (Milli-Q) or Dulbecco's Modified Eagle's medium (DMEM) with a volume of 
1.5 𝜇L was deposited and contact angles over 15 s were measured. Three replicates per sample 
were examined. In order to account for the porosity of electrospun webs, and determine its 
influence on wettability properties, films also were prepared out of the same spinning solutions 
to investigate the surface wettability in the absence of void space. PCL (6% w/w) and PCL/SAPs 
solutions in HFIP (with SAP contents reported in Table 3-4 and Table 3-5) were cast on glass 
slides and films were prepared by drying in a Gallenkamp OVL570 010J vacuum oven at room 
temperature under 10×103 Pa vacuum for 48 h. Contact angle measurements were carried out 
with deionised water and measurements were carried out in the same manner as described for 
fibrous samples (at the beginning of the current section). 
3.2.13 BS EN ISO 10993:2009 Biological Evaluation of Medical Devices 
(Cytotoxicity) 
The ISO 10993 standard describes methods to assess in vitro cytotoxicity of medical devices. 
These methods specify the incubation of cultured cells in contact with a device and/or extracts 
of a device either directly or through diffusion. This allows both qualitative and quantitative 
assessment of cytotoxicity. In this research, both extract cytotoxicity and direct cytotoxicity, 
methods were employed to study the electrospun materials (195, 196) (195, 196). 
3.2.13.1 Extract Cytotoxicity Method  
To prepare for extract toxicity testing, 300 mg of electrospun fibres, PCL, PCL/P11-4 and 
PCL/P11-8 (both with a peptide concentration of 20 mg mL-1), were prepared according to the 
method explained in Sections 3.2.1 and 3.2.2. The samples were sent to an external company to 
be sterilised under gamma irradiation. Samples were then incubated (80 r min-1) in Dulbecco's 
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Modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS) and 1% 
penicillin/streptomycin (P/S). The amount of fibres soaked in the medium was 100 mg mL-1 and 
they were incubated for 72 h at 37 °C in 5% (v/v) CO2 in air (pH 7.4). The fibres were then 
removed and 100 μl of the leftover medium was collected as the extract of the samples.  
For primary cell culture needed to perform the cytotoxicity tests, L929 mouse fibroblast cells 
were cultured in DMEM using an available cell line (provided in house), with 10% foetal bovine 
serum (FBS) and 1% penicillin/streptomycin (P/S) at 37 °C in 5% (v/v) CO2 in air until 
confluence (usually for 48 h until cell confluency is confirmed). An example image for an 
acceptable cell confluency level for L929 cells is shown in Figure 3-2. 
 
Figure 3-2. An acceptable level of L929 cell confluency for cytotoxicity test (image from the 
current study).   
 
The cell density was adjusted to 105 cells mL-1 by manually counting the cells. A counting 
chamber (haemocytometer) which is a microscope slide was used and a drop of cell culture was 
placed in its sink. The area of the sink is marked with a grid and by looking at the sample under 
an optical microscope, the number of cells in a given area can be counted. In this study, an 
Improved Neubauer haemocytometer was used, and based on the predefined depth of the sink, 
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the volume of the counted culture can be calculated. After measuring the cell density based on 
that, the required dilution took place to reach the density of 105 cells mL-1. 
For the cytotoxicity experiment, a 96-well plate (Corning® Carbo-BIND) was used and 100 μl 
cell suspension with the density of 105 cells mL-1 was placed into each well plate. After 24 h the 
cell culture medium was carefully removed and replaced with 100 μl of PCL (negative control), 
PCL/P11-4 and PCL/P11-8 samples’ extracts, whilst the last two rows were fed with DMEM 
(blank control ) and positive control of DMSO (Dimethyl Sulfoxide, purity ≥ 99.9). Eight 
replicates were used for each samples and the controls as well. The well plates containing cells 
and extract of the samples were incubated at 37°C in 5% (v/v) CO2 in air for 48 h to allow the 
extracts react with the cells.  
Optical Cell Confluency Assessment 
After incubation, the well plates were optically examined under Leica DFC365 FX monochrome 
digital microscope and images were recorded at 200x magnifications to see the morphology of 
the cells. 
MTS Assay 
MTS assay is a colorimetric method to quantify viable cells in proliferation and cytotoxicity 
assay. In this method, MTS tetrazolium compound is reduced by viable cells to generate a 
coloured formazan product which is soluble in cell culture media. The formazan dye produced 
by viable cells can be quantified by measuring the absorbance at 490 nm. MTS reagent contains 
a novel tetrazolium compound [3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] and an electron coupling reagent (phenazine 
ethosulfate; PES) (197). 
In this study after incubating cells and samples for 48 h and optical analysis, the samples were 
exposed to 20 μl MTS reagent of ‘CellTiter 96® Aqueous One’ solution directly and incubated 
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for 4 h at 37°C. The 96-well plate was then placed in Varioskan Flash Reader and the absorbance 
was recorded at 490 nm. The quantity of formazan product as measured by UV absorption at 
490 nm is directly proportional to the number of living cells in culture. 
3.2.13.2 Direct Cytotoxicity Method 
A brief summary of the method of test performed for direct cytotoxicity is given below. 
To prepare for direct toxicity testing, electrospun samples of PCL, PCL/P11-4 and PCL/P11-8 
(both at a peptide concentration of 20 mg mL-1), were prepared according to method explained 
in Sections 3.2.1 and 3.2.2 and they were sterilised under gamma irradiation in an external 
company. Samples were cut into 10×10 mm squares. Electrospun PCL was used as negative 
control as its non-cytotoxicity response is well documented in the literature (27, 31). 
For primary cell culture needed to perform the cytotoxicity tests, L929 mouse fibroblast cells 
were cultured in DMEM (Dulbecco’s modified Eagle’s medium) using available cell line 
(provided in house), with 10% foetal bovine serum and 1% Penicillin/Streptomycin (P/S) at 37°C 
in 5% (v/v) CO2 in air till confluence (usually for 48 h). 
The cell density was adjusted to 105 cells mL-1 by manually counting the cells. A counting 
chamber (hemocytometer), which is a microscope slide, was used and a drop of cell culture was 
placed in its sink. The area of the sink is marked with a grid and by looking at the sample under 
an optical microscope the number of cells can be counted in a given area. In this study, an 
Improved Neubauer hemocytometer was used, and based on the predefined depth of the sink, 
the volume of the counted culture can be calculated. After measuring the cell density based on 
this, the required dilution took place to reach the density of 105 cells mL-1. 
For the direct cytotoxicity experiment, two 24-well plates (Corning® Costar) were utilised and 
400 µL of either cell suspension (cells +DMEM) with the density of 105 cells mL-1or DMEM 
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only was placed into each row of 24-well plate (6 replicates for each sample). The plates were 
incubated at 37°C for 24 h and the sub-confluency of cells were verified with a microscope. 
After that the culture medium were removed from each plates and 500 µL of fresh DMEM were 
placed into the wells. The electrospun samples were firstly soaked with culture medium for 2 h 
to prevent additional adsorption of DMEM in the test and then each sample was carefully placed 
in the cell layer in the centre of wells. The blank row was left with DMEM only and in the 
positive control wells, 250 µL of DMSO (Dimethyl Sulfoxide, purity ≥ 99.9) and 250 µL of 
DMEM was added. Plates were incubated for 48 h at 37°C in 5% (v/v) CO2 in air. 
Optical Cell Confluency Assessment 
After incubation, the well plates were optically examined under a phase-contrast monochrome 
digital microscope of Leica DFC365 FX to see the morphology of the cells at the edges of fabrics 
in contact with the cells, and images at 200x magnifications were recorded. 
MTT Assay 
To quantify the viability of cells in direct contact with eletrospun samples, MTT assay was 
employed. MTT assay is colorimetric assay to assess viability of cells via cell metabolic activity. 
Yellow water soluble MTT compound (3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazoliumbromid) is metabolically reduced in viable cells to a blue-violet insoluble 
formazan. A solubilisation solution (usually either dimethyl sulfoxide, an acidified ethanol 
solution, or a solution of the detergent sodium dodecyl sulphate in diluted hydrochloric acid) is 
added to dissolve the insoluble purple formazan product into a coloured solution. After 
dissolving the formazan, the colour intensity was determined by optical density readings of 
photometric measurements at 570 nm and 650 nm.  
In this study, after the incubation and optical assessment, the culture medium was aspirated from 
each of the wells and the wells were washed using 200 µL of PBS (Phosphate buffered saline). 
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Then 200 µL of a filtered sterilised MTT solution (1 mg.ml-1 of (3-(4, 5-dimethylthiazol-2-yl)-
2, 5-diphenyltetrazoliumbromid) was added to each well and the plates were incubated at 37 ºC 
for 2 h. The MTT solution was removed from every well and replaced with 400 µL isopropanol 
to dissolve the generated blue-violet insoluble formazan. After swaying the plates they were 
placed in a micro-plate reader and readings were obtained at 570 nm and 650 nm. The quantity 
of formazan product measured as ODT (Equation 3-3 and Equation 3-4) is correlated to the 
number of living cells in each culture. 
Equation 3-3 
OD = (OD570 – OD650) 
Equation 3-4 
ODT = OD – ODB 
Where; 
OD570 is the mean value of the measured optical density of each sample at 570 nm. 
OD650 is the mean value of the measured optical density of each sample at 650 nm. 
ODB is the measured optical density of the blank sample. 
ODT is the overall optical density of the test sample.   
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3.2.14 BS ISO 23317:2014 In Vitro Evaluation for Apatite-Forming Ability of 
Materials Using Simulated Body Fluid (SBF) 
Different kind of materials can bond to living bone through a layer of apatite and this apatite can 
be reproduced on the surface of the materials in an acellular and protein-free Simulated Body 
Fluid (SBF). Ion concentrations in SBF is nearly equal to those of human blood plasma and 
therefore composition and structure of apatite which is formed in SBF is similar to bone mineral 
(198). A brief summary of the method of test performed in SBF is described below. 
3.2.14.1 Preparation of Test Specimens 
According to the international standard any configuration and size of the specimens can be used 
in this test. In the first run, electrospun samples were cut into 10±2 × 10±2 mm rectangular 
shapes (regardless of the weight). In the second run, samples were prepared with regard to their 
weight and content of peptide in them. However as in needle electrospinning there is always 
waste of fibres and/or polymer solutions, the calculation would be approximate. The aim was to 
prepare samples in which there is approximately 40 mg of peptides. Therefore, electrospinning 
solutions for PCL/SAPs (at peptide concentration of 20 mg mL-1), were electrospun and the 
fibrous webs (size ~ 150 mm × 150 mm) were folded twice to make them thicker and with higher 
concentration of peptide in unit area. Then based on Equation 3-1 and Table 3-6, 240 mg fibres 
of PCL/P11-4 and 285 mg fibres of PCL/P11-8 were cut and weighed out. The samples were in 
rectangular shape (70±10 mm × 70±10 mm) and with approximate 40 mg of peptide. A control 
sample of 100% PCL with 250 mg weight was also prepared. 
3.2.14.2 Preparation of Simulated Body Fluid (SBF) 
The concentration of ions in SBF was defined based on the standard and with this SBF a 
correlation between in vivo bone ingrowth and in vitro apatite-forming ability has been observed 
(198).   
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SBF Ion Concentration 
The ion concentration in SBF and blood plasma is defined in Table 3-7. 
Table 3-7. Ion concentration of SBF and human blood plasma. 
Ion 
Concentration (10-3 mol) in 
SBF (pH 7.4) 
Blood plasma  
(pH 7.2 to 7.4) 
Na+ 142.0 142.0 
K+ 5.0 5.0 
Mg+ 1.5 1.5 
Ca+ 2.5 2.5 
Cl- 147.8 103.0 
HCO3- 4.2 27.0 
HPO42- 1.0 1.0 
SO42- 0.5 0.5 
 
Reagents Used in SBF 
To prepare SBF, ion-exchanged and distilled water in accordance with ISO 3696:1987 (provided 
in house) and the following amount of recognised analytical grade chemicals (Table 3-8) were 
used.  
Table 3-8. Reagents for preparation of SBF in the required order of dissolution. 
Order Reagent Amount Purity 
Formula 
weight (g/mol) 
1 Sodium chloride (NaCl)  8.03 g 99.5 % 58.44 
2 Sodium hydrogen carbonate (NaHCO3)  0.35 g 99.5 % 84.00 
3 Potassium chloride (KCl) 0.25 g 99.5 % 74.55 
4 
Di-potassium hydrogen phosphate 
trihydrate (K2HPO4 . 3H2O) 
0.23 g 99.0 % 228.22 
5 
Magnesium chloride hexahydrate 
(MgCl2 . 6H2O) 
0.31 g 98.0 % 203.30 
6 
Hydrochloric acid solution 
(HCl) = 1 mol/L 
39 mL - - 
7 Calcium chloride (CaCl2) 0.29 g 95.0 % 110.98 
8 Sodium sulphate (Na2SO4) 0.07 g 99.0 % 142.04 
9 
Tris- hydroxymethyl aminomethane 
((HOCH2)3CNH2)  
6.11 g 99.0 % 121.13 
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 SBF Preparation Procedure 
An inappropriate preparation method could lead to precipitation of apatite in solution since SBF 
is supersaturated with respect to apatite. Therefore during the preparation, additional care must 
be taken and the solution must remain colourless, transparent and without any deposit on the 
surface of glass. 700 mL water was put in a 1 litre plastic beaker with a stirrer bar and covered 
with a watch glass and they were set in a water bath on top of the stirrer. The water was heated 
to 36.5 ± 1.5 °C while stirring. Figure 3-3 shows an example of the apparatus for preparing SBF. 
After that, the required reagents were dissolved in the order given in Table 3-8 in distilled water 
at the set temperature. The reagents were dissolved one by one only after the preceding one was 
completely dissolved. This was more sensitive in the case of TRIS, and therefore by careful note 
of the pH and temperature change, it was added little by little taking only when pH was stable 
and temperature was at 36.5±0.5 °C. This is because addition of large amount of TRIS can 
radically increase the local pH of solution which could lead to precipitation of apatite. Increase 
in solution temperature can decrease the pH so the pH was kept below 7.4 by the addition of HCl 
solution. After dissolving all of TRIS, the pH of solution was adjusted to 7.4 ± 0.1 at 36.5 ± 0.2 
°C using HCl solution. Then the solution was transferred into a 1 litre volumetric flask and after 
cooling down to 20°C, a 1 L the solution was prepared by adding required amount of distilled 
water. 
 
Figure 3-3. Apparatus for preparing SBF (198). 
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3.2.14.3 Calculation of Volume of SBF 
In this study and in the first run, where the specimens were prepared according to their area, the 
required volume of SBF for each specimen was calculated based on Equation 3-5:  
Equation 3-5 
Vs = 100mm ×  Sa 
Where; 
VS is the volume of SBF in mm3. 
Sa is the apparent surface area of the specimen in mm2. 
In this equation, based on the international standard (198), if the material is porous volume of 
SBF should be greater than the calculated VS. Therefore for a 10 ± 2 mm × 10 ± 2 mm rectangular 
electrospun sample, the consumed SBF was greater than 20 mL and in this study 25 mL was 
used for each sample. 
In the second run, where the samples were prepared based on their weight, a sample to SBF ratio 
of 0.5 mg mL-1 was chosen with inspiration from the work done by Poologasundarampillai et al. 
(199). Therefore for each 250 mg fibrous sample, 500 ml SBF was used.  
The calculated amount of SBF (in each run) was poured in a plastic bottle with a cap. After SBF 
was heated up to 36.5˚C, the samples were placed in each bottle and they were put in an incubator 
at 36.5˚C. In the first run samples were soaked in SBF for three time points of 3 d, 1 week and 
2 weeks and in the second run three time points of 1 week, 2 weeks and 4 weeks were applied.   
After incubation for different periods within four weeks, the specimens were taken out from SBF 
and some of them were gently rinsed with distilled water and some were kept unwashed to see 
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the effect of the washing process. Then the samples were dried in a desiccator at room 
temperature.   
After all the above procedures, to detect any apatite crystals formed on the surface of fabrics 
they were examined using SEM/EDX, FTIR and XRD analysis. 
3.2.15 Peptide Release from Electrospun PCL/SAPs Fibres in Water 
The main purpose of this experiment was to see the release behaviour of SAPs from PCL/SAP 
fibres in aqueous solution at different pH. Self-assembly of the peptides used in this study are 
pH-sensitive and they can form amphiphilic tapes in water (and further assembly to ribbons and 
fibrils) depending on pH of the solution and their concentration in solution (200). In principle, 
all of the transformation from monomeric random coil to fibrils are reversible (47). Therefore 
based on this behaviour, PCL/SAPs fibres with peptide concentration of 40 mg mL-1 were 
dissolved in aqueous solution at different pH to find out the kinetics of peptide disassembly and 
release and therefore to estimate the stability of peptides within the fibres in biological 
conditions. Fibres were first weighed out at their dry state and then they were dissolved in 
deionised water at pH 3.5, 7.5 and 10.5.  The ratio of fibre to deionised water was 1 mg in 3 mL 
and the pH of deionised water was titrated with 1 µL additions of HCl (1 M) or NaOH (1 M). 
The samples were incubated at 120 rpm in an orbital shaker incubator of ES-20 model from 
Grant Bio and the temperature was set at 37°C. After the time points of 30 min, 1 h, 24 h, 48 h 
and 1 week the samples were taken out of the solution. In some of the time points, the samples 
were washed three times in the same pH solution to make sure all the peptide residues are washed 
off. Then the samples were air-dried and weighed out to measure the weight loss. After that the 
dried samples were subjected to SEM to study any possible morphological changes during the 
degradation. To confirm the release of peptides into the solution, the supernatant fluid was 
subject to CD analysis according to the method described in Section 3.2.11. In order to determine 
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that the overall weight loss in the samples is exactly related to which component (PCL or SAP), 
the samples were analysed via TGA.   
3.2.15.1  Thermogravimetric Analysis (TGA) 
The degradation rate of PCL/peptides in aqueous solutions was measured by determining the 
weight loss of a sample by linearly increasing the temperature in a conventional TGA machine. 
The thermogravimetric analyses were performed on a TGA Q50 model from TA Instruments, 
using nitrogen as purge gas. Inert gas flow was 40 mL min-1 for balance purge flow and 60 mL 
min-1 for sample purge flow. The heating rate used was 10°C per minute and temperature range 
was 25°C through to 800°C. 
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3.2.16  IVN Tank Apparatus  
The ability of fibres to nucleate hydroxyapatite mineral and support mineral growth in vitro was 
determined using a steady state agarose gel system, based on the method originally described by 
Hunter and Goldberg (201, 202). Briefly, there are 18 individual cells in a single 10 mm thick 
sheet of PTFE (sample holder) and each cell was filled with 1 mL of a solution and was allowed 
to gel. Squares of dialysis membrane (SpectraPor-3 dialysis membrane) large enough to cover a 
single sample cell were cut and placed on both sides of the gels. The samples were then fixed 
and screwed using two other plastic cover plates (with perforated holes related to the cells) on 
either side of the dialysis membranes, and the whole sample holder was placed in the middle of 
a tank vertically and it was screwed using a u-shaped protector. The inner component of the cells 
have been coated by dichlorodimethylsilane treatment for several seconds, which creates a 
hydrophobic surface to minimise any unwanted nucleation point which can result in false 
positives. Two reservoir buffers (calcium- and phosphate-containing solutions) were prepared 
and poured on either side of the sample holder and therefore the buffers would perfused through 
the cells. The entire apparatus was incubated at 37°C for 5 d. Figure 3-4 is showing the 
schematics of the tank apparatus and its components and how it is set up step by step (part 1 to 
5). 
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Figure 3-4. In vitro nucleation tank apparatus.  
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3.2.16.1  Preparation of Calcium and Phosphate Buffers  
The masses of reagents required for calcium and phosphate buffers are shown in the Table 3-9 
and Table 3-10 respectively. To make the solutions, first all the reagents were added into a 5 L 
volumetric flask and then they were volumised using distilled water. Stirrer and stirrer bar were 
used to dissolve all reagents (until clear solutions were obtained). Buffers were then pH adjusted 
to 7.4 through the use of concentrated NaOH (5M) immediately before final volume correction. 
At the end, the solutions were filtered using a vacuum pump and a 22µm filter. 
Table 3-9. The reagents required to make 5 L of calcium buffer. 
 
 
 
 
 
Table 3-10. The reagents required to make 5 L of phosphate buffer. 
 
 
 
 
 
 
 
Calcium Buffer 5L 
Concentration 
required 
Mass 
required 
Calcium nitrate 6.5mM 7.67g 
HEPES 20mM 23.83g 
NaCl 150mM 43.84g 
Phosphate Buffer 5L 
Concentration 
required 
Mass 
required 
Sodium phosphate dibasic dihydrate 3.9mM 3.41g 
HEPES 20mM 23.83g 
NaCl 150mM 43.84g 
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3.2.16.2  Preparation of Negative and Positive Control Samples 
In each run of the tank, there were normally negative and positive sample gels in triplicate. To 
prepare the samples the following steps were followed; 
1) A solution of 2x steady state buffer was prepared according to Table 3-11. It was then 
filtered using 50 mL syringe fitted with a 22 µm filter tip. 
Table 3-11. The reagents required to make 1 L solution of 2x steady state buffer. 
 
2) 0.8 g of agarose was dissolved in 40 ml of filtered distilled water (filtered with 50ml 
syringe fitted with a 22µm filter tip) to produce a 2% solution. The mixture was heated 
in a microwave until it begins to bubble and it was mixed in vortex to make a 
homogeneous mixture, it was then placed into a 60°C water bath.  
3) A 2 mg mL-1 high molecular weight (83 kDa) poly-L-glutamic acid (PGA) solution was 
prepared by adding 1 mg PGA into 0.5 mL filtered distilled water (filtered with 22µm 
filter) and it was mixed until homogenous solution was obtained. Poly(l-glutamic acid) 
is a known nucleator of hydroxyapatite in this system (203). 
4) 20 mL of 2x steady state was added to a 50 ml falcon tube and it was labelled as 
negative. 
5) 19.8 mL of 2x steady state and 0.2 mL of the 2 mg mL-1 PGA solution were added to a 
50 ml falcon tube and it was labelled as positive. This produced a 20 μg mL-1 PGA/2x 
steady state solution. 
6) 20 mL of the agarose sample was added into each of the negative (prepared in step 4) 
and the positive (prepared in step 5) solutions and they were used as the final negative 
2x Steady State Buffer 1L Concentration Required Mass required for 1L 
HEPES 40mM 23.81g 
NaCl 300mM 43.83g 
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control and positive control respectively. In brief the negative and positive samples are 
indicated in Table 3-12. 
7) The control samples were then sonicated to remove any air bubble using a heated 
sonicator (60°C water bath). 
Table 3-12. Negative and postive control samples in IVN tank. 
Negative control 1% agarose prepared in 150 mM NaCl, 20 mM HEPES, pH 7.4. 
Positive control 10 µg/mL poly-L-glutamic acid   in 1 % agarose solution as above. 
 
3.2.16.3 Assembling the Samples and the Controls for Testing 
To set up the experiment, first of all the tank components were soaked in 0.1 M HCl overnight 
and then were thoroughly brushed using Decon® and rinsed with distilled water to remove any 
contamination. To prepare the sample holder a dialysis membrane square was paced over each 
cell on one side (Figure 3-5, step 1 and 2) and clamped in place using the Perspex® clamping 
plate and all the small bolts were screwed (Figure 3-5, step 3). Sample holder was then turned 
around and sample holes were filled with either samples (self-assembled peptide gels) or controls 
until each cell was full (approx. 1 mL) (Figure 3-5, step 4). Samples were then left to set 
(approximately 20 min) and a square of dialysis tubing was then placed over each sample and 
the second the second Perspex® clamping plate  were screwed into place (Figure 3-5, step 5 and 
6). After that the outside of the sample holder was greased and was placed into the tank. Lastly 
the system was sealed by adding the U-shaped protector on the top and the sample holder was 
screwed with the large screws (Figure 3-5, step 7). The seal was further supported by applying 
a high viscosity grease on the inner surface of U-shape protector prior to assembly. The tank was 
then placed onto two stirrers (in each side) with a stirrer bar in each reservoir, then the two 
buffers were poured in each side and the lid was placed on the tank and wrapped with para film 
(Figure 3-5, step 8). The whole setup was incubated at 37˚C for 5 d. After 5 d, the samples were 
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removed from the sample wells and phosphate assay were done to determine the phosphorous 
content spectrophotometrically (204).  
  
Step 1 Step 2 
  
Step 3 Step 4 
  
Step 5 Step 6 
 
 
 
Step 7 Step 8 
Figure 3-5. Steps 1 to 8 to assemble the samples in the IVN tank. 
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Conventionally in this method the samples are self-assembled peptide gels, however in this study 
it was intended to study the ability of fibrous samples to nucleate hydroxyapatite mineral. To 
prepare fibrous samples, the electrospun PCL/SAPs (at peptide concentration of 40 mg mL-1) 
were spun according to method described in Section 3.2.2 until a very thick layer is deposited 
(spinning time: 4 h). The fibre mats were then folded twice to obtain approximately 4 mm thick 
layer and after that the mats were cut into disks of 10 mm dimension (same as inner diameter of 
cells in the sample holder) using a punch cutter. The fibrous sample weights were 13 ± 1 mg and 
based on Equation 3-1 each disk contains approximately 4 mg peptide. The aim was to embed 
the fibrous disks within two layers of agarose negative sample (with neutral effect on nucleation) 
on both sides of the fibrous disks. In order to do this, first approximately 0.4 mL aliquots of 
agarose solutions were pipetted into each cell, then the fibrous disk was carefully placed on top 
of it, and at last another aliquot of agarose solution was poured on the top of the fibres for the 
sample cell to be sealed. The samples were then left to gel (for approximately 20 min) and then 
steps 5 and 6 was followed as above. Figure 3-6 shows the schematic and a picture of embedded 
fibrous disk in agarose gel.  
  
Figure 3-6. Fibrous disk sample embedded in agaorse gel. 
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3.2.16.4  Phosphate Assay 
After removing the samples from the tank, each sample was transferred to a single labelled glass 
vial. 2 mL of concentrated nitric acid was added to each sample and they were boiled on a 
hotplate at 80°C until a volume of ≤ 1 mL was achieved. 3 replicates of blank sample (2 mL 
nitric acid) also underwent this process as was required during the analysis. After boiling, each 
sample (approx. 1 mL) was made up to 10 mL using distilled water and then each sample was 
diluted another 10 times (30 μL of sample to 270 μL of distilled water). This 100-time dilution 
is to bring the phosphate content in to the range of the plotted calibration curve. 
Stock solution of AB was made of one part (A) of 10% ascorbic acid (0.5 g in 5 mL distilled 
water) and six parts (B) of 0.42% ammonium molybdate. 4H2O in H2SO4 (4.2 g ammonium 
molybdate.4H2O, 27.8 mL H2SO4 and 972.2 mL H2O). By adding 700 μL of AB solution to each 
300 μL of sample solutions, the final samples were produced from which 300 μL was pipetted 
in triplicate into a 96 well plate and was incubated for 1.5 h at 37°C. The 96-well plate was then 
placed in Varioskan Flash Reader and the absorbance was recorded at 820 nm. 
A calibration standard for the assay was also prepared by dissolving 0 – 100 µM of Na2HPO4 
(phosphate standard solution 1000 ppm) in distilled water. The standard solution dilution (with 
AB) was then followed in the same way as the sample dilution expressed above. The standard 
solution was then analysed by reading their absorbance at 820 nm and the resulting standard 
curve is corresponding to the expected phosphorous content of the gels.   
3.2.16.5 Statistical Analysis of Data 
Statistical analysis was carried in order to determine if the positive and negative controls 
significantly differ in each run to assure the success of the assay. Moreover each data set was 
subjected to a Kolmogorov-Smirnov test to ascertain if the data were normally distributed. After 
that, a t-test was carried out comparing each data set with its corresponding controls data set. 
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CHAPTER 4 
 
Characterisation of Electrospun PCL/SAPs Fibres 
4 Characterisation of Electrospun  
4.1 Introduction  
As reported in Section 2.5.3, electrospinning of PCL with peptide is an area of interest in tissue 
engineering and drug delivery applications. Electrospun PCL/peptide webs have shown 
significant improvement in biological properties compared to 100% scaffolds in terms of 
wettability, adhesion, and proliferation of different cell models (32, 36, 37, 45). Accordingly, 
the aim of this chapter was to investigate the feasibility of combining specific self-assembling 
peptides (SAPs), P11-4 and P11-8, with PCL in a one-step manufacturing process to produce 
electrospun fibres. It was also of interest to verify the incorporation and presence of the SAPs in 
the electrospun fibres as well as to determine how the secondary conformation of the SAPs 
changes before and after spinning.   
4.2 Experimental Details  
4.2.1 100% PCL Electrospun Fibres  
Different concentrations of PCL solution in HFIP were prepared to investigate suitable spinning 
conditions to produce fibres free from defects. The majority of previous studies have reported 
electrospinning of PCL with a molecular weight of 80,000 resulting in fibres free from beads 
(27). Initial experiments were carried out to check the spinning ability of PCL with a molecular 
weight of 80,000 in HFIP solution. With regards to the previous works reported in the literature 
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using different solvents (27), different PCL concentrations ranging from 6% (w/w) to 12% (w/w) 
at 2%-increment interval were prepared. The solutions were prepared according to the method 
explained in Section 3.2.1. The prepared PCL solutions were electrospun to determine spinning 
ability of each solutions using the needle electrospinning method described in Section 3.2.2. 
Based on previous literature (36), a flow rate of 1 mL h-1, voltages of 20 kV or 25 kV and tip to 
collector distances of 160 - 200 mm were employed. 
4.2.2 PCL/SAPs Electrospun Fibres 
Based on preliminary experiments involving spinning of 100% PCL solutions at 6% (w/w), 8% 
(w/w), 10% (w/w), and 12% (w/w) it was found that a 6% (w/w) concentration of PCL in HFIP 
was the most favourable for producing fine and smooth fibres free from defects. The smallest 
mean fibre diameter of 520 nm (standard deviation: 107 nm) was achieved with a 1 mL h-1 flow 
rate, a voltage of 20 kV and a spinning distance of 180 mm on an aluminium foil collector (results 
are presented in Section 4.3.1). According to the literature (43, 46, 47), both P11-4 and P11-8 can 
self-assemble and form nematic gels at a minimum concentration (critical chain entanglement 
concentration: C*) of 10-20 mg mL-1 (depending on the pH, temperature and ionic strength of 
the solution). Therefore, 20 mg mL-1 of each the SAPs (P11-4 and P11-8) was added to the 
prepared PCL solution. Over the course of this study, the concentration of peptides used in 
electrospinning solutions was fixed at 20 mg mL-1 unless otherwise stated. HFIP was selected as 
electrospinning solvent in light of its fast evaporation and ability to break down hydrophobic 
interactions and hydrogen bonds even at 20 mg mL-1 SAP concentration (205) so that clear 
solutions of PCL and SAPs random coils could be obtained prior to spinning. The method of 
peptide solution preparation was extensively explained in Section 3.2.1. After 24 h, clear 
solutions were obtained and the solutions were ready for spinning. Electrospinning for all of the 
solutions was conducted according to the method explained in Section 3.2.2. The flow rate was 
set at 1 mL h-1, with a tip to collector distance of 180 mm and a voltage of 20 kV. These were 
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found to be the optimum spinning conditions in the preliminary experiments dealing with 100% 
PCL solutions (Section 4.3.1). The samples were subjected to SEM analysis and the fibre 
diameters were analysed according to the methods explained in Sections 3.2.4.  In order to 
further understand the fibre morphology and formation of the nanofibres, TEM and ESEM 
analysis were performed using the methods detailed in Sections 3.2.5 and 3.2.6.       
4.2.3 Influence of the Polarity of the High Voltage Power Supply during 
Electrospinning on Fibre Morphology 
As discussed in Section 2.5.2.2, the polarity of the high voltage power supply during 
electrospinning can potentially affect fibre formation. In a conventional electrospinning setup, 
the power supply is connected to a positive polarity electrode and this arrangement was also used 
in the present experiments, unless otherwise stated. In order to investigate the effect of a change 
in the polarity on the fibre morphology in PCL/SAP webs, PCL/P11-4 and PCL/P11-8 solutions 
with a SAP concentration of 20 mg mL-1 were electrospun at constant spinning conditions 
explained in Section 4.2.2, with either negative or positive polarity electrodes. The resulting 
electrospun samples were subjected to SEM analysis to critically analyse any changes in fibre 
morphology.  
4.2.4 Effect of Concentrations of SAP in PCL/SAPs Electrospun Fibres 
 To investigate the effect of peptide concentration in the electrospinning solution on fibre 
morphology, solutions of 10 mg mL-1, 20 mg mL-1 and 40 mg mL-1 of P11-4 and P11-8 were 
prepared according to the method in Section 3.2.1. These solutions were electrospun at room 
temperature at a flow rate of 1 mL h-1, a voltage of 20 kV and a spinning distance of 180 mm. 
The samples were subjected to SEM analysis to critically analyse any changes in fibre 
morphology. 
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4.2.5 Peptide Presence in Fibres; Energy-Dispersive X-Ray Spectroscopy 
Energy-dispersive X-ray spectroscopy analysis was employed to detect nitrogen, which is 
indicative of the presence of peptide within the as-spun PCL/SAP fibres, as described in Section 
3.2.8. Dry electrospun samples produced from PCL/P11-4 and PCL/P11-8 solutions at a peptide 
concentration of 20 mg mL-1 were sputter coated with platinum with a thickness of 8 nm. 
Electrospun fibres were subjected EDX spectroscopy (Oxford Instruments, AztecEnergy) and 
the electron beam was focused with the help of a field emission gun scanning electron 
microscope (LEO1530 Gemini) under high vacuum. An accelerating voltage of 15 kV was 
applied and three random spots per sample were tested across each sample.  
EDX was also applied to samples of PCL/P11-8 with a peptide concentration of 20 mg mL-1 in 
conjunction with TEM to be able to achieve higher magnification. The FEI Tecnai TF20 TEM 
microscope was fitted with an EDX system (Oxford Instruments INCA 350). As EDX is mainly 
considered a qualitative analysis in which some elements may be missed or falsely identified, a 
control sample of electrospun PCL fibres was also analysed to validate data. Three random spots 
per sample was tested using both SEM/EDX and TEM/EDX, and the results are expressed as 
mean ± standard deviation. 
4.2.6 Peptide Distribution in Fibres; Florescent Microscopy  
In order to visually observe the peptide distribution throughout the fibres, the peptides in the 
spinning solution were fluorescently labelled with oppositely charged functionalised peptides by 
a fluorescein moiety [ratio of flour-P11-4:P11-8 = 1:60 and ratio of flour-P11-8:P11-4 = 1:60] to 
aid viewing by confocal microscopy. The method is extensively explained in Section 3.2.7. 
Opposite charged functionalised peptide was used in this case to produce a polyelectrolyte -
sheet complex. Mixing an anionic and cationic peptide is an alternative way to induce self-
assembly (206), which in this case was the preferred method to ensure full mixing of the fluoro-
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tagged peptides with peptides in solution. Electrospun fibres produced from PCL/P11-4 and 
PCL/P11-8 solutions at a peptide concentration of 20 mg mL-1 (doped with oppositely charged 
flouro-SAPs) along with a blank sample of PCL were observed by confocal laser scanning 
microscopy (Zeiss LSM510).  
4.2.7 Peptide Secondary Structures in Solution and in As-Spun Fibres 
Both Fourier Transform Infra-Red spectroscopy (FTIR) and Circular Dichroism spectroscopy 
(CD) were employed to determine the secondary structure of the peptides in solution (before 
electrospinning) and in the fibre state. The methods are detailed in Sections 3.2.10 and 3.2.11.   
4.2.7.1 Peptides Secondary Structure in Spinning Solution 
The secondary state of peptides withiun the solutions prior to spinning were investigated using 
FTIR and CD methods. 
FTIR and CD on PCL/SAPs Solutions  
Spinning solutions of PCL/P11-4 and PCL/P11-8 at different peptide concentrations were 
prepared in a same manner to that used for electrospinning and they were assessed for both CD 
and FTIR analysis. A control sample of PCL in HFIP (6% w/w) was analysed by FTIR and the 
spectrum of HFIP was subtracted from the solutions spectra in both the CD and FTIR results.  
CD spectroscopy is a fast photometric technique that can determine the secondary structure of 
peptides/proteins in the "far-UV" spectral region (190-250 nm). At these wavelengths, the 
chromophore is the peptide bond and the signal arises when it is located in a regular, folded 
environment. α-helix, β-sheet and random coil structures each give rise to a characteristic CD 
spectrum. The CD software gives the output in ellipticity (symbol θ), and its unit is millidegrees 
(mdeg). However to be able to compare the results with those of others, the ellipticity θ is usually 
converted to the molar ellipticity (symbol [θ]) with the unit of deg cm2 dmol-1 (Equation 4-1).  
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Equation 4-1 
[θ] = θ / (10 x c x l) 
c = (1000 x n x cg)/Mr 
Where; 
c is the molar concentration of the sample (mole L-1). 
l is the pathlength in cm. 
cg is the macromolecule concentration in g ml-1. 
Mr is the molecular weight of the species. 
Alternatively, for far UV CD measurements, the data can be reported in mean residue molar 
ellipticity (symbol [θ] MRW) with the unit of deg cm2 dmol-1, and it can be calculated by 
Equation 4-2 and Equation 4-3; 
Equation 4-2 
[θ] MRW = θ/ (10 x cr x l) 
Equation 4-3 
cr = n x c 
Where;  
cr is the mean residue molar concentration. 
n is the number of peptide bonds in the protein or peptide (207-210). 
The CD data herein were converted to mean residue ellipticity (deg cm2 dmol-1) and each 
spectrum is the average of two scans. The spectrum of HFIP as a blank solvent was subtracted 
from all the spectra and finally a seventh order fitting operation was performed using OriginPro 
software (0.95<R2<0.99). 
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4.2.7.2 Peptides Secondary Structure in As-Spun Fibres  
The secondary state of SAPs within the fibres after spinning and vacuum drying procedures were 
evaluated using ATR-FTIR method. 
ATR-FTIR on PCL/SAPs Fibre Webs 
Infrared spectra of PCL, PCL/P11-4 and PCL/P11-8 fibres (at different peptide concentrations) 
deposited on the aluminium foil were obtained using a Perkin Elmer FTIR with diamond 
Attenuated Total Reflectance (ATR) attachment system. A total of 64 scans were averaged for 
each spectrum in the range between 4000 and 400 cm-1 with a resolution of 4 cm-1 and interval 
scanning of 2 cm-1. 
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4.3 Results and Discussion 
4.3.1 Fibre Morphological Results of 100% PCL Electrospinning  
A summary of the needle electrospinning behaviour of PCL solutions at different 
concentrations and by applying different electrospinning parameters is given in Figure 4-1. 
This reports visual observations during electrospinning as well as SEM micrographs of samples 
produced using successful spinning conditions. SEM micrographs were taken at a 
magnification of 800-3Kx to provide an initial examination of morphological characteristics of 
the as-spun PCL fibres. At the highest PCL concentration of 12% (w/w) regardless of spinning 
parameters used in this study, spinning was not possible. This can be attributed to the relatively 
high viscosity of PCL polymer solutions at 12% (w/w) and the insufficient electrostatic force 
that could be generated to overcome the surface tension. At 10% (w/w) PCL concentration, the 
polymer solution dried at the needle tip. Particularly, when a higher voltage (25 kV) was 
applied, an electrospinning jet was formed but it produced very thick merged fibres similar to 
a film.  At a reduced solution concentration of 8% (w/w), regardless of the spinning conditions 
employed in this study, wet and thick fibres were formed and merged fibres could be observed 
at their junctions. Again, it appeared that the applied electrostatic charges (20-25 kV) were not 
able to stretch the viscoelastic solution and form elongated and defect free fibres. 
Electrospinning was found to be possible at 6% (w/w), although not at voltages as high as 25 
kV. When a lower voltage of 20 kV was applied, fibres could be formed when the spinning 
distances were between 160 – 180 mm. However, when the distance was increased to 200 mm, 
the polymer solution dried at the tip of the needle and no fibres were produced. A spinning 
distance of 160 mm produced fibres that were very thick (average: 4.3 µm), which could be 
attributed to insufficient time for the polymer solution to elongated. When the spinning distance 
was 180 mm, there was sufficient time to allow the applied electrostatic charges to elongate the 
jet and create fibres free from defects in a submicron diameter range from 400-600 nm.   
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Figure 4-1. SEM micrographs of electrospun webs produced from PCL in HFIP solutions at 
different PCL combination of concentration, voltage (V) and tip to collector distance (D). 
V 
(kV) 
D 
(mm) 
Concentration (w/w) 
6% 8% 10% 
20 160 
  
 Unspinnable 
20 180 
  
Unspinnable 
20 200 
Polymer dried at the needle 
tip 
 
Unspinnable 
25 160 Unspinnable 
 
Polymer dried at the 
needle tip 
25 180 Unspinnable 
  
25 200 Unspinnable 
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4.3.2 Fibre Morphological Results of PCL/SAPs Electrospinning   
Electrospun webs of PCL and SAPs were successfully produced and the nano- and submicron 
scale structures were studied to elucidate fibre morphology and fibre diameter. In this section, 
electrospun fibres made of 100% PCL (control sample), PCL/P11-4 and PCL/P11-8 solutions at 
a peptide concentration of 20 mg mL-1 were studied; spinning parameters are given in Section 
4.2.2  (1 mL h-1 flow rate, a voltage of 20 kV and a spinning distance of 180 mm on an 
aluminium foil collector) and were not varied for these experiments.   
4.3.2.1 SEM of As-Spun Fibre Webs 
Spinning conditions that produced good coverage of fibres on the collector were analysed by 
SEM imaging using the method explained in Section 3.2.3. Figure 4-2 shows micrographs 
taken from low (12Kx) to high magnifications (102Kx) for 100% PCL, PCL/P11-4 and 
PCL/P11-8 electrospun fibres. It can be seen from Figure 4-2 that electrospinning of the 
commixed PCL and SAPs induced detectable changes in the fibre morphology as compared to 
100% PCL. PCL fibres were uniformly distributed in terms of their shape and diameter. In 
contrast, the PCL webs containing P11-4 or P11-8 peptide consisted of two superimposed fibre 
networks. The first network consisted of submicron fibres and the second was a nanofibre 
network in which the constituent fibres were substantially smaller in diameter than the first. 
There was a marked difference between the PCL/P11-4 and the PCL/P11-8 fibre webs in terms 
of this biphasic fibre diameter. In the PCL/P11-8 webs, two distinct networks were evident, 
consisting of both submicron and nanofibre phases. Micrographs of the PCL/P11-4 fibre webs 
revealed relatively fewer nanofibres, which were distributed locally rather than uniformly 
across the submicron fibre network.  
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Figure 4-2. SEM micrographs of, first row: 100% PCL; second row: PCL/P11-4 and third 
row: PCL/P11-8 electrospun fibres.  
 
4.3.2.2 Fibre Diameter in the PCL/SAPs Electrospun Webs 
Fibre diameter was measured according to the method described in Section 3.2.4 and data is 
reported in Figure 4-3. Figure 4-3 reveal that the 100% PCL fibres were quite uniformly 
distributed with diameters ranging between 300 nm and 500 nm. The peptide enriched samples 
however revealed a bimodal fibre diameter distribution attributable to the regions of 
submicron- (100-1000 nm) and nano-scale (below 100 nm). The nanofibres had a mean fibre 
diameter of around 30 nm and the submicron fibre diameter was typically between 100 nm and 
700 nm. The mean, standard deviation (SD), and the minimum and maximum values of fibre 
diameters are summarised in Table 4-1. In order to take the bimodal distribution into account, 
the measurements were obtained by treating the biphasic data as two independent distributions, 
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the first containing fibres with a diameter below 100 nm and the second with fibres above 100 
nm.  
Table 4-1. Fibre diameter in PCL, PCL/P11-4 and PCL/P11-8 webs (all data is nm). 
Sample 
Distribution for fibres <100 nm Distribution for fibres >100 nm 
Mean SD Min Max Mean SD Min Max 
PCL     386.9 47.7 302 514 
PCL/P11-4 28.5 8.9 15.3 51.2 418.7 125.2 112.9 734.2 
PCL/P11-8 36.9 20.1 10.1 95.9 326.9 113.2 106.5 700 
 
 
  
Figure 4-3. Fibre diameter distribution of (A) PCL, (B) PCL/P11-4 and (C) PCL/P11-8 webs. 
 
A 
 
B 
 
C 
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4.3.2.3 SEM Of Fibres Produced with Different Electrode Polarities in the 
Electrospinning Setup 
As discussed in Section 4.2.3, electrospinning was conducted with negative and positive 
polarity electrodes. This resulted in successful production of four samples of PCL/P11-4 and 
PCL/P11-8 (Figure 4-4).  In Figure 4-4 no marked observable difference was seen in the 
nanofibres extent and morphology of PCL/P11-4 and PCL/P11-8 (6% w/w PCL at 20 mg mL-1 
SAP concentration) fibre webs related to polarity which was in contrary to the literature (177).  
   
   
   
   
Figure 4-4. SEM micrographs of PCL/P11-4 produced with: (first row) negative electrode and 
(second row) positive electrode. SEM micrographs of PCL/P11-8 produced with: (third row) 
negative electrode and (fourth row) positive electrode.  
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4.3.2.4 TEM of As-Spun Electrospun Fibre Webs 
To investigate the nano-scale architecture of the PCL/SAP electrospun webs, PCL/P11-8 (6% 
w/w) solutions containing 20 mg mL-1 peptide concentrations were directly electrospun onto 
TEM grids (mounted on aluminium foil). Only a thin layer of the fibres were collected (3 min 
spinning time) and TEM analysis was performed subsequently using a FEI Tecnai TF20. Figure 
4-5 shows TEM micrographs of PCL/P11-8 webs deposited on the TEM grids at low (top row) 
and high magnification (bottom row) of 150Kx and 231Kx respectively. In these images, the 
overlaid nano- (<100 nm) and submicron (>100 nm) diameter fibres are clearly visible.  
  
  
Figure 4-5. TEM images of PCL/P11-8 with a peptide concentration of 20 mg mL-1 at 150Kx 
(top row) and 231Kx (bottom row) magnifications. 
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It is apparent from Figure 4-5 that the micro and nano-scale fibres are in contact at certain 
intersections, but in many locations the nanofibres appear to overlay the larger submicron fibres 
without merging.  
4.3.2.5 ESEM of PCL/SAPs Multi-Scale Fibrous Structure  
In solution electrospinning, the solvent is predominantly evaporated during the flight of the 
polymer jet from the tip of needle to the collector. However, it is conceivable that some residual 
solvent can be left in the fibres of the web and that evaporation can continue to some extent 
after deposition. The self-assembly of peptides here, is thought to be driven by solvent 
evaporation due to the critical peptide concentration (C*) being reached (43, 46, 47). Therefore, 
the evaporation rate of the solvent can be hypothesised to be connected with the formation of 
peptide beta-sheets, which could resemble a nanofibre network. When P11-8 are self-assembled 
into β sheets, they form fibres of 20–30 nm in dimensions (48) and it therefore may be partly 
responsible for the bimodal fibre diameter distributions observed in PCL/SAP networks. It was 
reasoned that by gradually drying the as-spun fibres, it might be possible to track the formation 
of fibrils post spinning, especially when it was known that residual solvent was left on board 
the fibres. The ESEM was used to track the effect of the drying procedure and solvent 
evaporation on the fibre and fibril morphology according to the procedure explained in Section 
3.2.6. A 6% (w/w) PCL solution with 20 mg mL-1 P11-8 peptide concentration was electrospun 
for up to 3 min under the conditions described in Section 3.2.2, and the as-spun fibres were 
then immediately transferred into liquid nitrogen to minimise the solvent evaporation. In order 
to eliminate the effects of vacuum pressure in coating and in the SEM chamber, the samples 
were first imaged in the uncoated state. From liquid nitrogen, the wet fibres were then 
immediately mounted on SEM stubs and transferred into the low vacuum mode of the ESEM. 
The results are shown in Figure 4-6, both immediately after mounting (A) and after 25 min (B). 
It can be observed that in Figure 4-6 (A), the nanofibres are not visible, whereas in image (B) 
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one or two nanofibres might be seen which can be contributed to the solvent being gradually 
evaporated but not fully, because the samples are still in low vacuum environment. 
  
Figure 4-6. ESEM micrographs of wet and uncoated PCL/P11-8 with peptide concentration of 
20 mg mL-1, (A) immediately after mounting in microscope and (B) after 25 minutes. 
 
In the next step, the same sample was left to be dried completely in vacuum for 24 h under the 
vacuum conditions explained in Section 3.2.2 and then subjected to ESEM in uncoated state to 
see any changes followed by complete solvent residue evaporation. The images are shown in 
Figure 4-7 at 30Kx (left) and 60Kx (right) magnifications and it can clearly be seen that some 
nanofibres are formed and appeared following the drying procedure. However, compared with 
PCL/P11-8 images in Figure 4-2 and Figure 4-4, the nanofibres here (in Figure 4-7) may be less 
visible which can be due to the low resolution of images and lack of surface conductivity on 
the fibres, which is because of lack of coating. Therefore the same sample were subjected to 
Pd/Pt coating (procedure explained in Section 3.2.3) and it was imaged under high vacuum 
mode (normal SEM conditions). The result is shown in Figure 4-8 (at different magnifications 
of 30K-60K x) and the presence of extensive nanofibre networks are evident in this image 
(similar to Figure 4-2). 
A 
 
B 
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Figure 4-7. ESEM micrographs of vacuum dried but uncoated PCL/P11-8 with peptide 
concentration of 20 mg mL-1, at 30Kx (left) and 60Kx (right) magnifications. 
 
  
Figure 4-8. ESEM (high vacuum mode) micrographs of vacuum dried and coated PCL/P11-8 
with peptide concentration of 20 mg mL-1, at 30Kx (left) and 60Kx (right) magnifications. 
 
By investigation of these results, it can be suggested that as the as-spun fibres are gradually 
dried, the nanofibres network may be more formed even after spinning. This can be due to the 
residual solvents being evaporated and consequently the concentration of SAPs being 
increased. However due to the nature of fibrous samples, it is not favourable to use ESEM 
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technique to image uncoated and wet samples which may result in low resolution images, and 
false conclusions. 
4.3.3 Effect of Peptide Concentration on Fibre Morphology and Diameter 
In order to investigate the effect of SAP concentration on fibre morphology, solutions of 
PCL/P11-4 and PCL/P11-8 with peptide concentrations of 10 mg mL-1, 20 mg mL-1 and 40 mg 
mL-1 were prepared and electrospun according to the method explained in Section 3.2.1 and 
3.2.2. A control sample of 100% PCL was prepared as well. The fibres were then critically 
analysed using SEM imaging. Electrospinning parameters were set at 1 mL h-1 flow rate, a 
voltage of 20 kV and a spinning distance of 180 mm. 
4.3.3.1 Effect of P11-8 Concentration on PCL/P11-8 Fibre Morphology  
Figure 4-9 shows SEM micrographs at two different magnifications, 12Kx (left column) and 
60Kx (right column) of webs containing PCL and varying concentrations of P11-8 peptide (0-
40 mg mL-1). It can clearly be seen that increasing the concentration of P11-8 results in an 
increase in the extent of nanofibrous network formation.  
4.3.3.2 Effect of P11-4 Concentration on PCL/P11-4 Fibre Morphology  
Figure 4-10 shows SEM micrographs at three different magnifications (5Kx, 12Kx, and 25Kx 
from left to right) of webs containing PCL and varying concentrations of P11-4 peptide (0-40 
mg mL-1). It could be seen from the SEM images that the addition of P11-4 into pure PCL 
solution results in network of nanofibres being introduced to the structure. However as 
explained before (Section 4.3.2.1), with P11-4 (in contrast with P11-8) the nanofibre network 
are not dominantly distributed and they are locally formed. By increasing P11-4 concentration 
from 10 mg mL-1 to 20 mg mL-1, the extent of the nanofibrous network increased. Any further 
addition of P11-4 from 20 to 40 mg mL-1 does not create any observable difference in the web.  
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Figure 4-9. SEM micrographs of (first row) PCL fibres, (second row) PCL/P11-8 with peptide 
concentration of 10 mg mL-1, (third row) PCL/P11-8 with peptide concentration: 20 mg mL-1 
and (fourth row) PCL/P11-8 with peptide concentration: 40 mg mL-1.  
 
 98 
 
  
   
   
   
   
Figure 4-10. SEM micrographs of (first row) 100% PCL fibres, (second row) PCL/P11-4 with 
peptide concentration of 10 mg mL-1, (third row) PCL/P11-4 with peptide concentration of 20 
mg mL-1 and (fourth row) PCL/P11-4 with peptide concentration of 40 mg mL-1.  
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4.3.4 Peptide Presence and Distribution in Fibres 
4.3.4.1 Elemental Analysis on PCL/SAPs Fibre Webs by SEM-EDX 
The SEM-EDX spectra of the PCL control, PCL/P11-4 and PCL/P11-8 fibres at a peptide 
concentration of 20 mg mL-1 are shown in Figure 4-11. The presence of nitrogen peaks are 
observed in PCL/P11-8 and PCL/P11-4 spectra. The nitrogen peak in the EDX spectra is 
attributed to the peptide molecules which indicate the successful incorporation of peptides in 
the PCL/P11-8 and PCL/P11-4 fibres. As expected, nitrogen peak is not present in the PCL 
control spectrum.  
     
.      
    
Figure 4-11. SEM/EDX analysis of electrospun (A) PCL, (B) PCL/P11-4 and (C) PCL/P11-8 
fibres. 
 
 
A 
 
B 
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Table 4-2 summarises the average ± standard deviation of atomic percentage results of the 
chemical elements in each samples. 
Table 4-2. Atomic percentages of chemical elements in the elctrospun fibres by SEM/EDX. 
Sample C% N% O% 
PCL 91.8 ± 3.6 0.0 8.2 ± 3.7 
PCL/P11-8 80.4 ± 13.1 7.3 ± 2.9 12.3 ± 6.6 
PCL/P11-4 81.5  ± 13.7 5.4 ± 3.9 13.1 ± 4.2 
 
4.3.4.2 Elemental Analysis on PCL/P11-8 Fibre Webs by TEM-EDX 
In addition to SEM-EDX, EDX spectrometry was applied to high resolution TEM images of the 
nano- and submicron scale fibres in the PCL/P11-8 web (samples which were analysed in Section 
4.3.2.4). Figure 4-12 shows one example of typical submicron fibre (diameter around 300 nm) 
and a single connected nanofibre (diameter less than 50 nm). EDX spectrometry was applied to 
each of these fibres and an average nitrogen content of 6.5 ± 1.4% in the submicron fibres and 
4.1 ± 1.3% in the nanofibers were confirmed. There is a large peak in the TEM spectra attributed 
to cupper, which is related to the TEM grids. Table 4-3 summarises the average ± standard 
deviation of atomic percentage results of the chemical elements in each of the two types of fibres. 
The fact that TEM-EDX was carried out in 100% vacuum mode excludes the possibility of 
detecting environmental nitrogen residue. These observations are indicative of the presence of 
peptide within both the larger submicron (100-700 nm) and nanofibre architecture (10-100 nm), 
providing evidence of the absence of phase separation between PCL and the peptide during 
electrospinning.  
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Figure 4-12. (A) TEM micrograph of PCL/P11-8 and magnified micrographs are showing 
both submicron fibre and nanofibre. EDX spectroscopy analysis (full scale and magnified 
scale) are showing the presence of nitrogen element in both of (B) submicron and (C) 
nanofibre. 
 
 
 
B 
 
C 
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Table 4-3. Atomic percentages of chemical elements in the submicron and nanofiber of the 
elctrospun PCL/P11-8 fibres by TEM/EDX. 
EDX spot C% N% O% 
Submicron fibre 86.3 ± 3.2 6.5 ± 1.4 7.2 ± 2.8 
Nanofibre 91.1 ± 1.9 4.1 ± 1.3 4.8 ± 2.1 
 
4.3.4.3 SAPs distribution analysis on PCL/SAPs fibre webs by CLSM  
Micrographs of electrospun PCL/P11-4 and PCL/P11-8 webs containing fluorescently tagged 
peptides as well as PCL control sample are shown in Figure 4-13. No fluorescence background 
was detected in the PCL control. In contrast, the PCL/P11-4 and PCL/P11-8 samples clearly show 
individual fibres (green fluorescence). This confirms homogenous incorporation of peptides 
throughout the entire fibrous structure and the results are in agreement with the SEM/EDX and 
TEM/EDX elemental analysis.  
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Figure 4-13.  CLSM micrographs of electrospun (A) PCL, (B) PCL/P11-4 and (C) PCL/P11-8 
fibres in which peptide samples are fluorescently tagged.  
 
A 
 
B 
 
C 
 
 104 
 
4.3.5 Peptide Secondary State in PCL/SAPs Solutions 
The secondary state of peptides within the solutions prior to spinning were investigated using 
FTIR and CD methods and the results are presented in this section. 
4.3.5.1 Peptide Secondary Structure in PCL/SAPs Solutions by CD Analysis 
P11-4 and P11-8 solutions were prepared by dissolving 20 mg of the peptides in 1 mL of PCL 
solution (6% w/w in HFIP) same as the method based of which, solutions for electrospinning 
were prepared (explained in Section 3.2.1). In addition, solutions of only peptides (P11-4 and 
P11-8) in HFIP at a concentration of 20 mg mL-1 were prepared and left for 24 h to obtain clear 
solutions, to compare with the electrospinning solutions. CD spectra were recorded according 
to the method described in Section 4.2.7.  
The CD spectra of the P11-4 and P11-8 spinning solutions (in PCL/HFIP) display a negative 
minimum at around 190-200 nm and a positive maximum at around 210-215 nm (Figure 4-14 
A-B), which is consistent with the random coil peptide conformation in the solution (211). This 
explanation is supported by the lack of a negative band at 218 nm and a strong positive 
maximum at lower wavelengths (198 nm), which would be characteristic of a β-sheet 
conformation (43, 46). This behaviour was also observed in the peptide solutions without PCL 
(Figure 4-14 C-D) with a small difference in the intensities. Generally a slight shift in 
wavelengths and slight shift in intensity of the peptide bands herein was observed when 
comparing the obtained spectra with previously reported CD plots (43, 46). This effect is likely 
to be related to much higher concentration of peptide used in this study (20 mg mL-1) compared 
to the average concentrations previously analysed during CD spectroscopy of P11-X peptides 
(0.15 mg mL-1) (43, 46). The random coil conformation showed herein, is due to the HFIP-
triggered breakdown of hydrogen bonds along the peptide molecules within the solutions. HFIP 
is a strong and volatile solvent and it was selected as electrospinning solvent in this study. In 
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the light of its fast evaporation and ability to break down hydrophobic interactions and 
hydrogen bonds, clear solutions of PCL and peptide random coils were obtained prior to 
spinning (205). 
 
 
 
 
    
Figure 4-14. CD spectra of (A) 20 mg mL-1 P11-4 solution in 6% w/w PCL/HFIP; (B) 20 mg 
mL-1 P11-8 solution in 6% w/w PCL/HFIP (Electrospinning condition), (C) 20 mg mL-1 P11-4 
solution in HFIP and (D) 20 mg mL-1 P11-8 in HFIP.  
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4.3.5.2 Peptide Secondary Structure in PCL/SAPs Solutions by FTIR Analysis 
Figure 4-15 and Figure 4-16 display FTIR spectra obtained for PCL/P11-4 and PCL/P11-8 
solutions respectively at different peptide concentrations (0, 10, 20 and 40 mg mL-1). As 
reported in literature (212), PCL has a distinct carbonyl stretching band at around 1720 cm-1. 
In all of the spectra, the strong peak at around 1710 cm-1 can be attributed to the C=O stretching 
vibration in carbonyl group of PCL, however this peak might slightly be shifted in solutions, 
which can be because of a possible peptide/PCL/HFIP secondary interaction. By looking at 
these spectra in the amide Iʹ region (1600-1700 cm-1), a broad peak was observed at around 
1650 cm-1 in both peptide (P11-4 and P11-8) containing solutions, confirming a random coil 
configuration (43). This is due to the HFIP-triggered breakdown of hydrogen bonds along the 
peptide molecules in solution (26). Moreover, in the amide IIʹ region (1500-1600 cm-1), there 
is a band at 1550 cm-1 in SAPs containing solutions, which corresponds to COO- group at the 
peptides’ backbone (48). 
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Figure 4-15. FTIR spectra of PCL and PCL/P11-4 in a HFIP solution at different peptide 
concentrations.  
 
 
Figure 4-16. FTIR spectra of PCL and PCL/P11-8 in a HFIP solution at different peptide 
concentrations. 
Wavenumber (cm-1) 
 
Wavenumber (cm-1) 
 
 108 
 
4.3.6 Peptide Secondary State in PCL/SAPs As-Spun Fibres  
The secondary state of SAPs within the fibres after spinning and vacuum drying procedures 
were evaluated using ATR-FTIR method and the results are presented in this section. 
4.3.6.1 Peptide Secondary Structure in PCL/SAPs Fibre Webs by ATR-FTIR Analysis 
Figure 4-17 displays the ATR-FTIR results obtained for electrospun PCL and PCL/P11-4 fibres 
at different peptide concentrations (10, 20 and 40 mg mL-1). Beside the strong peak at 1727 
cm-1 representing the carbonyl stretching of PCL in all of the spectra (212), the broad band at 
around 1650 cm-1 in peptide samples can be the result of random coil/non-assembled state of 
P11-4 peptide within the fibres. This peak at 1654 cm-1 can also be attributed to the glutamine 
amino acid side chain of P11-4 (213). However, by precisely looking at the spectra in amide Iʹ 
region, a weak absorbance at around 1630 cm-1 can be observed as well. This peak at 1630 cm-
1 coincides with β-sheet characteristic peak. Therefore, it can be assumed in PCL/P11-4 fibre, 
the conformation of peptide is dominantly in a non-assembled/random coil state, however an 
evidence of β-sheet conformation is found as well. Moreover, in the amide IIʹ region, it can be 
seen that by the increase in peptide concentration from 10 to 40 mg mL-1 in solutions, the band 
at 1550 cm-1 is intensified, which corresponds to COO- group at the peptides’ backbone (48). 
Figure 4-18 displays the ATR-FTIR results obtained for electrospun PCL and PCL/P11-8 fibres 
at different peptide concentrations (10, 20 and 40 mg mL-1). As reported previously in Section 
4.3.5.2, PCL has a distinct FTIR peak at 1727 cm-1 attributed to its carbonyl group and this 
characteristic peak is observed in all spectra of PCL/P11-8 fibres. In the amide Iʹ region, peaks 
at 1630 cm-1 and 1690 cm-1 give supporting evidence of the predominant anti parallel β-sheet 
conformation of peptide in the PCL/P11-8 fibres (in comparison with PCL/P11-4), the intensity 
of which increases with the increase in P11-8 concentration. Thus, the random coiled P11-8 
present in the PCL spinning solutions (Section 4.3.5) are likely to self-assemble during 
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electrospinning to yield predominant β-sheet conformation in the collected fibres. This can be 
the result of the critical peptide concentration (C*) being reached during electrospinning due 
to solvent evaporation. Moreover, in the amide IIʹ region, the band at 1550 cm-1 can be assigned 
to COO- group at the peptides’ backbone (48). 
 
Figure 4-17. FTIR spectra of PCL and PCL/P11-4 electrospun fibres at different peptide 
concentration. 
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Figure 4-18. FTIR spectra of PCL and PCL/P11-8 electrospun fibres at different peptide 
concentrations. 
 
4.4 Summary  
It was established that PCL at 6% (w/w) concentration in HFIP solution, can be electrospun 
using a single spinneret setup and produce smooth fibres that are free from defects. The smallest 
mean fibre diameter was achieved with a 1 mL h-1 flow rate, a voltage of 20 kV and a spinning 
distance of 180 mm on an aluminium foil collector. Then the successful encapsulation of self-
assembling P11-4 and P11-8 peptides within PCL fibres through a one-step electrospinning 
process was demonstrated. This resulted in a multiscale fibrous network containing both 
submicron (below 1 micron) and nano (below 100 nm) fibres; in contrast, the PCL control web 
was in submicron scale only. Polarity of the power supply does not create any observable 
difference in the morphologies of nanofiber in PCL/P11-4 and PCL/P11-8 fibres. Adjusting the 
peptide concentration in the electrospinning solution was found to be the main parameter in 
formation of the nanofibrous network; the nanofibrous network occurrence generally increased 
Wavenumber (cm-1) 
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by increasing the peptide concentration in the spinning solution. This was more obvious in the 
case of PCL/P11-8 webs. This further can be a useful means of systematically customising the 
internal nanoscale structure of the webs which provides a convenient way of controlling 
nonwoven architecture at a nanoscale. SEM/EDX confirmed the presence of peptides within the 
bulk of electrospun fibres. TEM/EDX revealed both the superimposed nano- and submicron 
scale fibres contain peptides, providing evidence of the absence of phase separation between 
PCL and the peptides during electrospinning. The homogenous distribution of peptides within 
the fibres was further confirmed by CLSM analysis. Peptide secondary conformation analysis of 
the spinning solution and as-spun fibres by CD and FTIR revealed a switch from monomeric to 
β-sheet peptide conformation and this was more apparent in PCL/P11-8 fibres compared to 
PCL/P11-4 fibres. This can confirm that electrospinning process of PCL/SAPs was able to trigger 
the molecular self-assembly mechanism and induce nanofibre formation. The hydrogen bonding 
mediated self-assembly of peptides during electrospinning is most likely related to the rapid 
solvent evaporation (above C*). Within the constraint of using ESEM method for uncoated 
fibrous samples, it is still reasonable to assume that some of the solvent evaporation-driven self-
assembly and the consequent nanofibre formation occurs after fibre deposition during the 
vacuum drying procedure. Although, most of the solvent is evaporated via the solvent jet from 
the nozzle tip to the collector, it is also possible that changes in peptide conformation continue 
if residual solvent is present in the deposited fibres.  
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CHAPTER 5 
 
Biological Properties of Electrospun PCL/SAPs 
Fibre Webs 
5 Biological Properties of El 
5.1 Introduction 
In Chapter 4, the production of PCL/SAPs fibres was successfully carried out via needle 
electrospinning resulting in a multiscale (submicron and nano-) diameter fibrous scaffold. 
Moreover, it was shown that the peptides were thoroughly incorporated into the fibrous 
network and electrospinning was able to trigger self-assembly and therefore resulting fibres 
contained β-sheet structure, though to varying extents. The aim of this chapter is to evaluate 
characteristics of the produced fibres when placed in a biological environment relevant to tissue 
repair and regeneration. Specifically, as key factors affecting the suitability of a scaffold for 
biological implantation, the wettability, cytotoxicity and degradation of the new materials were 
investigated. 
5.2 Experimental Details 
5.2.1 Wettability of PCL/SAPs Fibre Webs 
In the present study, by commixing PCL with SAPs, one of the intentions was to enhance and 
expand the potential applicability of PCL in tissue engineering by altering its hydrophilicity as 
well as its biofunctionality. Wettability can be characterised by contact angle measurements, 
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specifically the angle between the wetting liquid and the wetted surface, which is the result of 
the surface energy interactions between the solid-liquid-air phases. Given that water represents 
most of the weight fraction of the extracellular matrix of biological tissues, wetting is important 
and the contact angle of electrospun webs made of PCL and PCL/SAP were measured via 
application of deionized water and DMEM (Dulbecco's Modified Eagle's medium), to simulate 
biological medium. Since the surface of electrospun webs comprises solid fibres and pores such 
that the resulting discontinuities can potentially influence wetting behaviour, films were also 
prepared using the same polymer solutions as electrospinning solutions, to investigate the 
surface wettability of the non-porous material. 
The goniometer (explained in Section 3.2.12) was used to measure the contact angles of pristine 
PCL controls and samples containing the peptide. Electrospun samples of 100% PCL, PCL/P11-
4, and PCL/P11-8 (both at peptide concentrations of 10, 20 and 40 mg mL-1) prepared as 
described in Section 3.2.1 and 3.2.2, were cut out into 10×10 mm squares. A 1.5 𝜇L drop of 
either deionised water (Milli-Q) or DMEM was deposited on the surface and the contact angles 
were recorded for 15 s. Three replicates per sample were examined. For each image the contact 
angles for both the right and left sides of the droplet boundary were measured and the mean 
angle calculated. In some PCL/SAP samples, the duration of the test was substantially less than 
15 s because of substantially improved wetting behaviour compared to 100% PCL.  
Contact angle can be useful in the evaluation the hydrophilicity in electrospun webs, however 
in porous media such as this, the value also depends on the surface porosity and surface 
roughness based on Wenzel theory (214). In contact angle measurements of fibrous webs, only 
a fraction of the liquid is directly supported by contact with the fibres because of the large void 
volume. Therefore, to be able to verify the effects of SAPs content on the observed contact 
angle, two samples of identical material compositions as used to make the electrospun webs 
i.e. PCL and PCL/P11-8 at peptide concentrations of 10 and 20 mg mL-1 were also prepared as 
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films. 1 mL of PCL and PCL/P11-8 in HFIP were poured on to glass slides and films were cast 
by drying the solution under vacuum for 48 h in a Gallenkamp OVL570 010J vacuum oven at 
room temperature under 10×103 Pa vacuum. Contact angle measurements were then carried out 
with deionised water as described in the previous paragraph. 
5.2.2 Cytotoxicity Evaluation of PCL/SAPs Fibre Webs  
In this research, PCL/SAPs electrospun materials were analysed by both extract cytotoxicity 
and direct cytotoxicity methods as below. 
5.2.2.1 Extract Cytotoxicity Method 
Extract cytotoxicity assays are used to analyse the reaction of cells in contact with the material 
extracted from samples. The method employed in this study is explained in Section 3.2.13.1. 
Extracts of PCL/P11-4 and PCL/P11-8 electrospun web samples at a medium peptide 
concentration of 20 mg mL-1 were obtained. The extract of 100% PCL fibres was also taken as 
negative control because of its non-cytotoxicity (27, 31) and DMSO was used as positive 
control due to its strong cytotoxicity effect on cells and DMEM (cell culture medium) was used 
as blank control. After culturing the prepared cells in suspension for 24 h, the culture medium 
was replaced with these extract samples or with control solutions. The position of each sample 
(with 8 replicates) in a 96-well plate is shown in Figure 5-1.  
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Figure 5-1. Positioning of samples in a 96-well plate for the extract cytotoxicity assay. PCL 
extract was used as a negative control in row one, PCL/P11-4 extract in row two and PCL/P11-
8 extract in row three. Blank DMEM is in row four and the positive control (DMSO) in row 
five. 
 
The well plates containing cells and extracts from each of the samples (or controls) were 
incubated at 37°C in 5% (v/v) CO2 in air for 48 h to allow the extracts to react with the cells. 
After that the well plates were optically examined under a Leica DFC365 FX monochrome 
digital microscope to observe the cell morphology. To quantify cell viabilities after exposure to 
the sample extracts, the samples were directly exposed to 20 μl of CellTiter 96® AQueous One 
Solution reagent and incubated for 4 h as described in Section 3.2.13.1. This reagent can be bio-
reduced by cells into a coloured formazan product that is soluble in DMEM. The 96-well plate 
was then placed in a Varioskan Flash Reader and the absorbance was recorded at 490 nm. The 
quantity of formazan product as measured by the absorbance at 490 nm is directly proportional 
to the number of living cells in culture. Additional work reported in the next section (5.2.2.2) 
was carried out to address the response of cells cultured directly on to the surface of the 
nonwoven samples. 
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5.2.2.2 Direct Cytotoxicity Method 
A direct cytotoxicity assay was used to assess in vitro cytotoxicity of electrospun PCL/P11-4 and 
PCL/P11-8 fibres in direct contact with cultured L929 mouse fibroblasts. The method employed 
in this experiment was extensively explained in Section 3.2.13.2. PCL fibres were used as a 
negative control and DMSO as a positive control. After culturing the prepared cells in suspension 
for 24 h, the culture medium was replaced with fresh DMEM. In the case of the positive control 
wells, DMEM was replaced with 250 µg of fresh DMEM and 250 µg of DMSO. Then the pre-
soaked fibrous scaffolds (in DMEM) were placed in each sample well. A blank row was also left 
with DMEM only. The position of each sample (with 6 replicates) in two 24-well plates is shown 
in Figure 5-2.  
 
 
 
Figure 5-2. The position of samples in two 24-well plates for direct cytotoxicity assay. 
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The well plates containing cells and the electrospun scaffold samples (or controls) were 
incubated for 48 h at 37 ˚C in 5% (v/v) CO2 in air to allow the samples to interact with the cells. 
After incubation, the cell morphologies were analysed under a phase-contrast microscope at 
200x magnification. To quantify the viability of cells in direct contact with electrospun samples, 
a MTT assay was used as described in Section 3.2.13.2. MTT is metabolically reduced in viable 
cells to a blue-violet insoluble formazan. The quantity of formazan product as measured by the 
absorbance at 570-650 nm (Equation 3-3 and Equation 3-4), is directly proportional to the 
number of living cells in culture.   
5.2.3 Peptide Release Behaviour of PCL/SAPs Fibre Webs into Aqueous 
Solution 
Additionally, in this chapter the SAP release behaviour from the PCL/SAP fibre webs was 
explored in a simulated biological environment. For biomedical applications, it is of major 
importance to know the degradation or release kinetics of polymeric material components as it 
plays a major role in determining functional performance in situ. It is known that PCL is 
biodegradable through hydrolysis as reported in several studies depending on its molecular 
weight (27). However, the degree to which the SAPs are stable and remain within a PCL fibrous 
structure is currently unknown and it was therefore of interest to study the release of this 
material due to hydrolytic or diffusion effects.  
The release of SAP in an aqueous environment is to be anticipated because of its water 
solubility. Moreover because of the reversible transient self-assembly properties of P11 SAPs 
(47), such peptides structures are readily diffused in water-based media (upon a change in the 
environment i.e. pH or decrease in the concentration) even at the self-assembled state. 
Therefore, there is a risk they will migrate away from where they are needed to remain in a 
biological environment. Figure 5-3 shows self-assembly of P11 peptides from monomeric 
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random coil into hierarchical structures of fibrils and fibres and in principle, all of these 
transformations are reversible (47).  
 
Figure 5-3. Self-assembly of peptides from monomers in isotropic fluid to β-sheet tapes, 
ribbons, fibril and fibres in nematic gel form. 
 
Moreover it is known that peptide self-assembly into hierarchical structures in the case of P11-
4 and P11-8 is a pH dependant phenomena with the opposite phase behaviour (Figure 5-4) (200). 
Therefore, based on this behaviour, fibres containing peptides were incubated in aqueous 
solution at different pH to find out the kinetics of peptide disassembly and release and therefore 
to estimate the stability of peptides within the fibres in biological conditions. 
  
 
Figure 5-4. Transformation from isotropic fluid (monomer) to nematic gel (β-sheet) of (A) 
P11-4 and (B) P11-8 as a function of pH (47). 
Monomers  Tapes  Ribbons  Gel 
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The incubation method is described in Section 3.2.15. In brief, fibres were incubated in 
deionised water at pH 3.5, 7.5 and 10.5 at a stirring rate of 120 r min-1 and temperature of 37 
°C for 1 h, 24 h, 48 h and 7 d. After the incubation, the fibrous samples were analysed based 
on mass loss (TGA) and fibre morphology (SEM), and the peptide release in the supernatant 
of solutions was analysed through UV-CD. 
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5.3 Results and Discussion 
5.3.1 Wettability Behaviour of Electrospun PCL/SAPs Fibre Webs 
The wetting behaviour of electrospun webs composed of PCL and PCL/SAPs has not been 
previously studied and revealed remarkable differences in behaviour, as detailed in the 
following sections. 
5.3.1.1 Contact Angle of Water on PCL/SAPs Electrospun Fibres 
Figure 5-5 shows examples of a droplet of deionised water on the surface of the electrospun 
webs at time = 0 s. Contact angles greater than 90° were observed on electrospun PCL, whilst 
decreased contact angle values were measured in PCL/SAPs samples. Furthermore it can be 
seen that as the P11-4 and P11-8 concentration (0-20 mg mL-1) increased, the contact angle 
values decreased. The contact angles on both PCL/P11-4 and PCL/P11-8 at a peptide 
concentration of 40 mg mL-1 could not be imaged and measured because of the rapid 
penetration of the droplet into the web structure due to its super hydrophilicity. Table 5-1 
summarises the average of three replicates for initial contact angles ± standard error.   
Table 5-1. Contact angle of a droplet of deionised water on electrospun samples at time = 0 s. 
Sample 100% PCL 
PCL/ P11-4 
(10 mg mL-1) 
PCL/ P11-4 
(20 mg mL-1) 
PCL/ P11-8 
(10 mg mL-1) 
PCL/ P11-8 
(20 mg mL-1) 
Contact angle (°) 130 ± 0.5  70.3 ± 0.8 57.6 ± 1.1 78.8 ± 0.6 23.9 ± 1.2 
 
To improve the characterisation of wettability in these porous samples, the time factor was 
taken into the account and the rate of wetting was determined over 15 s using goniometry 
wherein several contact angles were measured at 1 s time interval. Figure 5-6 shows the 
dynamic contact angles of the liquid on the surfaces of each electrospun sample. Wetting was 
found to progressively increase by addition of only 10 mg peptide in each mL of the 
electrospinning spinning solution. However interestingly, when the concentration of both of 
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the peptides is at 20 mg mL-1, the rate of wetting was very quick, such that after 2-3 s the 
droplet completely penetrated the web surface. The contact angle could not be satisfactorily 
measured when the peptide concentration was increased to 40 mg mL-1 because of the rapid 
penetration of the droplet into the web structure due to its increased wettability. 
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Figure 5-5. Initial contact angle of a deionised water droplet on electrospun fibre webs (at 
time = 0 s) on (A) 100% PCL, (B) PCL/P11-4 at a peptide concentration of 10 and (C) 20 mg 
mL-1, (D) PCL/P11-8 at a peptide concentration of 10 and (E) 20 mg mL-1. 
 
 
B 
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A 
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Figure 5-6. Dynamic contact angle measurements of a droplet of water on (A) PCL, (B) 
PCL/P11-4 and (C) PCL/P11-8 electrospun fibre webs up to 15 s.  
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5.3.1.2 Contact Angle of DMEM on PCL/SAPs Electrospun Fibres 
Figure 5-7 shows representative examples of the behaviour of droplets of DMEM on the 
surface of electrospun webs at time = 0 s. Contact angles greater than 90° were also observed 
herein on electrospun PCL, whilst decreased contact angle values were measured for the 
PCL/SAPs samples. Furthermore, it can be seen that as the P11-4 and P11-8 concentration (0-20 
mg mL-1) increased, the contact angle values decreased. From a biological perspective, this 
effect can be expected to be beneficial because it is likely to promote cell adhesion and 
proliferation in PCL-based materials (215). Table 5-2 reports the average of three replicates’ 
initial contact angles ± their standard errors.   
Table 5-2. Contact angle of a droplet of DMEM on electrospun samples at time = 0 s. 
Sample 100% PCL 
PCL/ P11-4 
(10 mg mL-1) 
PCL/ P11-4 
(20 mg mL-1) 
PCL/ P11-8 
(10 mg mL-1) 
PCL/ P11-8 
(20 mg mL-1) 
Contact angle (°) 125 ± 0.8 65.9 ± 2.2 46.5 ± 1.0 56.8 ± 0.7 50.6 ± 0.3 
 
The wetting rate of DMEM on electrospun samples was also determined over 15 s (Figure 5-8). 
It was observed here that by increasing the concentration of peptide from 0 to 20 mg mL-1 
wetting increased similar to the case of deionised water. When the concentration of peptide in 
the electrospinning solution was 40 mg mL-1, the initial contact angle of DMEM on fibres could 
not be measured above 0° due to the very high wettability. 
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Figure 5-7. Initial contact angle of a DMEM liquid droplet on electrospun fibre webs   (at 
time = 0 s) on (A) 100% PCL, (B) PCL/P11-4 at a peptide concentration of 10 and (C) 20 mg 
mL-1, (D) PCL/P11-8 at a peptide concentration of 10 and (E) 20 mg mL-1. 
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Figure 5-8. Dynamic contact angle measurements of a droplet of DMEM on (A) PCL, (B) 
PCL/P11-4 and (C) PCL/P11-8 electrospun fibre webs up to 15 s.  
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5.3.1.3 Contact Angle of Water on PCL/SAP Films 
Three electrospinning solutions of PCL and PCL/P11-8 at peptide concentrations of 10 and 20 
mg mL-1 were selected to make continuous cast films to eliminate the effect of porosity on 
contact angle measurements.  The contact angles of droplets of deionised water on the surface 
of the cast films are shown in Figure 5-9 (A-C). Similar to the trend observed with the 
electrospun fibre webs, the hydrophilicity increased with increasing peptide concentration from 
0 up to 20 mg mL-1. This corresponded to contact angles ranging from 79 ± 3° for 100% PCL 
film, 59 ± 2° for PCL/P11-8 at a peptide concentration of 10 mg mL-1 and 18 ± 3° for PCL/P11-
8 at peptide concentration of 20 mg mL-1. Figure 5-9 (D) shows the wetting rate of deionised 
water on cast films over a 15 s period of time, which also increased at the higher peptide 
concentration. The contact angles on films were found to follow the same trend as the 
electrospun samples, which verifies the primary influence of peptide content on wettability, 
although the range of contact angles for the films was lower. This difference in wetting may be 
attributed to the surface roughness effects of electrospun samples at the nano- and submicron 
scales, which has previously been reported in the literature (216). Based on Wenzel theory this 
lower contact angle is related to the higher specific surface area in films and based on the Cassie 
and Baxter theory, it can be attributed to the trapped air in the cavities of a rough surface in 
fabrics (214). 
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Figure 5-9. Initial contact angle of a droplet of deionised water on (A) PCL and (B) 
PCL/P11-8 cast films at a peptide concentration of 10 and (C) 20 mg mL-1. (D) Dynamic 
contact angle measurements of a droplet of deionised water on PCL and PCL/P11-8 cast 
films.  
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5.3.2 Cytotoxicity Assessment of PCL/SAPs Electrospun Fibres 
Extract and contact cytotoxicity results for the samples were of interest because of the lack of 
existing data on the cytotoxic response of PCL/SAP fibres. This assessment was crucial to 
understand the degree to which the materials would be suitable for practical use as biomaterials 
in a biological environment.  
5.3.2.1 Result of Extract Cytotoxicity assessment of PCL/SAPs Fibres 
Cell Morphology 
Figure 5-10 shows the morphology of cells exposed to the sample extract after incubation. 
Microscopic examination revealed that mouse fibroblasts are still able to proliferate in contact 
with the extract of all of PCL/P11-4 and PCL/P11-8 samples and the cellular morphologies were 
healthy with no evidence of cytotoxicity, comparable with that of negative control (PCL). The 
blank sample (DMEM) exhibited slightly lower cell proliferation while the positive control 
(DMSO) exhibited the lowest number of cells being elongated and proliferated.   
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Figure 5-10. Optical monochrome digital micrographs of cells treated with the sample 
extracts; (A) PCL, (B) PCL/P11-4, (C) PCL/P11-8, (D) DMEM and (E) DMSO. 
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MTS Assay 
The cell response in terms of metabolic activity quantified by MTS assay is shown in Figure 
5-11, which relates to the average absorbance values (mean ± standard error).    
 
Figure 5-11. UV absorption of extract samples at 490 nm related to the quantity of formazan 
produced and the number of living cells. 
 
The quantitative results indicated that all of the fibrous webs exhibited significantly greater 
average absorbance (p ≤ 0.05) compared to the DMSO positive control sample. The results for 
the fibrous webs were also significantly better in terms of absorbance than the DMEM blank 
control sample. Evidently, the PCL (negative control) fibrous scaffold exhibited the greatest 
average absorbance value (p ≤ 0.05) followed by PCL/P11-8 and PCL/P11-4 fibrous scaffolds, 
which had comparable average absorbance values (p ≥ 0.05). The quantity of formazan is 
directly proportional to the number of living cells and the higher absorbance values observed for 
the PCL and PCL/SAPs samples is indicative of greater cell viability on these samples, as 
compared to the DMEM and DMSO controls. Therefore all the results suggest that electrospun 
webs of PCL as well as PCL/SAP fibres were nontoxic to L929 cells and may be considered 
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good candidates for evaluation as tissue scaffolds. The lower formazan absorbance of PCL/P11-
4 and PCL/P11-8 compared with the PCL control extracts may indicate that some peptide release 
occurred during the extract preparation (72 h incubation at 37°C). This is possible as peptides 
can be diffused into monomeric form when in a water-based medium, which may have slightly 
affected the metabolic activity of L929 mouse fibroblasts, despite the cell affinity to peptides 
when they are in self-assembled form (27).  
5.3.2.2 Results of Direct Cytotoxicity assessment of PCL/SAPs Fibres 
Further to the extract cytotoxicity data, direct cytotoxicity was explored to understand the 
response of cell morphology and the MTT assay.  
Cell Morphology 
The PCL, PCL/P11-4 and PCL/P11-8 fibres in contact with cells were examined under a phase-
contrast microscope and the digital micrographs of cells exposed to the fibrous samples at 200x 
magnification are shown in Figure 5-12. Based on the microscopic examination, L929 mouse 
fibroblasts were clearly observed to proliferate in contact with the PCL/P11-4 and PCL/P11-8 
samples as well as the PCL control sample. The cells grew with healthy cellular morphologies 
towards the edges (dark areas) of both the negative control and peptide samples with no evidence 
of cytotoxicity. It is also obvious from Figure 5-12 that PCL/P11-8 fabric is more promoting the 
cell growth compared with PCL/P11-4 fabric.  
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Figure 5-12. Optical monochrome digital micrographs of cells treated with (A) negative 
sample of PCL, (B) PCL/P11-4 and (C) PCL/P11-8 fibres. 
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MTT Assay 
 Figure 5-13 shows the average absorbance obtained from the MTT assay of the cells cultured 
with the fibrous web samples as well as the blank and positive controls (mean ± standard error). 
 
Figure 5-13. Optical density absorption of samples at 570-650 nm correlated to the number of 
living cells. 
 
The quantitative results from the direct cytotoxicity assay also revealed that the number of living 
cells in the PCL/P11-4 and PCL/P11-8 samples were comparable to that of the PCL negative 
control sample (p ≥ 0.05) and the DMEM blank control. This is to be expected due to the non-
cytotoxic nature of PCL and self-assembled SAPs during the 24 h cell culture incubation. 
Generally, it was observed that the electrospun webs containing PCL/SAPs fibres were nontoxic 
to L929 cells, which is consistent with their potential application as tissue scaffolds.   
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5.3.3 Peptide Release Behaviour of PCL/SAPs Fibres   
According to an unpublished in vivo study by Burke et al. (53), P11-4 and P11-8 hydrogels injected 
into full thickness calvarial defects in rabbits have shown to be capable of partially supporting 
bone repair (53). Although there was evidence of peptide hydrogel release/diffusion within the 
cavity by day 7, which could have contributed to the defect not being fully repaired, there was 
evidence of healing from the defect margins with differences in healing patterns according to the 
type of SAP used. Based on these results, the degradation study in the present work was carried 
out until day 7 to investigate the stability of SAPs combined with fibres as a function of time.  
5.3.3.1 Mass Loss of Electrospun Fibres after Dissolution  
Fibres were first weighed in their dry state and after incubation samples were taken out of the 
solution and were air-dried and weighed out to measure mass loss. Figure 5-14 shows that the 
mass loss of fibres increased over a period of 7 d. However, the PCL control fibres were not 
degraded over the same period of time since no mass loss could be observed in the PCL only 
control fibres regardless of the pH of the solutions. Therefore, the overall mass loss in the 
PCL/SAPs fibres can be reliably attributed to the release of SAPs from the fibres into solution. 
Table 5-3 summarises the mass loss (%) of PCL/P11-4 and PCL/P11-8 fibres after degradation at 
different pH and different time points.  
As expected, the highest mass loss in PCL/P11-4 fibres took place after 7 d of incubation at pH 
10.5 (up to 9.3%) and for PCL/P11-8, after 7 d of incubation at pH 3.5 (up to 14.5%). Note that 
these are the pH values at which each of the peptides can be expected to transform from self-
assembled β-sheet to isotropic fluid (monomer) (200). Based on Equation 3-1, Equation 3-2 and 
Table 3-6 in Chapter 3, the initial concentration of peptides prior to degradation in the PCL/P11-
4 and PCL/P11-8 fibres (both at peptide concentration of 40 mg mL-1) is 28% and 24% 
respectively. Therefore, since the maximum mass losses in both PCL/SAPs fibres does not reach 
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the estimated on-board peptide content after 7 d, it can be posited that some SAPs remains 
combined with the fibres. Based on this analysis, it is apparent that in the PCL/P11-4 fibres, up 
to only 33% (9.3% out of 28%) of the on-board SAP was released. For the PCL/P11-8 fibres, up 
to 60% (14.5% out of 24%) of the available SAP was released over the same seven-day period. 
These are the maximum mass losses taking place at the least favourable pH for each of the SAPs. 
At pH 7.5 however, which is the closest pH to biological conditions (pH 7.4), 75% of the P11-4 
and 45% of the P11-8 still remained within the electrospun fibres which is a promising result, 
bearing in mind how much SAPs appears to have been lost when they are presented only in 
hydrogel form as reported in the work in-vivo of Burke et al. (53).  
 
Figure 5-14. Overall percentage (%) of mass loss from electrospun fibres at different pH.  
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Table 5-3. Overall mass loss (%) of PCL/P11-4 and PCL/P11-8 fibres after degradation at 
different pH. 
 PCL/P11-4 PCL/P11-8 
pH 3.5 pH 7.5 pH 10.5 pH 3.5 pH 7.5 pH 10.5 
1 h 1.8 6.3 5.9 5.0 5.0 6.0 
1 d 6.0 7.0 6.0 6.8 6.0 7.8 
2 d 7.0 7.0 6.9 7.4 7.6 7.2 
7 d 6.8 6.7 9.3 14.5 13.1 8.4 
 
To ensure that any residual peptide was washed off after taking the samples out of the solution, 
samples were washed three times in a fresh solution with the same pH. However, by weighing 
out the air-dried samples after this three step washing process, it was found that there were no 
marked changes in the mass loss percentages of the fibre webs.  
Mass Loss Analysis of PCL/SAPs Fibres by TGA 
The overall mass loss related to the PCL or SAP content in each sample was analysed via TGA 
as well. Measurements were made on the PCL/P11-4 fibres after 7 d of incubation at pH 10.5 
after three washes and on the PCL/P11-8 fibres after 7 d of incubation at pH 3.5 after three 
washes. Figure 5-15 shows the TGA results of PCL/SAPs fibres at their maximum mass loss 
condition versus the TGA of the untreated PCL/SAPs fibres before incubation. Two major mass 
loss phases were observed. The first, between 200-350 °C corresponds to the peptide component 
and the second, between 350-420 °C corresponds to the PCL component (Mw = 80,000) (217, 
218). Note that the only difference between the untreated and dissolved samples in both the 
PCL/SAP fibres is in the temperature range of the peptide component and there is no mass 
decrease in the PCL phase after incubation. This confirms that the overall mass loss reported in 
Section 5.3.3.1, is solely related to the peptide component. Secondly, it is clear that even after 
incubation, in both samples there are two mass loss phases, which confirms that even after 7 d 
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peptide is still left in fibres. Moreover, from the TGA results, it is apparent that the peptide 
component mass loss was between 40-60% of the original peptide mass, and this is in agreement 
with the mass loss percentages reported at the beginning of Section 5.3.3.1. This further confirms 
the stability afforded by combining the peptide with the PCL polymer in fibres, wherein nearly 
40% of the SAPs within the electrospun fibres remains after 7 d of degradation, despite the 
unfavourable pH and aqueous solution.   
The practical and clinical significance of this is that it could provide a means of retaining peptide 
within the site of a tissue defect for longer than it can currently be achieved when the peptide is 
applied in the form of a hydrogel. 
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Figure 5-15. Mass loss analysis by TGA of (A) PCL/P11-4 fibres after 7 d incubation and 3-
times wash in pH 10.5 and (B) PCL/P11-8 fibres after 7 d incubation and 3-times wash in 
pH 3.5. 
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5.3.3.2 Effect of Peptide Release on the Morphology of PCL/SAPs Fibres  
To detect any changes in the morphology of the electrospun fibre web, SEM micrographs of 
PCL, PCL/P11-4 and PCL/P11-8 fibres before and after incubation in water at different pH were 
studied. Figure 5-16 shows SEM micrographs of the untreated PCL control sample before and 
after 24 h and 7 d of incubation at the lowest pH (3.5) and highest pH (10.5). No major change 
in the PCL fibre morphology was observed after incubation apart from minor swelling. The mean 
fibre diameter of 100% PCL fibres after 7 d increased from 390 nm to 490 nm, which may be 
attributed to a small degree of water absorption. 
As-spun PCL/P11-8 electrospun fibres with their distinctive two-phase nanofibre network were 
incubated at pH 3.5, 7.5 and 10.5 for 1 h and 24 h and then studied to detect any morphological 
changes. It was hypothesised that if the very small nanofibrous phase mainly contained peptide, 
this would not be visible after incubation. Figure 5-17 shows the SEM micrographs of the 
PCL/P11-8 electrospun fibres before and after incubation at pH 3.5, 7.5 and 10.5. It can be 
observed that fibres started to swell in water regardless of the pH and some fissures and holes 
can be detected especially in the surface of the larger submicron fibres in the network. This may 
be explained by the possible release of peptides incorporated within the surface of the submicron 
fibres. What is also apparent is that the second nanofibrous phase remains intact after incubation 
suggesting that these fibres are not entirely formed from peptides. It is possible that peptide is 
also released from these nanofibres, which are known to contain peptide (see Section 4.3.4.2). 
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Figure 5-16 SEM micrographs of 100% PCL fibre webs before and after incubation at pH 3.5 
and 10.5 for 1 d and 7 d. 
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PCL/P11-8 before incubation 
 
PCL/P11-8 after incubation 
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Figure 5-17. SEM micrographs of PCL/P11-8 fibre webs before and after incubation at pH 
3.5, 7.5 and 10.5 for 1 h and 1 d. 
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Subsequently, both PCL/P11-4 and PCL/P11-8 samples incubated for up to 2 d and 7 d were 
studied by SEM. Figure 5-18 and Figure 5-19 show SEM micrographs of incubated PCL/P11-4 
and PCL/P11-8 fibres respectively incubated in the lowest and highest pH conditions (pH 3.5 and 
pH 10.5 respectively). In all the SEM micrographs shown, fibres were washed three times using 
solutions of the same pH. It is evident in Figure 5-18 and Figure 5-19 that there is no major 
morphological change or fibre degradation in either PCL/P11-4 or PCL/P11-8 fibres even after 7 
d of incubation apart from fibres becoming flattened and swollen. The mean fibre diameter after 
7 d in the PCL/P11-4 sample increased from 420 nm to 800 nm and in the PCL/P11-8 sample, 
from 330 nm to 710 nm, most probably due to water uptake in the hydrolytic conditions. 
Specifically in these incubated samples, the nanofibrous network is still present, with an apparent 
fusing together of fibres at their intersections. Nanofibres can be observed locally in the PCL/P11-
4 webs and all around the fibrous network in the PCL/P11-8 web, which is similar to the findings 
reported in Section 4.3.3, where the nanofibres in PCL/P11-4 (unlike PCL/P11-8) webs were 
distributed locally and not across the entire fibrous web.  In the samples washed three times, the 
appearance of merged fibre intersections may be related to peptide residues on the surface of the 
fibres being washed out by the washing process resulting in morphological changes.  
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Figure 5-18. SEM micrographs of PCL/P11-4 fibre webs after incubation at pH 3.5 and 10.5 
for 2 and 7 d. 
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PCL/P11-8 before incubation 
 
PCL/P11-8 after incubation 
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Figure 5-19. SEM micrographs of PCL/P11-8 fibre webs after incubation at pH 3.5 and 10.5 
for 2 and 7 d. 
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5.3.3.3 Peptide Release into Solution by CD analysis   
To confirm release of peptides into the solution, the supernatant fluid was subject to CD analysis 
according to the method described in Section 3.2.11. The supernatant of PCL, PCL/P11-4 and 
PCL/P11-8 webs incubated at the lowest (pH 3.5) and highest (pH 10.5) pH for 1 d and 7 d periods 
of time, were analysed via CD and the results are shown in Figure 5-20. The spectra of each 
relevant blank solution, which is water at the pH 3.5 or 10.5, has been subtracted from these 
spectra.  
As is evident from Figure 5-20, all the CD spectra for the PCL/P11-4 and PCL/P11-8 supernatants 
exhibit a negative minimum centred at 195-200 nm and a slightly positive band at around 220 
nm, which is consistent with the random coil peptide conformation in the solution (46, 211). 
This explanation is supported by the lack of a negative band at 218 nm and a strong positive 
maximum at lower wavelengths (198 nm), which would be characteristic of a β-sheet 
conformation (43, 46). By comparing these results with the results of the PCL fibre supernatant, 
which exhibits no peaks in the far-UV spectral region (190-250 nm), it can be confirmed that 
peptides have been disassembled into solution over time.  
Moreover, by observing peak intensities in the CD spectra, the results of the mass loss 
experiments (Section 5.3.3.1) can be verified, in which the highest mass losses obtained for the 
PCL/P11-4 and PCL/P11-8 webs after 7 d of degradation were at pH 10.5 and pH 3.5 respectively.  
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Figure 5-20. CD spectra of supernatant of fibrous samples dissolved in water for 1d and 7 d 
at (A) pH 3.5 and (B) pH 10.5. 
 
Even though it has been shown that a three-step washing procedure did not have a major effect 
on the mass loss of peptide, and had only a slight effect on fibre morphology, the supernatants 
from the washing process were also analysed via CD.  
The CD spectra of the original supernatants and the three-step washing procedure supernatants 
obtained for the PCL/P11-4 and PCL/P11-8 fibres dissolved for 7 d at pH 10.5 and pH 3.5 
respectively, are shown in Figure 5-21. Note that only in the original supernatant did peptide 
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release occur, and after each of the three step washes, no marked peptide release could be 
observed.    
 
 
Figure 5-21. CD spectra of the original supernatant and the three step washing process 
supernatants of electrospun web samples dissolved for 7 d of (A) PCL/P11-4 fibres in pH 
10.5 and (B) PCL/P11-8 fibres in pH 3.5. 
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5.4 Summary 
The contact angle studies of deionised water and DMEM on electrospun webs have shown that 
the hydrophilicity and wetting characteristics of PCL electrospun fibre webs are considerably 
improved by incorporation of peptides in the fibres.  This was evidenced by a decrease in the 
contact angle from above 90° (hydrophobic) to 0° when the peptide concentration in the 
electrospinning solution was increased from 0 to 40 mg mL-1. The importance of the peptide 
content on wetting was confirmed by studying contact angles on continuous cast films made of 
exactly the same material compositions.  
Extract cytotoxicity assays were used to assess the cytocompatibility of PCL/P11-4 and PCL/P11-
8 fibres with L929 mouse fibroblasts. This preliminary experiment showed no toxic response in 
cells cultured with PCL/SAP sample extracts, although the cell viability in PCL/SAP extract was 
slightly reduced, compared with the PCL control sample. This could be due to peptide 
disassembly in the aqueous solution during extraction, which could affect the metabolic activity 
of L929 mouse fibroblasts. Therefore, a direct cytotoxicity assay was conducted in which L929 
mouse fibroblasts were cultured in contact with electrospun peptide loaded samples. The 
PCL/SAPs fibres proved to be well tolerated by mouse fibroblast cells and nearly no cytotoxic 
response (<90% cell viability) was observed, providing additional confirmation that the 
PCL/SAPs fibres are good candidates to be used as tissue scaffolds. 
Furthermore, a 7-day mass loss degradation study in aqueous medium demonstrated that at least 
40% of SAPs in the PCL fibres is still available even in conditions of unfavourable pH where 
their transformation to monomers can be expected to take place. The peptide release into the 
solution was further confirmed via CD analysis. At pH 7.5, which is close to biological pH, at 
least 75% of the P11-4 and 45 % of the P11-8 were found still to be present within the fibres. The 
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considerably greater release of P11-8 compared to P11-4 can be explained by the morphological 
characteristics of the PCL/P11-4 and PCL/P11-8 electrospun fibres.  
The PCL/P11-8 fibres form a biphasic web structure in which fibre diameters are distributed 
widely, with some below 100 nm and others above 100 nm. The nanofibrous network (<100 nm) 
was confirmed to contain P11-8, and by having smaller diameters and therefore higher surface 
areas can contribute to faster release of peptide in solution. By comparison, in the PCL/P11-4 
fibres, where the fibres were mostly of submicron scale, with fewer in the nanofibre scale range, 
P11-4 peptide incorporated into the fibres will be less freely available for diffusion in to solution 
because of the larger diffusion boundary. In terms of fibre morphological changes during 
degradation, it was found that regardless of the pH of the solution, the PCL/SAPs fibres do not 
change markedly apart from small regions in which fibres appear to become slightly flattened 
giving the appearance of being fused at their intersections. The morphological stability of fibres 
was maintained even after 7 d of degradation, and it was shown that the nanofibrous network is 
also stable.  
The conclusions in Section 4.3.4.2, were that both the nanofibre and submicron fibre phases in 
the web contained peptides, however it could not be concluded that the nanofibre phase also 
contained PCL. However, the results in the present chapter clearly suggest that the nanofibre 
phase in both the PCL/P11-4 and PCL/P11-8 electrospun webs contain both PCL and peptide 
components, as during 7 d of hydrolytic incubation the nanofibers were still stable. Furthermore, 
combining peptide with PCL appears to improve its stability in terms of the rate at which it is 
solubilised and removed from the simulated biological environment. When combined with 
fibres, a large proportion of the original peptide loading is still present even after 7 d incubation 
in conditions that are unfavourable to peptide stability (aqueous medium and wide variations in 
pH).  
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CHAPTER 6 
 
In Vitro Evaluations for Apatite Forming Ability 
of PCL/SAPs Fibre Webs 
6 In Vitro Evaluations for  
6.1 Introduction  
In Chapter 5, it was shown that electrospun PCL/SAPs fibres were non-cytotoxic when cultured 
with L929 cells and therefore biocompatible to be used as hard tissue regeneration scaffolds. 
Moreover, it was shown that at least 40% of the SAPs content is still present within fibres webs 
even in the most unfavourable aqueous conditions for at least seven days. As reported previously 
in Section 2.4.5, P11-4 and P11-8 SAPs have demonstrated their ability to nucleate hydroxyapatite 
de novo (50) and they have shown to be able to repair early enamel caries (“decay”) lesions by 
restoring mineral in clinical trials (55). Accordingly, the purpose of this chapter is to evaluate 
the apatite-formation ability of electrospun fibres enriched with SAPs. To the author’s 
knowledge, no such study has ever previously been performed. The fibres were assessed for their 
capacity to promote mineral crystal nucleation and to support their subsequent growth. In this 
study, two methods were employed based on the BS ISO 23317:2014 standard method and the 
IVN tank method, details of which were outlined in Sections 3.2.14 and 3.2.16 respectively.  
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6.2 Experimental Details 
6.2.1 Nucleation of Apatite in Simulated Body Fluid (SBF) 
The ability of fibres to nucleate apatite was firstly evaluated using the BS ISO 23317:2014 
standard method, which was extensively explained in Section 3.2.14. The electrospun fibre webs 
were exposed to simulated body fluid (SBF) solution to determine their ability to nucleate Ca-P 
crystallisation using a method previously used to evaluate textile materials (199, 219-221). In 
summary, electrospun samples of PCL, PCL/P11-4 and PCL/P11-8 (both at a medium 
concentration of peptide, 20 mg mL-1) were prepared and cut into 10±2 × 10±2 mm (first run) 
or 70±10 × 70±10 mm (second run) squares. The SBF was prepared according to the standard 
method (Section 3.2.14.2) and the samples were immersed in SBF for different lengths of time 
(3 d, 7 d and 14 d) in the first experiment. Then, the fibres were dried in a desiccator and 
examined under SEM and EDX spectroscopy for the purpose of detecting the formation of any 
apatite crystals on the fibres, and to determine the Ca:P ratio of the crystals based on the EDX 
method.  
Following the initial evaluation, in the second experiment samples were prepared according to 
the mass and content of peptide within them, and then incubated in SBF for an extended period, 
up to four weeks. Thus, electrospinning solutions for PCL/SAP (at peptide concentration of 20 
mg mL-1), were electrospun and the fibrous webs (size ~ 150 mm × 150 mm) were folded twice 
to make them thicker and to increase the effective concentration of peptide per unit area. Then, 
based on Equation 3-1and Table 3-6, 240 mg fibres of PCL/P11-4 and 285 mg fibres of PCL/P11-
8 were cut and weighed out. The samples were prepared as rectangles (70±10 mm × 70±10 mm) 
containing 40 mg peptide. A control sample of 100% PCL with a weight of 250 mg and size of 
70±10 mm × 70±10 mm was also prepared. The specimen to SBF weight to volume ratio was 
0.5 mg mL-1. Incubation was carried out at 37 °C for up to 4 weeks. Moreover, to ensure no 
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extraneous material was present on the samples following incubation, in the second experiment, 
half of the samples were washed with deionised water to remove superficial deposition of 
magnesium, sodium and chlorine ions and then samples were dried in the desiccator.  
In addition to SEM/EDX, samples were examined under XRD to identify the configuration of 
any nucleated crystals, and FTIR was used to determine the degree of SAP dissolution/stability 
during the assay, as well as the persistency of self-assembled structures within the fibres.    
6.2.2 Nucleation of Apatite in the In Vitro Nucleation (IVN) Tank 
To evaluate the ability of PCL/SAP fibres to nucleate mineralisation and support mineral growth 
in vitro, the IVN tank method, described in Section 3.2.16 was followed as well. In this method 
electrospun PCL/P11-4 and PCL/P11-8 fibres were tested against P11-4 and P11-8 hydrogel 
samples respectively, with regard to the concentration of peptide in each cell of the sample holder 
in both fibrous and hydrogel samples. As a positive control specimen, 10 µg mL-1                       
poly-L-glutamic acid in 1 % agarose hydrogel and as negative control only 1% agarose hydrogel 
and 100% PCL electrospun fibres were used. As indicated in Section 3.2.16.3, all the fibrous 
electrospun samples were embedded within two layers of 1 % agarose hydrogel. The fibrous or 
hydrogel samples prepared for this experiment and the peptide concentration in each of them 
(for both P11-4 and P11-8) are shown in Figure 6-1. 
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Figure 6-1. Preparation of fibrous electrospun or hydrogel samples for the IVN tank assay 
(A) positive, negative and PCL fibre control, (B) SAP hydrogel samples and (C) 
PCL/SAPs fibre samples with their associated SAP concentration.  
 
 
 
 
A 
 
B 
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At the end of each experiment, after five days incubation, samples were analysed using a 
phosphate assay and the PO43- content was determined spectrophotometrically using a standard 
calibration curve. Figure 6-2 shows the calibration curve obtained by dissolving different 
concentrations (0-100 μM) of phosphorus standard solution of 1000 ppm (Na2HPO4), in 
deionised water and analysing the absorbance at 820 nm. The calibration curve shows a linear 
relationship between light absorption at 820 nm and µg mL-1 of phosphate (PO43-).  
 
Figure 6-2. Calibration curve of phosphate concentration (µM) using spectrophotometry.   
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6.3 Results and Discussion 
6.3.1 Apatite Forming Ability of PCL/SAPs Fibres in SBF 
Results of two SBF studies of PCL/SAPs along with PCL control fibres are presented in this 
section.  
6.3.1.1 SBF Method - First Experiment  
Figure 6-3, Figure 6-4 and Figure 6-5 show SEM micrographs of each sample and the associated 
deposited mineral elements with their atomic percentage for each samples after three days, seven 
days and fourteen days of incubation respectively. As it can be observed, no Ca-P crystal 
deposition could be observed on these samples apart from some small particles that can be 
attributed to the precipitation of salts during incubation in the SBF. In the elemental analysis 
results, no substantial mineral deposition of calcium or phosphorus was found to be deposited 
on the fibres and the small amounts of mainly chlorine or sodium can be attributed to the 
precipitation of these minerals on the samples while in SBF. Among these results PCL sample, 
as control, and PCL/SAPs samples look similar to each other with no substantial mineral 
deposition.  
The lack of mineral deposition observed in the first experiment can be attributed to the very 
small amount of SAP present in each of the 10±2 × 10±2 mm samples. During the preparation 
of a 150 × 150 mm sample in electrospinning, 2.5 mL of electrospinning solution was used with 
a 20 mg mL-1 concentration of peptide in solution. This means that only 50 mg of SAP in total 
will be distributed throughout a 150 × 150 mm sample. Therefore, assuming all of the SAPs in 
the solution are contained within the spun fibres and that there is a uniform distribution, only 
0.22 mg of SAP will be present in each square centimetre of fibrous web. This was considered 
in the design of the second experiment, such that more SAP would be available in the samples.  
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Cl = 0.53% 
 
Na = 0.43%  
Cl = 0.88% 
Figure 6-3. SEM micrographs of electrospun fibres after 3 d incubation in SBF along with 
the atomic percentage of element content as determined from EDX analysis (A) PCL 
fibres, (B) PCL/P11-4 with peptide concentration of 20 mg mL-1 and (C) PCL/P11-8 with 
peptide concentration of 20 mg mL-1. 
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Na = 0.91%  
Cl = 1.59%  
Ca = 0.28% 
 
Cl = 0.55% 
 
 
Figure 6-4. SEM micrographs of electrospun fibres after 7 d incubation in SBF along with 
the atomic percentage of element content as determined from EDX analysis (A) PCL 
fibres, (B) PCL/P11-4 with peptide concentration of 20 mg mL-1 and (C) PCL/P11-8 with 
peptide concentration of 20 mg mL-1. 
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Ca = 0.18%  
K = 0.10% 
 
Na = 1.51%  
Cl = 3.27% 
 
 
Figure 6-5. SEM micrographs of electrospun fibres after two weeks incubation in SBF 
along with the atomic percentage of element content as determined from EDX analysis (A) 
PCL fibres, (B) PCL/P11-4 with peptide concentration of 20 mg mL-1 and (C) PCL/P11-8 
with peptide concentration of 20 mg mL-1. 
 
6.3.1.2 SBF method - Second Experiment 
Based on the results obtained from the first study, further experiments were carried out with the 
intention of providing more peptides in each sample, and by increasing the incubation time in 
SBF. SEM micrographs of electrospun fibres incubated in SBF for one, two and four weeks are 
shown in Figure 6-6 and Figure 6-7 and Figure 6-8 respectively. In this experiment, half of the 
samples were washed with deionised water after incubation to remove superficial precipitations, 
and SEM micrographs of washed fibres were obtained as well. It was reasoned that nucleation 
of apatite was more likely to occur after incubation times beyond one week, so washing was 
performed after two and four weeks to determine residual apatite content.  
As expected, in Figure 6-6, after one week incubation in SBF, the control PCL and PCL/P11-8 
samples showed no mineral crystals and only in the PCL/P11-4 fibres was a small amount of 
mineral crystallisation observed. However, after longer incubation times in SBF, as shown in 
Figure 6-7 (2 weeks) and Figure 6-8 (4 weeks), crystal growth on the surface and in between 
electrospun fibres was clearly observed. It was established from all the SEM evidence, that PCL 
control fibres containing no SAP, even after 4 weeks are not capable of supporting crystal 
A 
 
B 
 
C 
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formation. This is to be expected, given that no SAP was present. Moreover it can be observed 
in Figure 6-7 and Figure 6-8 that the washing process does affect the morphology of the fibres 
at the surface and therefore it is possible that some of the crystals may be removed during the 
process if present in the exterior surface. However, crystals were still visible in between the 
fibres after washing. The higher magnification images, Figure 6-7 (unwashed PCL/P11-4 and 
PCL/P11-8), revealed that deposited minerals formed on the surface and in between the fibres 
and their structures appear as a globular cauliflower shape, resembling the crystal morphology 
of hydroxyapatite (199). Moreover, from the SEMs of unwashed PCL/SAPs fibres in Figure 6-7 
and Figure 6-8, it can be observed that a primary layer of calcium phosphate at the surface of the 
fibres is formed over which further growth of spheroidal clusters proceeds.  
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Sample 
Incubation time 
1 week 
washed unwashed 
 
 
PCL 
 
 
N/A 
 
 
 
PCL/P11-4 
 
 
N/A 
 
 
 
PCL/P11-8 
 
 
N/A 
 
Figure 6-6. SEM micrographs of electrospun fibres after one week incubation in SBF. 
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Sample 
Incubation time 
2 weeks 
washed unwashed 
 
 
PCL 
  
 
 
PCL/P11-4 
  
 
 
PCL/P11-8 
  
Figure 6-7. SEM micrographs of electrospun fibres after two weeks incubation in SBF. 
 162 
 
 
Sample 
Incubation time 
4 weeks 
washed unwashed 
 
 
PCL 
  
 
 
PCL/P11-4 
  
 
 
PCL/P11-8 
  
Figure 6-8. SEM micrographs of electrospun fibres after four weeks incubation in SBF. 
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 In Figure 6-9, the low magnification (1-3 Kx) SEM micrographs of PCL/P11-4 fibres after 1, 2 
and 4 weeks incubation in SBF, show the distribution of mineralised crystals all around the 
fibrous structure. It was observed that by increasing the incubation time in SBF, the prevalence 
of formed crystals within the fibrous structure increases. Thus, it was established that PCL/SAPs 
fibres are capable of nucleating apatite crystals, as well as providing a structural support for the 
crystals as they grow. Furthermore, they could be substantially retained on the electrospun webs 
even after washing. 
   
Figure 6-9. Low magnification SEM micrographs of mineralised PCL/P11-4 fibres after (A) 
1 week, (B) 2 weeks and (C) 4 weeks incubation in SBF showing the distribution of 
crystals formed all over the fibres. 
 
 
The EDX data was also collected for all the PCL and PCL/SAPs fibres immersed in SBF for 
different period of times. A representative exemplar is given in Table 6-1, which summarises the 
atomic percentages of chemical elements in the washed PCL/P11-4 fibres immersed in SBF for 
2 weeks. The calcium to phosphorous ratio in this particular PCL/P11-4 sample was 1.72, and 
the accompanying EDX pattern is shown in Figure 6-10.  
 
B 
 
C 
 
A 
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Table 6-1. Elemental analysis of chemical elements in the PCL/P11-4 fibres immersed in SBF 
for 2 weeks obtained by SEM/EDX. 
Element Atomic Content (%) 
C 37.07 
O 40.54 
Na 1.40 
Mg 0.44 
P 6.85 
Cl 1.61 
K 0.09 
Ca 11.80 
Cu 0.02 
Ir 0.19 
Total: 100.00 
 
 
 
Figure 6-10. EDX spectra of PCL/P11-4 fibres immersed in SBF for 2 weeks. 
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Similar to this example of the EDX results, in most of the EDX data for the incubated PCL and 
PCL/SAPs fibres, peaks corresponding to C and O together with some minor peaks, e.g. Na, Cl, 
K and Mg related to ion precipitation were visible. While in the mineralised scaffolds containing 
PCL/SAPs fibres, a characteristic peak corresponding to phosphorous at 2.01 eV and one 
corresponding to calcium at 3.69 eV was also observed. The Ca:P ratio obtained from EDX 
measurements of minerals deposited on all samples before and after washing are summarised in 
Table 6-2. The EDX analysis was carried out on specific points on individual mineralised 
particles, to make the results comparable. Three random spots per sample were tested and the 
mean of each Ca:P ratio together with the standard deviation are expressed. 
In the PCL control sample no calcium-phosphorous mineral deposition was observed, which is 
in agreement with the visual observations in the SEM images. The Ca:P ratios obtained from the 
EDX analysis also show that in the PCL/P11-4 samples from week 1, regardless of the washing 
process, the Ca:P ratio was very close to 1.67, which is that of hydroxyapatite (199). In PCL/P11-
8 fibres however, the ratio increases with time of exposure to the SBF and reaches 1.65 after 4 
weeks. The ratios reported herein also express that the washing process does not affect 
remarkably the Ca-P mineral deposition on PCL/P11-4 fibres, despite its marked effect on the 
Ca:P ratio of minerals deposited on PCL/P11-8 fibres. This can be attributed to differences in the 
morphology of the PCL/P11-4 fibres compared to the PCL/P11-8 fibres. Since PCL/P11-8 fibres 
comprised a larger number of peptide-enriched nanofibres, which fill the pores between the 
submicron fibres at the surface, these nanofibres may be dissolved faster due to their higher 
surface area and fragility. The diffusion lengths of SAPs to the surface of these fibres will also 
be shorter than in coarser fibres, making the peptides together with crystals more readily 
removable during washing. In contrast, in the PCL/P11-4 fibres, where most of peptides are 
incorporated within larger submicron fibres, any minerals attached to the nucleating site of the 
SAP, will also be attached to a more stable substructure, less likely to be removed by washing. 
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Moreover, the superficial washing out of peptide at the surface of these fibres, will be replenished 
as more of the functional material diffuses towards the surface to support crystal growth.  
Table 6-2. Ca:P ratio of the electrospun fibre webs incubated in SBF for up to 4 weeks based 
on EDX analysis. 
 
Sample 
Incubation time 
Ca:P (1 week) Ca:P (2 weeks) Ca:P (4 weeks) 
washed unwashed washed unwashed washed unwashed 
PCL N/A 0 0 0 0 0 
PCL/P11-4 N/A 
1.77 
(SD=0.03) 
1.72 
(SD=0.09) 
1.64 
(SD=0.42) 
1.76 
(SD=0.30) 
1.82 
(SD=0.27) 
PCL/P11-8 N/A 
0.31 
(SD=1.8) 
0.50 
(SD=0.7) 
1.50 
(SD=0.1) 
0.21 
(SD=0.33) 
1.65 
(SD=0.39) 
 
The spheroidal growth of the calcium phosphate crystals on the SAP enriched fibres may arise 
from the chemistry and structure of the nucleating site in SAPs and their affinity for mineral 
ions. Moreover, the molecular organisational structure of the peptides in to fibrils and 
presentation of charge domains at the fibrillar surface can effect on the ability of the assembled 
peptides to nucleate and support crystal growth in vitro. Moreover, it is known that the 
persistence of the assembled fibrils during the experimental period will contribute as a driver for 
mineral deposition and growth. To determine this, FTIR was performed on the incubated fibres 
in SBF after 1, 2 and 4 weeks to analyse the secondary structure of peptides within them and the 
spectra are shown in Figure 6-12.  
As can be observed from the spectra, and as reported previously in Chapter 4, Section 4.3.6,        
as-spun PCL/P11-4 fibres initially exhibited a combination of β-sheet and random coil states and 
PCL/P11-8 fibres exhibited a predominant β-sheet state. It can be noted that after incubation for 
up to 2 weeks in highly ion concentrated SBF, there was still evidence of β-sheet in the both of 
the PCL/SAPs fibre web samples, even though there was some transition from β-sheet to a 
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random coil state during this time. However, after 4 weeks of incubation there was a marked 
decrease in the β-sheet peptide content and in turn some of the SAPs appears to have diffused 
into the solution or transformed into monomer at the surface of the fibres. This is evidenced by 
the decrease in the density of the peak at 1630 cm-1 and also in some samples, there was decrease 
in the peak density of COO- at 1550 cm-1 in week 4, which reflects a decrease in the overall 
concentration of peptide regardless of its secondary conformation. The FTIR spectra of PCL-
only samples are shown in Figure 6-11 for reference.  
 
Figure 6-11. FTIR bands of electrospun PCL fibres before and after incubation in SBF. 
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Figure 6-12. FTIR bands of electrospun (A) PCL/P11-4 and (B) PCL/P11-8 fibres before and 
after incubation in SBF.  
 
 
A 
 
B 
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X-ray diffraction patterns were also recorded to understand the chemical structure of the 
mineralized crystals on the electrospun PCL, PCL/P11-4 and PCL/P11-8 fibres after two and four 
weeks and are reported in Figure 6-13, Figure 6-14 and Figure 6-15 respectively. Two distinct 
diffraction peaks are observable for all samples at 2θ = 21.5° and 2θ = 23.8° which were indexed 
to crystalline structure of PCL (222, 223). As it can be observed from the PCL patterns (Figure 
6-13), there were no additional peaks after incubation in SBF in all PCL samples. However after 
the incubation of PCL/SAPs fibres in SBF (Figure 6-14 and Figure 6-15), additional X-ray 
diffraction peaks were observed.  
The peak at 2θ = 31.8 and an isolated peak at 2θ = 46.6, in PCL/P11-4 and PCL/P11-8 fibres after 
incubation is indicative of the presence of hydroxyapatite (HAP) (220). The patterns related to 
HAP in the PCL/SAPs fibres are sharper when the fibres are unwashed indicating that the 
crystallinity of HAP or the concentration of crystals is decreased after the washing process. 
However, the XRD patterns of both mineralised PCL/SAPs fibres after two weeks are 
substantially equivalent to those of after four weeks, which may indicate that there was no 
significant increase in nucleation or growth of minerals after two weeks.   
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Figure 6-13. X-ray diffraction patterns of electrospun PCL fibres (A) before, (B) and (C) after 2 weeks, (D) and (E) after 4 weeks incubation in 
SBF.   
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Figure 6-14. X-ray diffraction patterns of electrospun PCL/P11-4 fibres (A) before, (B) and (C) after 2 weeks, (D) and (E) after 4 weeks 
incubation in SBF.   
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Figure 6-15. X-ray diffraction patterns of electrospun PCL/P11-8 fibres (A) before, (B) and (C) after 2 weeks, (D) and (E) after 4 weeks 
incubation in SBF.  
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6.3.2 IVN Tank Results 
The test samples, consisting of either electrospun fibres or hydrogel enriched SAPs, were 
incubated for 5 d, in in vitro IVN assay (described in Section 3.2.16). Subsequently, the samples 
were ashed (phosphate assay) and their PO4-3 content was quantified spectrophotometrically. 
Table 6-3 and Table 6-4 shows the average absorbance at 820 nm and the phosphate content of 
the SAPs hydrogels and PCL/SAPs fibres respectively, when only 4 mg of peptide is present in 
each well. The concentration of PO43- in µM was determined according to the standard curve 
obtained in Section 6.2.2.   
Table 6-3. Determination of phosphate concentration (µM) in IVN hydrogel samples, SAP 
concentration = 4 mg mL-1. 
 
Sample 
 
Absorbance 
average 
Phosphate 
(µM)  
Positive 0.57 95.5 
P11-8 gel 0.36 61.0 
P11-4 gel 0.23 39.6 
Negative 0.18 31.5 
 
Table 6-4. Determination of phosphate concentration (µM) in IVN fibrous samples, SAP 
concentration = 4 mg mL-1.  
 
Sample 
 
Absorbance 
average 
Phosphate 
(µM) 
positive 0.58 97.5 
P11-8 fibre 0.31 53.0 
P11-4 fibre 0.32 54.3 
PCL fibre 0.22 38.0 
Negative 0.18 30.4 
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The relative ability of the PCL/SAP fibres and SAPs in agarose hydrogel to nucleate mineral de 
novo, when there was only 4 mg peptide in each well together with positive and negative controls 
is shown in Figure 6-16. Figure 6-16 shows that positive control (poly-L-glutamic acid) 
performed significantly (p ≤ 0.001) better than all fibrous or hydrogel samples and also all the 
samples performed significantly (p ≤ 0.05) better than negative control (agarose only), which 
confirms that the experiment was successful. The statistical analysis comparing means of the 
hydrogel samples indicates that P11-8 performed significantly (p ≤ 0.01) better than P11-4. This 
is while when P11-4 and P11-8 were incorporated into the fibres, there were no significant 
difference (p ≥ 0.05) in their performance. Moreover, the assay confirmed that fibres with SAPs 
(both PCL/P11-4 and PCL/P11-8 fibres), performed significantly (p ≤ 0.05) better than PCL-only 
fibres. This confirms the ability of SAP enriched fibres to nucleate hydroxyapatite and 
supporting the crystal growth. This is the first time that PCL/P11-4 and PCL/P11-8 fibres 
electrospun fibres have been shown to nucleate apatite in the IVN tank, and for the first time 
fibrous samples, rather than hydrogels have been studied in this way. 
 
  
Figure 6-16. IVN assay response of (A) peptide hydrogel samples and (B) electrospun 
fibrous samples at peptide concentration of 4 mg mL-1. 
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Figure 6-17 compares the percentage (%) of minerals nucleated on fibre and hydrogel structure 
performance relevant to their own positive control in each assay, when the peptide concentration 
is 4 mg mL-1. It can be observed that in general, performance of SAPs in hydrogel form and in 
fibre form (at 4 mg mL-1) concentration were comparable. However, by statistically analysing 
the result, it was found that P11-8 in the gel form performed significantly (p ≤ 0.01) better than 
in the fibre form, while P11-4 peptide exhibited opposite behaviour. Based on these results, 
further experiments were carried out by doubling the concentration of peptide in each cell of the 
sample holder.   
 
Figure 6-17. IVN assay response of P11-4 and P11-8 in both hydrogel and electrospun fibrous 
structure at peptide concentration of 4 mg mL-1. 
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Table 6-5 and Table 6-6 give the average absorbance at 820 nm and the phosphate content of 
SAP hydrogels and PCL/SAP fibre web samples respectively, when the concentration of SAPs 
is increased to 8 mg in each well. The concentration of PO43- in µM is determined according to 
the standard curve obtained in Section 6.2.2.   
Table 6-5．Determination of phosphate concentration (µM) in IVN hydrogel samples, SAP 
concentration=8 mg mL-1. 
 
Sample 
 
Absorbance 
average 
Phosphate 
(µM)  
Positive 0.55 92.7 
P11-8 gel 0.75 125.9 
P11-4 gel 0.65 108.6 
Negative 0.18 30.3 
 
Table 6-6．Determination of phosphate concentration (µM) in IVN fibrous samples, SAP 
concentration = 8 mg mL-1. 
 
Sample 
 
Absorbance 
average 
Phosphate 
(µM)  
Positive 0.62 104.2 
P11-8 fibre 0.30 50.5 
P11-4 fibre 0.37 62.6 
PCL fibre 0.28 46.6 
Negative 0.21 35.4 
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Figure 6-18 shows the plotted assay response of the PCL/SAP fibre webs or SAP hydrogels, 
which reflects their ability to nucleate mineral de novo, when there is 8 mg peptide in each well. 
Statistical analysis was performed on the results, and this indicated a highly statistically 
significant difference (p ≤ 0.0001) between the positive control and the negative control of each 
experiment, which confirms that the experiment was successful. As it can be observed in Figure 
6-18 (A), both P11-4 and P11-8 peptides in the hydrogel form were more highly capable of 
nucleating hydroxyapatite and supporting significant crystal growth compared to the positive 
control, though to varying extents. However, when SAPs are incorporated in PCL fibres, even 
by doubling the concentration in the assay, they still did not perform better than their positive 
control. This was evidenced by a highly statistically significant difference indicated by a T-test 
(p ≤ 0.001).  
  
Figure 6-18. IVN assay response of (A) peptide hydrogel samples and (B) electrospun 
fibrous samples at peptide concentration of 8 mg mL-1. 
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The relative ability of SAPs at a concentration of 8 mg mL-1 in both fibrous and hydrogel form 
is shown in Figure 6-19. As can be observed, both the P11-4 and P11-8 samples performed 
significantly (p ≤ 0.0001) better in hydrogel form than in fibrous form at the same concentration 
of 8 mg mL-1. 
 
Figure 6-19. IVN assay response of P11-4 and P11-8 in both hydrogel and electrospun fibrous 
structure at peptide concentration of 8 mg mL-1. 
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Figure 6-20 shows the combination of the determined assay response for all fibrous and hydrogel 
samples (together with the negative control and the PCL fibre control), at both concentrations of 
4 and 8 mg mL-1. The results are presented based on the percentage mineral nucleated compared 
to the positive control in each experiment. This overview of the data reveals that even though 
the increase in the concentration of peptide within the fibrous structure, does have a small effect 
on the nucleated mineral content, it is not comparable with the effect of SAP concentration in 
hydrogel form. This may be due to this specific assay and on the design of IVN apparatus 
(Section 3.2.16), since in the IVN method, even when the amount of SAP containing fibre 
present is doubled, the surface area of fibres exposed to nucleating buffer solutions does not 
change.  
 
Figure 6-20. IVN assay response of fibrous and hydrogel together versus peptide 
concentration. (N/S)= p≥0.05, (*) = p≤0.05, (**) = p≤0.01, (***) = p≤0.001, (****) = 
p≤0.0001. 
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As indicated in the literature (53) (Section 2.4.5), mineralisation is nucleated on negatively 
charged surfaces (in this study P11-4) due to the attraction of positively charged Ca2+ ions (224) 
and eventually super-saturation of the local environment in physiological conditions. It is known 
that glutamic acid side chains (in both P11-4 and P11-8) can play an important role in the 
mineralisation as well (225). Moreover based on the previous release behaviour study of 
incorporated SAPs within the fibres (results presented in Section 5.3.3), it is known that the 
peptides are released gradually by the fibres since many are encapsulated within the body of the 
fibre, and at least 40% is still present at day 7. Given that the duration of the present IVN assay 
is 5 days, it is likely that even when there is more peptide within the fibrous disk, the nucleating 
points of SAPs (negatively charged surface groups or glutamic acid side chains) do not have 
sufficient time to be available at the surface of the fibres to increase the mineral nucleation.  
The IVN tank assay also showed that P11-4 in fibrous scaffold performs slightly better than P11-
8 enriched fibres in terms of mineral nucleation. However in this assay, it was shown that P11-8 
in hydrogel form performs significantly (p≤0.01) better than P11-4 hydrogel when the 
concentration of SAP in them is the same (both 4 and 8 mg mL-1), which is consistent with the 
unpublished data of hydrogels analysed via the IVN method previously in Leeds (53). 
In the IVN study, it was also interesting to note the extent to which a non-SAP enriched PCL 
fibre web was able to nucleate mineral using either one disk or two disks of PCL fibre webs. 
This is most likely due to the provision of solid surface area, at the interface between agarose 
gel and fibrous disks, within which nucleation could commence. This is in contrast with the 
results from the first method explained in Section 6.3.1 which was predictable, as this interface 
between fibres and hydrogel was not present in those samples.  
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The IVN data in particular was instructive in elucidating the effect of the SAP delivery vehicle 
on nucleation behaviour, and has implications in terms of the future design of clinical tools and 
therapies. In short, these data reveal that even if the peptide contents are comparable, the format 
of the delivery vehicle, i.e. a hydrogel or a fibre, will affect the rate at which it becomes available 
for apatite nucleation. In a porous gel, the peptide is immediately accessible in the IVN method, 
whereas in a 3D electrospun fibrous matrix, access to peptide is slower because of its 
encapsulation within a water-stable PCL polymeric matrix through which it must gradually 
diffuse. For the building of therapeutic devices for the clinic, this ability to deliver SAPs over a 
longer period than is likely to be possible with hydrogels, is potentially advantageous. By 
selecting an appropriate synthetic polymer carrier, such as PCL or other biodegradable polymers, 
delivery rates can be modulated. This is in addition to the advantage of a more mechanically 
robust delivery vehicle, as provided by an electrospun format compared to a fully hydrated 
hydrogel. 
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6.4 Summary 
SEM, EDX and XRD analysis of the electrospun fibre webs incubated in SBF, revealed that 
PCL/SAPs fibres have considerable capability to nucleate hydroxyapatite and support crystal 
growth in vitro. This was evidenced by observed spheroidal growth of calcium phosphate 
crystals on the SAP enriched fibres in SEM micrographs. The EDX elemental analysis showed 
that the Ca:P ratios of the nucleated crystals on the PCL/P11-4 fibres from week one, were very 
close to 1.67 which corresponds to that of hydroxyapatite. PCL/P11-8 fibres displayed a Ca:P 
ratio of 1.65 after four weeks, which is comparable and very close to the stoichiometric Ca:P 
ratio for hydroxyapatite. XRD analysis also confirmed the diffraction peaks corresponding to 
hydroxyapatite crystals in both PCL/SAPs incubated fibres from week two. 
A washing process carried out after incubation of fibres in SBF and before any analysis to 
remove unwanted precipitations that can affect the crystal content, which may be due to the 
instability of the crystals formed on the surface of the fragile nanofibres in the webs. However, 
this effect can only happen in in vitro studies and when in vivo, the crystals have more time to 
crystallise and become stable while the whole scaffold is in situ.  
FTIR analysis of the fibres after incubation in SBF for one, two and four weeks confirmed the 
presence of SAPs within the fibres after four weeks, and even the presence of β-sheet self-
assembled structure was evident to some extent after two weeks, although some transformation 
to monomeric form had taken place as well.    
Within the constraints of the IVN tank system, enhancement in the mineral nucleation 
performance of electrospun fibres was confirmed when the SAPs are incorporated in them. At 4 
mg mL-1 SAP concentration, PCL/SAP fibre web mineral nucleation performance was 
comparable to that of SAP hydrogel. However, when the concentration of SAP was increased in 
the fibrous scaffold to 8 mg mL-1, the ability of fibres to nucleate minerals or support their growth 
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did not significantly increase. This may be due to the unchanged interface area of the fibres 
exposed to nucleation buffers and also the additional SAPs in the fibres not having sufficient 
time (within the 5 d test period) to be available at the surface to promote nucleation.  
The IVN tank assay may not have provided remarkable evidence to show the capability of 
nucleating hydroxyapatite in PCL/SAP fibre, however it does evidence one of the initial 
objectives of this study. The objective was to make SAPs more stable in biological conditions, 
by incorporation of the SAPs into PCL electrospun fibres. As indicated in Chapter 5, in an in 
vivo study by Burke et al. (53), SAP hydrogels will be diffused out by day seven when in 
biological conditions, which is insufficient time for bio-mineralisation to fully take place. Thus, 
in this study and specifically in the SBF assay, it has been established for the first time that 
nucleation and growth of hydroxyapatite can be further increased by at least four weeks, while 
the SAP remains stable and partially still in self-assembled form within the fibres.   
The unsuitability of the IVN tank method to characterise fibrous scaffold structures can be 
addressed by the following modifications to the method: 
 Increase in the incubation time beyond 5 d to facilitate the delivery of SAPs at the 
surface of fibres, and the creation of nucleation points. 
 The design of apparatus could be changed to increase the contact area between the 
nucleating buffer and the interface of the fibres.  
Both the SBF and IVN assays indicated that PCL/P11-4 fibres generally performs better than 
PCL/P11-8 fibres in terms of nucleation of hydroxyapatite and supporting its crystal growth     
in vitro, which is due in part to differences in the electrospun fabric structure produced by each. 
 184 
 
CHAPTER 7 
 
Conclusion 
7 Conclusions  
7.1 General Conclusions  
Electrospun webs are promising structures for use as bone tissue engineering scaffolds due to 
their small mean fibre diameter and high surface area to volume ratio, which mimic structural 
features of natural bone ECM. These characteristics together with high porosity and pore 
interconnectivity are beneficial for cell attachment, proliferation and nutrient transport. 
Additionally, if bioactive materials known to promote nucleation and mineralisation of HAP can 
be incorporated into such scaffolds then there is an opportunity to produced advanced devices 
capable of assisting with mineralisation and the repair of damaged bone. 
The self-assembling peptides P11-4 (-2 charge) and P11-8 (+2 charge) in the form of hydrogels 
have previously been shown be non-cytotoxic to human and murine cells as well as to enhance 
bone tissue regeneration and remineralisation. However, in clinical practice despite their 
inherent biofunctionality, there are number of challenges in using SAPs hydrogels because of 
their poor mechanical strength and lack of structural stability. This also complicates their 
handling and fixation during implantation, particularly in large load-bearing tissue defects. 
Whilst the biomineralisation properties of SAP hydrogels have been reported before, the 
incorporation of P11-4 and P11-8 peptides within synthetic electrospun fibres and their 
biofunctionality has not previously been reported in the literature. For the first time, this research 
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has demonstrated a means of delivering SAPs in a form that could extend the clinical uses of 
SAPs, by providing them in a novel format. 
As a carrier material, PCL is a low-cost, non-toxic, biodegradable polymer and FDA approved 
devices containing PCL have previously been used in the human body. PCL has shown promise 
in regenerative bone therapies, and as such, it was selected as a means of delivering the SAPs of 
interest during this research. The feasibility of incorporating P11-4 and P11-8 into electrospun 
PCL scaffolds was explored, together with the resulting biological and mineralisation properties 
of the resulting fibres.   
Initially, the production of electrospun fibres was investigated in Chapter 4 using a single 
spinneret needle electrospinning, and successful incorporation of P11-4 and P11-8 into PCL in a 
one-step manufacturing process was demonstrated. Firstly, a range of PCL concentrations in 
HFIP solution were examined to determine the optimum spinning solution. It was established 
that PCL at 6% (w/w) concentration, could be electrospun by governing process parameters, and 
smooth fibres, free from defects were produced. The smallest mean fibre dimeter was achieved 
using a 1 mL h-1 flow rate, a voltage of 20 kV and a tip to collector distance of 180 mm on an 
aluminium foil collector. SEM, TEM and CLSM analysis revealed a bimodal fibre diameter 
distribution of superimposed nano- (below 100 nm) and submicron (below 1µm) scale fibre 
networks of PCL/SAP fibres in contrast to the PCL control fibres, which were narrowly 
distributed and of submicron dimensions only. Adjusting the peptide concentration in the 
electrospinning solution was found to be the main parameter governing formation of the 
nanofibrous network and the nanofibres became more pronounced as the peptide concentration 
in solution increased from 10 to 40 mg mL-1. This was most evident in the case of PCL/P11-8 
fibres. This observation provides a useful means of systematically customising the internal 
nanoscale structure of the webs, which provides a convenient way of controlling nonwoven 
architecture at the nanoscale during scaffold manufacture.  
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The presence of SAPs within the as-spun fibres was then confirmed by SEM/EDX, while 
TEM/EDX on the PCL/P11-8 fibres revealed that both the superimposed nano- and submicron 
scale fibres contained peptides. This provided evidence that there was no phase separation 
between the PCL and the peptide components during electrospinning. Moreover, the uniform 
distribution of peptide within the fibres was investigated and confirmed by CLSM analysis. 
It was important to determine how the secondary conformation of the SAPs changed during the 
spinning process. Analysis of the spinning solutions and the as-spun fibres by CD and FTIR 
revealed a switch from monomeric to β-sheet peptide conformation, though the β-sheet 
configuration was more predominant in the PCL/P11-8 fibres compared to PCL/P11-4. These 
results confirmed that the electrospinning process was able to successfully trigger the molecular 
self-assembly mechanism in the peptides, therefore inducing nanofibre formation among the 
submicron fibres. 
Having successfully produced PCL fibres loaded with SAPs, the properties of the webs were 
further investigated. Scaffolds for bone tissue engineering must fulfil several criteria such as 
biocompatibility. Accordingly, the wettability and cytocompatibility of PCL/SAPs electrospun 
fibres were investigated. It was found that the hydrophilicity of PCL electrospun fibre webs in 
the presence of SAPs substantially increases. This was evidenced by measuring the contact angle 
of deionised water and DMEM on electrospun webs, which revealed a decrease from above 90° 
(hydrophobic) to 0°, when the peptide concentration in the electrospinning solution increased 
from 0 to 40 mg mL-1.  
Although there have been many studies confirming the cytocompatibility of 100% electrospun 
PCL fibres, none have considered extract cytotoxicity in the presence of P11-4 and P11-8 peptides. 
A preliminary experiment determined no toxic response in L929 cells cultured with PCL/SAPs 
electrospun sample extracts, although the cell viability in PCL/SAPs extract was slightly reduced 
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compared with the PCL control sample. It was reasoned that this could be due to peptide 
disassembly into monomeric form in aqueous solution during the extraction time which affects 
the metabolic activity of L929 mouse fibroblasts. Therefore, the direct cytotoxicity assay was 
conducted whereby L929 mouse fibroblasts were cultured in contact with PCL/SAPs electrospun 
fibres. This provided additional confirmation that the peptide loaded samples had no cytotoxic 
response (<90% cell viability) and the data confirmed that the PCL/SAPs fibres have potential 
as candidates for use as bone tissue scaffolds. 
It is an important requirement for bone tissue scaffolds to maintain a stable structure, while the 
newly regenerated tissue can be formed and bone crystal mineralisation can take place. One aim 
of this study was to improve the stability of biofunctional SAPs when they are in a biological 
environment, by incorporating them into PCL scaffolds, as compared with their hydrogel 
structure. Therefore, a seven-day degradation study of the PCL/SAPs fibres was conducted in 
aqueous solutions at different pH. The percentage release of SAPs from PCL fibres was detected 
via mass loss analysis and it was demonstrated that at least 40% and 65% of the P11-8 and P11-4 
respectively, are still available and stable within the electrospun fibres after 7 d. This was the 
case even at the least favourable pH for SAPs structural stability, at which their transformation 
to monomers can take place.  
Using CD analysis, it was confirmed that the mass loss percentages were associated with peptide 
release into solution and not associated with PCL component degradation. At pH 7.5, which is 
close to biological pH, at least 75% of P11-4 and 45 % of P11-8 was still present within the fibres. 
This suggests that fibres containing SAPs could provide vehicles for delivery of the peptide over 
a longer period than is possible when they are delivered in the form of hydrogels. The difference 
in retained SAPs for the P11-8 and P11-4 peptides, could be partially explained by differences in 
the dimensions and morphology of PCL/P11-8 fibres, which influences the length of the diffusion 
pathway. In the larger PCL/P11-4 fibres, most of the SAPs are encapsulated within the submicron 
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fibres and therefore they will be slower to release than would be the case from the large number 
of nanoscale fibres present in the PCL/P11-8 webs. Interestingly, in the degradation study, the 
morphology of the fibres remained essentially unchanged suggesting that the PCL was stable 
and that the diffusion of the peptides did not cause structural instability in the web. This also 
provides further evidence that the nanoscale fibres in the webs were not composed entirely of 
peptide, but rather a commixture of both PCL and peptide. By further analysis of the SEM 
images, an increase of 25% in diameter of the PCL control fibres and a 90-115% increase in the 
diameter of the PCL/SAP fibres was observed. This was due to water uptake during hydrolysis 
and the fact that the PCL/SAP fibres are more hydrophilic compared to the PCL fibres, thereby 
promoting swelling.   
The apatite-forming ability of electrospun PCL/ SAPs fibres was then assessed to determine their 
suitability to promote mineral nucleation and support their subsequent growth. Firstly, the BS 
ISO 23317:2014 standard method was employed to determine if PCL/SAPs webs are able to 
nucleate HAP minerals. After incubation in SBF, spheroidal growth of calcium phosphate 
crystals confirmed considerable capability of PCL/SAPs fibres to nucleate and further grow HAP 
in vitro, compared with PCL only fibres. The Ca:P ratios of the nucleated crystals on the 
PCL/P11-4 fibres were very close to that of hydroxyapatite from week one, whereas the PCL/P11-
8 fibres displayed the relevant Ca:P ratio to HAP after four weeks. XRD analysis also confirmed 
the diffraction peaks corresponding to hydroxyapatite crystals in both PCL/SAP incubated fibres 
from week two.  
The stability of SAPs and their ability to remain within the fibres after four weeks incubation in 
SBF and even to remain in the β-sheet self-assembled form until after two weeks was evidenced 
via FTIR analysis. Moreover, the IVN tank method was used to determine apatite forming ability 
of PCL/SAP fibres and to determine whether their ability is comparable to hydrogel structures 
of the same SAP concentration. IVN tank studies had never previously been attempted using 
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fibre-based materials of the type produced in this research. Initial experiments with the IVN 
system revealed enhancement in the mineral nucleation performance of electrospun fibres when 
the SAPs are incorporated in them. At 4 mg mL-1 SAP concentration, PCL/SAP fibre 
performance was comparable with SAP hydrogel of the same concentration. However, when the 
concentration of SAPs increased in the electrospun webs to 8 mg mL-1, the ability of fibres to 
nucleate minerals or support their growth was not significantly increased compared to that of 
hydrogels. This was explained in terms of the accessibility of the peptides within the fibres, prior 
to their diffusion from the fibre surfaces or availability at the surface, when exposed to nucleation 
buffers. Since the duration of the assay did not exceed five days, the additional SAP present in 
the fibres did not have sufficient time to become available at the fibre surfaces to promote 
nucleation.  
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7.2 Recommendations for Further Work 
To further understand the incorporation of P11-4 and P11-8 peptides into fibrous structures and 
provide greater understanding of their performance in biological environments and in nucleation 
of bone minerals and regeneration, the following additional areas of study can be identified: 
- Use of different solvent systems in electrospinning, to stablish the morphological 
characterisation of SAP enriched fibres and to see whether or not similar bimodal fibre 
diameter network are produced in different solvent systems when the SAPs are present.  
- Use of different spinning techniques, which are not reliant on electrostatic forces such as 
force-spinning or wet-spinning to give further insight into the fibrous morphology and 
incorporation properties of SAPs into polymeric fibres. 
- The peptide release study provided herein was conducted for only up to 7 d. This was mainly 
to understand stability of the SAPs in the aqueous solution at a particular pH. Clinically, 
bone tissue scaffolds could be used in vivo for up to nine months or more in spinal fusion or 
three to six months for cranio-maxillofacial applications, until the newly bone tissue is 
grown. Ideally, the bioactive component (SAPs in this study) should not be diffused or 
depleted too quickly, while the polymer carrier component (PCL in this study) should be 
degraded by this time. Therefore, a thorough degradation study of the scaffolds produced in 
this work could be employed in aqueous solution with an ion concentration close to that of 
body fluid (i.e. in cell culture medium), and based on the results, the suitability of the scaffold 
for use in specific bone applications can be identified.  An enzymatic degradation of the SAP 
enriched fibres could be valuably explored to determine the effect of enzymes on the 
degradation profile of fibres, to reach to a more robust estimation of the scaffold degradation 
profile under simulated biological conditions.  
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- Further to the degradation profile, electrospinning of alternative polymer systems, which 
have potential to offer different degradation rates, enriched with SAPs, would be of interest 
in future studies to assist in customising the design of the scaffold for clinical use. 
- Working with different concentrations of SAPs in electrospinning solutions may also provide 
a route to identify optimum concentrations of SAPs (min and max) needed to achieve certain 
fibre morphologies and to meet the intended biofunctionality (e.g. apatite forming ability of 
fibres in SBF). 
- The current study provided a novel analysis of PCL/SAP fibres webs in the IVN system, and 
the minerals nucleation performance has been demonstrated. There is scope to further 
develop this method in order to be more compatible with fibrous rather than hydrogel 
structures. For example, since the encapsulated SAPs in fibres are more slowly released into 
the surrounding solution, a longer period is required for the assay, so that the SAPs can 
gradually become available as nucleation points. Moreover, the sample holders in the 
apparatus can be redesigned to provide more contact area at the interface of the fibres with 
nucleating buffers.    
- Tensile testing of PCL/SAP fibres can be carried out in future studies to provide a useful 
insight into the mechanical properties of the scaffolds. This would further help in defining 
the suitability of these scaffolds for clinical bone tissue regeneration.   
- Ultimately, evaluation of the PCL/SAP fibre webs in a bone remineralisation in vivo model 
would be instructive by implantation into rat/rabbit calvaria defects. 
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